Irish PharmaChem 2008

Irish Pharmachem Cover

25/09/2008

17:26

Page 1

Fisher Scientific Ireland IRISH PHARMACHEM

celebrates a successful first year

BUYERS GUIDE 2008

ONE SOURCE. INFINITE SOLUTIONS.

I N A S S O C I AT I O N W I T H P H A R M A C H E M I C A L I R E L A N D

Pharmachem08_w210xd297

6/6/08

10:47

Page 1

ib

t i o n . Vi s i b

le Su cce

s Invi

o le C

ib u r t n

ss.

Invisible Contribution – Our new plasticiser plays a crucial role in many innovative products. Providing vital flexibility to the plastic tubing essential for safe medical devices that sustain even the smallest patients.

Visible Success – Working closely with customers in many industries, we develop and optimise solutions.

The results of these partnerships are worth seeing.

Improved processes and increased quality contribute to the success of our customers. And a better quality of life for us all. www.basf.com/more

Contents

25/09/2008

16:23

Page 1

FOREWORD Dr Jimmy Devins TD, Minister for Science, Technology and Innovation, on the Government's mission to keep Ireland at the top of the league table for the pharmaceutical industry well into the 21st century . . . . . . . . . . . . . . . . . 3

threat to European patients’ health, writes Ronan Collins, Communications Manager, IPHA . . . . . . . . . . . . . . . . 39

SECTOR OVERVIEW Matt Moran, PharmaChemical Ireland, reports on the results of a new study into the pharmachem sector in Ireland . . . . 5

SCIENCE FOUNDATION IRELAND The vital role of Science Foundation Ireland in delivering on the Government’s Strategy for Science, Technology and Innovation. . . . . . . 23

BIOTECHNOLOGY Michael Gillen, Senior Executive, PharmaChemical Ireland, on how Ireland is building a world class biotechnology industry . . . . . . . . . . . . . . . . . 8

LABORATORIES The recently launched ‘Labs are Vital’ programme will promote the work of Ireland’s 3,000 laboratory professionals . . . . . . . . . . . . . . . . 26

MEDICAL DEVICES AND DIAGNOSTICS Sharon Higgins, Director of the Irish Medical Devices Association (IMDA) writes on the development of the sector, both in Ireland and globally . . . . . . . . 11

PHARMACEUTICAL INGREDIENTS Univar Pharma Ingredients is a world leader in pharmaceutical and chemical distribution, and its new site at Rathcoole, Co. Dublin, sets the standard for its European operations . . . . . . . 28

FINE CHEMICALS A new set of voluntary guidelines for the manufacture of fine chemical intermediates and active ingredients. . . . . . . . 15 COVER STORY In June 2008, Fisher Scientific, part of Thermo Fisher Scientific, celebrated a successful first year in Dublin, offering a new level of service when it comes to laboratory supplies. . . . . . . . . . . . . . 18 RESEARCH & DEVELOPMENT Europe is beginning to lose out to the US and Asia in R&D terms, according to Ronan Collins, Communications Manager, IPHA . . . . . . . . . . . . . . . . 21

ACCREDITATION AND STANDARDS The important work of the Irish National Accreditation Board (INAB) . . . . . . 31 SUPPLY CHAIN Edward Sweeney, NITL, writes on enhancing shareholder value in the Pharmaceutical industry: the supply chain dimension . . . . . . . . . . . . . . . . 32 PROCESS ANALYTICAL TECHNOLOGY Process Analytical Technology (PAT) will revolutionise the way pharmaceuticals are made, according to ABB . . . . . . . . . . . 34 COUNTERFEIT MEDICINES Counterfeit medicines pose a growing

PUBLISHED BY: TARA PUBLISHING CO. LTD.

T A R A

1/2 Poolbeg Street, Dublin 2. Tel: 241 3095 Fax: 241 3010 Email: kathleenbelton@tarapublishingco.com ISDN: 01 241 3050

Managing Director: Fergus Farrell Editorial and Marketing Director: Kathleen Belton Editorial: John Walshe Advertising Executives: Steven Larkin, David Kelly Design and Origination by: Rooney Media, 2(B) Ormond Lane, Ormond Road, Drumcondra, Dublin 9 Printed by: Graham & Heslip

1

TRACEABILITY The EPC Global Network is a technology solution for its time, with proven benefits for the healthcare sector, according to Jim Bracken, Chief Executive Officer, GS1 Ireland. . . . 40 PACKAGING Goliath Packaging Systems Ltd sources, supplies, installs and offers after-sales service on a comprehensive range of endof-line packaging, materials handling, and washing equipment. . . . . . . . . . . 42 CLINICAL TRIALS According to a new report from Datamonitor, the paperless clinical trial could be far closer than you think....46 RECRUITMENT The pharmaceutical and chemical sector is coping well, despite troubled economic conditions, according to Berkeley Recruitment . . . . . . . . . . . . . . . . . . . 47 ECONOMIC OUTLOOK There may be some belt-tightening ahead, but Ireland has the economic and cultural characteristics to ride out the current storm . . . . . . . . . . . . . . . . . . 49 LISTINGS Chemical Suppliers . . . . . . . . 51 General Suppliers . . . . . . . . . 53 Company Listings . . . . . . . . . 61 Useful Refernces . . . . . . . . . . 76 Irish Pharmachem 2008 gratefully acknowledges the assistance of PharmaChemical Ireland in the production of this publication.

Every effort has been made to ensure the accuracy of the information contained in this publication, but the publisher cannot accept responsibility for errors or omissions.

Project3

25/09/2008

15:50

Page 1

Reliable? More reliable!

Diagnosis and condition monitoring Process reliability included!

Festo Ltd. Unit 5 Sandyford Industrial Estate Dublin 18 Phone 01 207 55 91 Fax 01 295 56 80 sales_ie@festo.com www.festo.com/ie

Foreword

18/09/2008

16:08

Page 1

MINISTER’S FOREWORD

LIFE SCIENCES SECTOR FLOURISHES IN IRELAND

A

s Minister for Science, Technology and Innovation, I am very pleased to contribute to the 2008 Irish PharmaChem Industry Buyers

Science, Technology and Innovation. Our overall target is clear – Ireland by 2013 will be internationally renowned for the excellence of its research and will be at the forefront in generating and using new knowledge for economic and social progress, within an innovation driven culture.

Guide.

Yours is an extremely important industry and one that has enjoyed extraordinary success in Ireland, particularly over the past two decades.

Global pharmaceutical revenues from prescripA HEALTHY RESEARCH CULTURE tion drugs stand at over $600 billion, with forecasts that the total pharmaceutical market will We are committed to delivering significant expand at a compound growth rate of up to 8% increases in research capacity, quality and output. in the next five years. By 2010, the market is foreThis will be accompanied by increased levels of cast to reach a value of $800 billion, well on the investment in our Higher Education Institutions, way to an astonishing trillion dollar business. combined with renewal and reform. World-class Dr Jimmy Devins TD, Ireland is very fortunate to have a major slice Minister for Science, Technology research teams will be built and our output of and Innovation. of this enormous market and to have shared in PhDs will be almost doubled by 2013. the substantial growth and success of the indusOf course, a healthy research culture has to try in recent years. The facts speak for themselves: we are the involve companies themselves as active participants. The stratnumber one location in Europe for life sciences, enjoying 48% egy is clear about the types and levels of support that must be of the market share in 2004; 13 of the top 15 pharma compagiven to the most significant drivers of our economic wellnies have operations in Ireland; our pharmaceutical exports being, namely manufacturing and internationally-traded seramounted to €32 billion in 2005; we have 40,000 workers vices firms. employed in life sciences, including 18,000 in pharmaceuticals, While different challenges face enterprises in both sectors, and we have 33 FDA approved sites. we will bring about a transformational change to company attiOf course, the success of the pharmaceutical industry in tudes to R&D through our development agencies. We will Ireland did not occur by chance. Successive Irish governments grow business expenditure on R&D to €2.5 billion by 2013 have worked over many years to create the conditions, the infraand this achievement will be very much in line with the terms structure and the business friendly environment necessary to of the EU’s Lisbon goals that will place Ireland in the vanguard encourage foreign direct investment in this area, which has of countries addressing ‘knowledge’ issues. always been viewed as a major source of employment and exports for Ireland.

EXPANDING HORIZONS

ADDING VALUE

TO THE INDUSTRY

These are remarkable times both for our country and for your industry. Our horizons are expanding continuously as we regularly break out through the boundaries of our previous expectations. However, we must avoid complacency and strive to keep pressing forward relentlessly in order to maintain our competitive advantage.

Our commitment to major expansion of our research and development base under our Science and Technology strategy, our low level of corporation tax, our well educated workforce and our wholehearted EU participation will all be harnessed to keep Ireland at the top of the league table for the pharmaceutical industry well into the 21st century.

Having secured substantial manufacturing capacity, as I have already mentioned, Ireland must now turn to the value-added side of the industry. We can justifiably take pride in our achievements in this regard. What is particularly satisfying is the growing level of research and development taking place in this industry, particularly in the areas of process development, formulation development and drug discovery development. This is an essential complementary component to the manufacturing process and one that will help to underpin and secure the future of the industry in Ireland in the face of growing competition from other international marketplaces.

As you know, in Government, we continue to put research and development centre-stage through our Strategy for

Dr Jimmy Devins TD, Minister for Science, Technology and Innovation.

3

Smurfit Kappa

23/09/2008

11:46

Page 1

Sector Overview

18/09/2008

16:18

Page 1

SECTOR OVERVIEW

INDUSTRY FOCUSES ON OPERATIONAL EXCELLENCE Matt Moran, PharmaChemical Ireland, reports on the results of a new study into the Pharmachem sector in Ireland, which identifies areas which needed to be addressed in order to ensure the continued development of this key sector.

S

ince the first pharmachem companies were established in Ireland in the 1960s, the sector has continued to grow in prominence, to the point where it now accounts for over 45% of Ireland’s total exports, with goods worth over €41.7 billion exported in 2006. This phenomenal success story has ensured that Ireland is now firmly established as a preferred location for the major international pharmaceutical and life science companies. The substantial investments made by international pharmaceutical companies in Ireland can be measured by a recent study by the IDA, which estimated the replacement value of the sector to be approximately $40 billion.

The environment in which these companies are operating is now presenting a number of challenges. The issue of upward pressure in non-pay related costs has been exacerbated by increased global competition. In addition, regulatory requirements are becoming more stringent. Taken in combination, these and other factors necessitate a new approach to manufacturing processes.

It was against this background that PharmaChemical Ireland, in conjunction with Enterprise Ireland, Forfás and the IDA, commissioned a study on the industry in Ireland, to identify those areas which needed to be addressed in order to ensure the continued development of this key sector.

GLOBAL INFLUENCES

ON THE

Matt Moran, PharmaChemical Ireland.

The industry in Ireland will not be immune to these pressures and, in facing these challenges, it is imperative that it remains competitive and demonstrates its ability to deliver value to the industry.

SECTOR NEW TECHNOLOGIES

In response to a major upheaval in the global healthcare industry, driven by a combination of factors, leading international companies are examining how best to maintain and optimise earnings from their existing product portfolios. The factors driving the change are affecting businesses to varying degrees and include: • • • •

In response to the pressures outlined above, the industry is turning to new technologies, including the manufacture of drugs through bio-technology and expansion into the development of new and more effective drug delivery systems.

These new developments will be important for the pharma manufacturing sector in Ireland and several companies have made major investments in recent years both in primary biotech, as well as in fill and finish operations.

Such development requires the highest levels of good manufacturing practice, as defined by regulatory agencies, as well as the availability of scientists and engineers with cutting-edge education and skills. In both of these key areas,

The lack of a steady stream of new products entering the market / weak new product pipelines; Competition between established brands coming off patent and generic drugs; Increased cost pressure from healthcare providers; Over-capacity in manufacturing networks.

5

Sector Overview

18/09/2008

16:18

Page 2

SECTOR OVERVIEW

CGMP

COMPLIANCE

The industry track record on cGMP inspections with the IMB, FDA and customer audits is world class and the competencies of the companies in this area gives Irish companies a key competitive advantage against industries in other regions around the world.

No pharmaceutical manufacturing site in Ireland has received a warning letter from a regulatory body in the past 10 years, which is an exceptional record. In a US study of 45 sites (manufacturing APIs, injectables, oral and topical grade pharmaceuticals) between 1999 and 2003, 12 sites (27%) were found to have received warning letters or operated under consent decree.

Ireland has a superb track record that continues to underpin the attraction of future foreign direct investment to this sector of the Irish economy.

BENCHMARKING METHODOLOGY Unlike the electronic and automotive industries, benchmarking has only recently been adopted by process industries, including pharmaceuticals. This study undertook a comprehensive examination of chemical and pharmaceutical manufacturing and support processes in 30 sites around the country. The major objectives of the exercise were to: • Enable sites to position themselves against best practice and thus facilitate learning and improvement; • Identify how Government policy can help resolve issues affecting business performance; • Internationally benchmark the competitiveness of Irish sites.

CUSTOMER SERVICE In the area of customer service, as defined by number of ontime sales, and results of customer inspections and level of customer complaints, it is clear again that the industry in Ireland is achieving benchmark standards. As with compliance, the challenge to the industry here is to adopt new and innovative processes to maintain this level of customer service while lowering the cost base.

A task force was established comprising PharmaChem Ireland, IDA, Forfás, Enterprise Ireland and McKiernan Associates to direct and oversee the project. An important aspect of the study was the identification of comparable benchmarks of international Pharma sites. A number of sources of such data were found. These are listed in Appendix 2.

The exercise was overseen and directed

by Jim McKiernan of McKiernan Associates, based in Basel, Switzerland (www.mckiernan.ch)

DETAILED STUDY FINDINGS: THE COMPETITIVENESS OF PHARMA IRELAND Table 1 summarises the main findings of the study. Irish sites fared particularly well in the two key areas of cGMP compliance and customer service: in fact, Irish sites could be said to be setting the global benchmark standard in these areas.

6

Sector Overview

18/09/2008

16:18

Page 3

SECTOR OVERVIEW

Sources: 1

2

3

0

Operational Excellence in the Pharmaceutical Industry, February 2006, Friedli et al, University of St Gallen & APV, Editio Cantor Verlag Benson & McCabe, Pharmaceutical Engineering, July/August 2004 Pharmaceutical Manufacturing Research Project, December 2005. Georgetown University, Washington DC & Washington University in St Louis, Missouri Benchmarking in the Process Industries, 1999, Ahmad & Benson, I Chem E

Appendix 1 Participating Sites

THE NEXT PHASE Though the overall performance of the sector is strong, areas for improvement were identified. An output of the study has been the establishment of a full time operational excellence working group within PharmaChemical Ireland. This group has identified a list of areas for improvement and is now setting about bringing the entire industry up to identified best practice within the sector.

As far as can be determined, this is the first example in the world of a benchmarking exercise being conducted on a national pharma sector. PharmaChemical Ireland believes strongly that the outputs and actions driven by the study will help to copper-fasten the relative competitiveness of the Irish pharmachem sector well into the future.

SUMMARY

AND

NEXT STEPS

This study was intended to form the framework for a plan for the future development of the industry, and to serve as a specific source of information for the individual companies, assisting them in their efforts to achieve the highest standards.

In conclusion, it is clear that Ireland remains a leading location for the manufacture of pharmaceuticals and chemicals. Even while this sector globally is under severe cost pressures, the industry in Ireland can use its proven track record of success to build a platform for sustainability and future development.

It is clear that to be successful in this endeavour will require a fully-integrated approach, with the involvement of all partners, including the sponsors of this report, the Government and educational institutions. This will be necessary to secure the future of those companies already established in Ireland and to project the image of Ireland as the preferred location for the chemical and pharmaceutical industry.

Appendix 2 International Benchmarks 1. Pharmaceutical Manufacturing Research Project, December 2005. Georgetown University, Washington DC & Washington University in St Louis, Missouri 2. Operational Excellence in the Pharmaceutical Industry, February 2006, Friedli et al, University of St Gallen & APV, Editio Cantor Verlag 3. Benchmarking in the Process Industries, 1999, Ahmad & Benson, I Chem E 4. Benson & McCabe, Pharmaceutical Engineering, July/August 2004

7

Biotechnology

18/09/2008

14:53

Page 1

BIOTECHNOLOGY

GROWING THE IRISH BIOINDUSTRY Michael Gillen, Senior Executive, PharmaChemical Ireland, on how Ireland is building a world class biotechnology industry.

T

he biotechnology industry has found a natural home in Ireland. The establishment of the Irish BioIndustry Association in 1998 coincided with a period of unprecedented investment by the Irish government. A series of Technology Foresight reports in the late 1990s recommended that: “the government must immediately invest, on a realistic scale, in a co-ordinated biotechnology programme, which builds strong links between universities, industry, agriculture and the financial services sector.”

Since then, Ireland has created a highly structured supportive environment that provides the right conditions for encouraging strategic investment in innovation, research and development and commercial success in the biotech sector.

Under the Strategy for Science Technology and Innovation Programme (SSTI), the Irish Bio-technology industry will benefit from funding of more than €1.3 billion.

3.

BIOTECH IN IRELAND Biotechnology will increasingly influence pharmaceutical research and manufacturing; agriculture, food production and safety; industrial processes and the environment. It will become an integral part of the industries that represent the backbone of Ireland’s new economy.

Over recent years, major biologics investments have been won by Ireland. The largest included Wyeth, Eli Lilly, Pfizer, Centocor and Merck Sharp & Dohme. These projects have included both large molecule and cell based vaccines plants.

The projects have been focused upon both development and manufacturing, which is proving to be a key competitive competence of Ireland. Industry trends in the direction of personalised, predictive and preventive medicine support the strategic positioning of Ireland in terms of building out the complete industry value chain and focusing from discovery through process development and manufacturing to regulatory and full commercialisation.

4.

BUILDING THE IRISH BIO-ECONOMY Putting in place the infrastructure to support this development has been a national priority over the last decade. Significant progress has been achieved consequently, and includes: • Science Foundation Ireland (SFI) which was established 8

in 2000 with responsibility to invest €1.4 billion, which has been allocated for scientific research as part of the National Development Plan (2007-2013) and the Strategy for Science, Technology and Innovation (2006-2013). SFI has already invested over €100m in the establishment of research Centres for Science Engineering and Technology (CSET’s). These include: 1.

The Biomedical Diagnostics Institute (BDI) in Dublin City University, which specialises in the development of next generation biomedical diagnostic services.

2. The Alimentary Pharmabiotic Centre in University College Cork, which focuses on the discovery, development and commercialisation of proprietary products for the treatment of gastro-intestinal disorders and other inflammatory conditions.

The Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN), based in Trinity College Dublin, is an internationally recognised centre of excellence in nanoscience where there is a convergence of the disciplines of biology, chemistry and physics.

The Regenerative Medicine Institute (REMEDI), based in the National University of Ireland, Galway, is developing gene therapy to promote tissue repair and is currently working in cooperation with Medtronic Inc, a world leader in medical devices, currently focusing on cardiovascular disease.

Biotechnology

18/09/2008

14:53

Page 2

BIOTECHNOLOGY

new bio-companies include: Merrion Pharmaceuticals, Opsona, Trinity Biotech, Biotrin.

A strong and innovative R&D environment is attracting internationally recognised researchers; five new biotechnology research centres and institutes have been established; and the number of researchers employed has risen dramatically in line with investment. Strong links between industry, higher education, state agencies, research institutes and government are facilitating rapid sustainable development.

BIOPHARMACEUTICALS IN IRELAND •

Enterprise Ireland (EI), the Irish development agency whose focus is on accelerating the development of Irish companies, has established EI Bio, which is a specialised Biotechnology Commercialisation Group that supports the commercialisation of applied bioresearch into technologies. Since 2005, EI Bio has invested in excess of €15m in new biotechnology projects.

•

NIBRT (National Institute for Bio-processing Research and Training) is a world-class institute supporting the development of the bioprocessing industry in Ireland. The institute is based on collaboration between University College Dublin, Trinity College Dublin, Dublin City University and the Institute of Technology Sligo, and provides training and specialist research for the bioprocessing industry. NIBERT is funded by the IDA.

•

The Industrial Development Authority (IDA) has been particularly successful in attracting substantial investments into Ireland from global biopharmaceutical companies including Wyeth, Schering Plough, Genzyme, Elan, Gilead, and Pfizer.

Many of the pharmaceutical companies in Ireland have established a number of significant operations. For example, Wyeth’s new development is one of the largest integrated biopharmaceutical campuses in the world and is the only facility in Europe to manufacture biopharmaceuticals, pharmaceuticals and vaccines within the same facility. Wyeth’s new facility in Grangecastle, Co. Dublin, produces Enbrel, which is a leading biologics blockbuster. The project is Wyeth’s largest capital investment globally.

Elsewhere, Centocor (J&J) has completed the construction in Ringaskiddy, Co. Cork, of its new biologics launch facility. This is also the largest capital investment ever undertaken by J&J, as part of a major global biotech investment plan.

Eli Lilly is building a new facility in Kinsale, Co. Cork which will be central to its corporate plans.

Merck Sharp & Dohme are setting up a human vaccines and biologics facility in Carlow. The plan includes a formulation and sterile filling operation as well as an R&D facility to support a number of recently launched vaccines.

Gilead has acquired Nycomed in Cork and is backward integrating into full scale manufacturing.

Other organisations have as many as six manufacturing operations in the country. Nine of the top ten Global Pharma companies have operations in Ireland and 6 of the top 10 global drugs are manufactured here. 33 Irish based plants are approved by the FDA. Indeed, altogether Ireland has 170 companies employing some 35,000 people in the pharmaceutical, biopharmaceutical, medical devices and diagnostic sectors.

INNOVATION DRIVEN CULTURE The vision and objective of the Irish Strategy for Science, Technology and Innovation is to achieve international renown for the excellence of its research, and to be at the forefront in generating and using new knowledge for economic and social progress within an innovation driven culture.

The Health and Life Sciences sector is integral to realising this objective and is central to Ireland’s National Development Plan (2007-2013), the key strategy for sustaining Ireland’s economic growth and contributing to the overarching objective of the renewed Lisbon Agenda to make Europe the most competitive and the most dynamic knowledge-based economy in the world.

CREATING THE FUTURE It is not easy to identify an area of modern scientific research and discovery that does not or may not in the future include some aspect of biotechnology. It has been suggested by some experts, for instance, that by 2020, as much as 50% of all pharmaceutical products will incorporate some aspect of biotechnology.

Ireland is fully committed, focused and well on the way to achieving its primary goal of becoming a centre for worldclass research, a knowledge-based economy and a global hub for the biotechnology industry. The results achieved so far are impressive. The environment and culture for business in Ireland is progressive and is characterised by a ‘can do’ attitude. Biotechnology has much to offer the world; and Ireland has much to offer biotechnology.

SUBSTANTIAL INVESTMENTS Recent substantial investments in Biopharmaceuticals in Ireland by Global companies include: Wyeth; Schering Plough; Elan; GeneMedix; Genzyme; Gilead; Pfizer; Merck Sharp &Dohme and Allergan. At the same time, Ireland is growing new indigenous biopharma biotechnology industry 9

Medical Devices

18/09/2008

15:09

Page 1

MEDIC AL DEVICES AND DIAGNOSTICS

BRIGHT FUTURE FOR MEDICAL DEVICES Sharon Higgins, Director of the Irish Medical Devices Association (IMDA), reflects on the industry in Ireland and globally, and reports on IMDA’s strategy for future growth.

I

reland’s medical devices and diagnostics sector is a significant contributor to the Irish economy, in terms of exports, direct employment and indirect employment. The industry accounts for the export of goods worth over $6 billion annually and employs 24,000 people directly and many more indirectly. Many of the world’s top medical technology companies have invested significantly in Ireland and a number of exciting, research based, indigenous companies are emerging and competing internationally.

This industry globally is set to grow and Ireland will continue to be a key player. People everywhere want to live longer, healthier more fulfilled lives. Every single day, thousands of Irish-made products are used around the world to diagnose disease and alleviate pain. Advances in technology enable earlier detection and offer new, more effective treatment options for diseases such as cancer and heart failure. Prevention, diagnosis and treatment of diseases are more closely linked than ever before to offer highly focused, individualised patient care programmes.

Devices and diagnostic products are becoming ever smaller, smarter, less invasive, simpler to use and more patient-friendly. More and more devices and diagnostic products are developed for home use, such as defibrillators and HIV testing kits. Medical technology products are increasingly complex, using new materials and combinations.

The Irish medical devices and diagnostics industry is extremely innovative. While increasing costs are certainly worrying, we believe that Ireland’s strength lies in its highly skilled labour force and in its ability to take a product through the development process and to take production to a level where that product can be supplied globally. The skills required to successfully achieve this should never be underestimated and are rarely found in other locations, giving Ireland a true competitive edge.

the process of developing innovative products, from research and marketing, right through to production.

Following intensive research and consultation, IMDA launched our 2008-2011 Strategy in February 2008. This strategy supports the existing manufacturing base and lays out a framework to leverage this base in order to attract greater levels of research and development and marketing to this country. The strategy promotes integrated thinking, calling upon the industry to work together and to think strategically, in order to ensure that Ireland remains the location of choice for R&D, manufacturing and marketing of highly innovative products and services. The four pillars are: Manufacturing and Operational Excellence: Sustain the manufacturing base and continue to grow investment in operations by delivering higher value to investors than that available in competing locations globally.

Innovation, Research, Development and Commercialisation: Exploit innovation and R&D opportunities in the medical technology sector by nurturing strong interdisciplinary and cross-sectoral collaboration, and thereby maximise the potential for commercialisation within Ireland.

CHANGING GLOBAL MARKET

Shared Services: Increase the value generated in medical technology companies operating in Ireland by attracting significant levels of shared services investment.

Without doubt, the global market is changing and Ireland must adapt to those changes by leveraging the skills that we possess and using these to create an environment that cannot be rivalled. We believe that it is vital that the manufacturing base is not only sustained but helped to grow. To do so, we must lengthen the existing value chain to create an environment in which companies can go end-to-end with

Skills and Knowledge: Continue to develop the sector’s highly educated talented 11

Soltec

26/09/2008

09:52

Page 1

Medical Devices

23/09/2008

16:30

Page 2

MEDIC AL DEVICES AND DIAGNOSTICS

workforce, which is key to meeting the future needs of the rapidly changing global industry,

IMDA STRATEGY The IMDA works to represent and support this industry and does so in a strategic manner. We believe that our strategy 2008-2011 will enable the medical devices and diagnostics sector to develop and grow in a manner consistent with the development of the global industry and that as a result, Ireland will retain its position as a world leader in the medical technologies sector.

With the framework in place, it is up to those active in the medical devices and diagnostics sector to work together to deliver the objectives of this strategy.

Co-ordinated, open-minded thinking will be the key to ensuring that Ireland not only keeps pace with best practice but creates unique attractions for foreign investment and enables indigenous industry to grow to international level.

expertise of the industry and academic base in Ireland to identify areas where Ireland can succeed in the future.

The final report will be published shortly.

IMDA has lobbied to improve the clinical trials infrastructure in this country in order to provide a lengthened value chain. We have achieved some success in this area and will continue to work to improve access to clinicians and to develop linkages between clinicians and industry.

One of the most high profile successes was the first joint Irish Medical Device Association (IMDA) & Association of Biomedical and Clinical Engineers (BEAI) forum, aimed at developing new products to benefit patient care globally. Hosted by Cork University Hospital, engineers from the medical technology industry and hospital based engineers came together to discuss how to enhance collaboration, increase potential for product development, improve patient care and improve product commercialisation activity.

The IMDA works to represent and support this industry and does so in a strategic manner. We believe that our strategy 2008-2011 will enable the medical devices and diagnostics sector to develop and grow in a manner consistent with the development of the global industry and that as a result, Ireland will retain its position as a world leader in the medical technologies sector.

With the framework in place, it is up to those active in the medical devices and diagnostics sector to work together to deliver the objectives of this strategy.

Co-ordinated, open-minded thinking will be the key to ensuring that Ireland not only keeps pace with best practice but creates unique attractions for foreign investment and enables indigenous industry to grow to international level.

KEY SECTOR INITIATIVES ForfĂĄs, on behalf of the Expert Group on Future Skills Needs published a report examining the trends and drivers of change in the industry, which will have the greatest impact on future skills needs over the period of 2007-2013.

Specific recommendations include the establishment of a Medical Device Manufacturing Centre of Excellence; increase involvement by clinicians in medical device innovation; and introduction of programmes, which bring together mechanical, electronic and biosciences technologies. IMDA is actively working with stakeholders to ensure that the recommendations are implemented efficiently and effectively.

The IMDA Manufacturing Excellence Skillnets programme in Operational Excellence has been developed with FĂ S support to create a training programme that will up-skill operatives to FETAC level-5, with minimal disruption to operations. Delivered through blended learning, the programme minimises costs to the companies by delivering the training to several companies at once. This programme puts operatives on the path to life-long learning and creates a measurable and standardised training.

Enterprise Ireland commissioned a study (supported by IMDA and the Medical Technology Council), to develop a technology roadmap outlining opportunities for the medical technology sector in Ireland in the medium term (five to 10 years hence). This study aims to identify current global trends in the market place by reviewing patents and mergers and acquisitions, utilising data therein as a source of information on technologies and their applications. That data is then being cross-referenced against the skills and 13

Graham Heart 12

23/09/2008

11:56

Page 1

Weighing Solutions... for Laboratory & Industry www.sartorius.ie

Laboratory Weighing Solutions

Process

Weighing Solutions

ServiceLeading Edge • SARTORIUS LTD., UNIT 41, THE BUSINESS CENTRE, STADIUM BUSINESS PARK, BALLYCOOLIN ROAD, DUBLIN 11 • • Tel: (01) 808 9050 • info.ireland@sartorius.com • Fax: (01) 808 9388 • www.sartorius.ie •

Fine Chemicals

24/09/2008

09:42

Page 1

FINE CHEMICALS

NEW VOLUNTARY MANUFACTURING STANDARDS FOR FINE CHEMICALS Tony Scott, European Fine Chemicals Group, and Dr Uwe Brunk of Saltigo and Chairman of EFCG’s Agrochemical Intermediates Manufacturers in Europe (AIME) subgroup introduce a set of voluntary guidelines for the manufacture of fine chemical intermediates and active ingredients.

T

he Pharmachem Yearbook is the ideal tool to spread the news on the voluntary guidelines for the manufacture of fine chemical intermediates and active ingredients.

With the rapid increase in the globalisation of most product supply chains and the increasing demands from consumers for higher quality and safer products, the need for responsible manufacturing in all industrial sectors has never been greater. The incidents currently being reported in the US and European public and trade press about sub-standard products sourced from foreign suppliers, in particular China and India, are a sharp reminder of this.

To help minimise exposure risks, high manufacturing and quality standards are necessary, not only for end products like food, toys, medicines and crop protection products, but also for the chemical intermediates used in their manufacture. For example, US chemical distributors, being concerned about how to ensure a safe supply chain, are currently collecting information to support their vision of a Responsible Distribution Process (RDP) and are working through International Council of Chemical Trade Associations (ICCA) to help spread best practice on a global basis.

In 2006, the ICCA recommended a broad range of actions as part of its long-term Global Product Strategy and Responsible Care Global Charter, including voluntary industry actions and cooperative efforts with industry groups and both customers and suppliers to the chemicals industry. It said at the time: “The implementation of the strategy at a global level requires a more structured and far wider process of engagement within the

chemicals industry, with customers and other stakeholders than ever before.”

Announcing the strategy, Andrew Liveris, president and CEO of Dow Chemical, said: “The public expects the chemicals industry to continuously improve and voluntary initiatives are an important way for us to do that. Voluntary initiatives are complementary to laws and regulations and, in some cases, can be much more effective than regulatory approaches. They can accomplish a great deal in shorter periods of time and are less bureaucratic.”

Against this background, the Agrochemical Intermediates Manufacturers in Europe (AIME), a subgroup of the European Fine Chemicals Group (EFCG), has developed a set of voluntary guidelines – or a set of minimum requirements – for worldwide manufacturers in the crop protection/agrochemical supply chain, to help maintain standards and further minimise the risk in the manufacture of crop protection products which subsequently enter the food supply chain.

The voluntary guidelines are based on the experience of leading European fine chemical custom manufacturers over the last decade in working with almost every crop protection company in the world, and are consistent with the principles of Responsible Care and Product Stewardship.

EFCG subsequently adopted these guidelines and extended them to apply to all fine chemical intermediates and active ingredients (except pharmaceuticals) used in a wide range of industrial, professional and consumer product supply chains. The aim is to help maintain standards and further minimise the risk in the manufacture of a range of downstream products, other than pharmaceuticals, where 15

Fine Chemicals

24/09/2008

09:42

Page 2

FINE CHEMICALS

with the law and to prevent a sudden close down of facilities.

Integrated ‘ESH & Quality Management Systems’ should be embedded, communicated to the entire organisation and easily audited. Products are to be produced and shipped under the guidelines of the relevant chemical legislation, waste streams must be properly managed in compliance with local laws and ISO 9001 certification must be auditable.

Auditable ‘Preventative Risk Assessments’ should be made in production and other parts of the supply chain, such as supplier quality and reliability, preventative equipment maintenance, reaction safety and the identification of potential hazards.

Formal, documented raw material purchasing arrangements must be put in place on a company basis to improve traceability and to enhance the quality and security of supply: the resulting counter measures must be implemented, monitored and auditable.

The ‘Qualifications & Training of Staff’, including subcontractors, is crucial. This should be appropriate to the relevant functional activity: for example research, sourcing, production, maintenance, analysis, QA and logistics.

Regular training needs to be provided in health, safety and environmental precautions and in product quality, especially for substance or product properties and altered risk classifications. Operating and engineering staff must be updated regularly on new or altered technical equipment and training for emergencies must take place regularly.

‘R&D’ staff must be well educated, trained and competent to develop and scale up any required capabilities through innovation and continuous improvement. As well as respect for IP and know-how, the development of manufacturing processes should reflect the EU ESH standards and a wide range of appropriate analytical equipment should be kept available and well maintained by qualified staff.

‘Production Procedures’ are also vital. These include process controls to deliver reproducible product quality, preventative maintenance procedures to ensure high plant reliability and reduce the risk of unit failures, keeping proper historical records on each batch for inspection and/or audit purposes, procedures to avoid cross-contamination (such as separate storage and analytical capabilities to validate cleaning) and proper and auditable measures to protect the health of employees Likewise, ‘Plant Infrastructure’ must meet certain key requirements. These are headed by a secure supply of energy, steam and water, safe filling and trans-filling devices, safe and secure storage facilities, regularly audited fire protection measures (such as firms having their own, on-site fire brigades), audited waste water treatment facility and monitored off gas treatment.

Finally, there is ‘Transport’. The key requirements here are reliable and secure transportation and documentation; proper and complete labelling to ease shipment; adherence to relevant transport, packaging and labelling legislation; being a member of the official local transport accident information system; and making substance information

enforceable manufacturing laws are already in place for all active pharmaceutical ingredients and intermediates destined for use in the world’s major markets, such as USA, Europe and Japan.

GUIDELINES As well as being the voice of European Fine Chemical Manufacturers, EFCG seeks to promote the highest level of risk management in the manufacture and use of fine chemical intermediates and active ingredients on a global basis beyond pharmaceuticals. It also works to identify and deal with the key issues affecting the competitiveness of member companies and the safe use of their products.

EFCG members are committed to sustainable development and continuous improvement in environmental, health and safety (ESH) performance. By adopting these new voluntary guidelines, they are extending this commitment further to include a set of management policies and practices used before, during and after manufacturing.

NINE ESSENTIAL AREAS They are convinced that doing so will bring them and their customers real business benefits, while also improving product quality and security of supply throughout the supply chain. To help deliver these benefits, the voluntary guidelines address nine essential areas in managing the business, using defined criteria in each case.

The first is ‘Policies’. Products may only be sold for those uses where the risks to human health and environment are understood and managed, including an audit if decided.

Contracts and secrecy agreements must always be binding.

In addition, it is recommended that parties set out where and how any dispute requiring legal action is to be conducted. Clear management and organisational structures must exist to provide for efficient normal working and to address problems quickly. Know-how is to be protected and IP respected.

Secondly, ‘Business Processes’ must be documented clearly and follow defined and reproducible guidelines.

Regulatory affairs staff should maintain a close working relationship with the authorities, in order to ensure compliance 16

Fine Chemicals

24/09/2008

09:42

Page 3

F I N E C H E M I C A L S / PA K E X ‘ 0 8

and first aid instructions available rapidly in case of chemical hazards during transportation These voluntary guidelines are aimed at all manufacturers of ISO-regulated fine chemical intermediates and active ingredients throughout the world. Each manufacturer or customer may individually decide to follow these guidelines either in full or partly, or not to follow them at all, based entirely on their individual decision-making processes.

FOR MORE INFORMATION, PLEASE CONTACT: Tony Scott Advisor – EFCG and AIME Avenue E. van Nieuwenhuyse 4 B-1160 Brussels Belgium Tel: +44 (0) 1428 641 168 E-mail: tscott@tsassoc.eu Web: www.efcg.cefic.org and www.efcg.cefic.org/aime

POTENTIAL BENEFITS The guidelines have been prepared with several aims in mind: • To address societal concerns about sustainable development and the use of chemicals by increasing the transparency of what we do.

• To help build confidence and trust in an industry that is essential to improving living standards and the quality of life around the world.

• To share best practice and to promote the highest level of risk management in the manufacture and use of fine chemical intermediates and active ingredients on a global basis.

• To enable fine chemical intermediate manufacturers to refer to certain set of standards when advertising their capabilities.

Dr Uwe Brunk Chairman of AIME and EFCG Board Member Head of Business Line Agro & Specialty Chemcials Saltigo GmbH Katzbergstr. 1 40764 Langenfeld/Rheinland Tel: +49 (0) 2173 - 2033 763 E-mail: uwe.brunk@saltigo.com Web: www.efcg.cefic.org/aime and http://www.saltigo.com priateness and how they might be developed for a worldwide audience of manufacturers, stakeholders and the public at large.

It also wishes to begin to build the global capacity and network of users of the voluntary guidelines and to consider the development of a quality audit template based on the voluntary guidelines to facilitate customer audits of their suppliers.

NEXT STEPS EFCG wishes to enter into dialogue with anyone who is willing to help it to raise awareness of the proposed voluntary guidelines throughout the global fine chemicals community and to promote a process to discuss their appro-

PAKEX IRELAND ‘08 PAKEX Ireland ’08, incorporating Manufacturing & Plant Maintenance & Industrial Environment, takes place at the RDS, Dublin, on October 21 and 22, 2008, and will incorporate packaging, plant, supply chain, maintenance and industrial environment.

Over 100 companies, many from outside Ireland, will exhibit and many of the technologies being demonstrated will be on display for the first time in Ireland.

The latest professional advice and guidance will be available, thanks to the ‘free to attend’ Info Live mini seminars, to help visitors and exhibitors alike stay ahead in today’s highly competitive industrial environment.

Manufacturing and process industries now have to run leaner operations, putting an increased burden on maintenance professionals.

The show now attracts a broad range of visitors across a diverse array of industries, including pharmaceutical, chemical, medical, packaging, handling, logistics, processing, electrical, engineering, industrial machinery, food & drink etc.

Another benefit of visiting Pakex Ireland is the opportunity to network with industry colleagues, allowing you to connect with world class companies to help meet your processing/handling/packaging needs.

For more information, contact: McCann McGuirk Presentations on (01) 4063892 or email mccannmcguirk@eircom.net.

17

--------Cover Story

23/09/2008

16:44

Page 1

COVER STORY

Fisher Scientific celebrates a successful first year in Ireland.

I

n June 2008, Fisher Scientific, part of Thermo Fisher Scientific, celebrated its first year of being the new source for laboratory supplies in Ireland. Fisher Scientific has proved, within a short space of time, that it can offer the laboratory customer a new level of service.

SO

JUST WHO ARE

highly customer-focused local company.

HUGE PRODUCT RANGE – SPOILT FOR CHOICE?

THERMO FISHER SCIENTIFIC? With more than 100,000 products covering everything from consumables, chemicals and equipment, Fisher Scientific offers the widest choice available to laboratories, making the company a truly ‘one stop shop’, with premium brands such as Thermo Scientific, Bibby, Grant, Schott, Whatman, Millipore, Nunc, Corning, Nalgene, IKA, Zeiss and Kimberley Clark, amongst others.

The Fisherbrand Series is a name you can trust, with quality you can depend on, and positive proof that low cost doesn’t have to mean low quality!

When choosing a Fisherbrand product, the customer can expect, at the very least, three basic attributes: Quality.

Reliability. Value. As part of Thermo Fisher Scientific, Fisher Scientific draws on global purchasing power to ensure it is able to offer superior products with additional features and benefits not normally found in comparable products at similar prices.

The Fisherbrand product range consists of approximately 6,000 product lines, and the range is continually evolving and being added to. Fisherbrand covers many application areas that one would expect to find in general use in virtually any laboratory, be it research, clinical, analytical or university.

Products range from glass and plastic disposables, paper products and safety general consumables to bench top equipment and accessories.

Thermo Fisher Scientific is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer.

Fisher Scientific is a Thermo Fisher Scientific brand and provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, biotechnology, scientific research, analytical testing, safety and education.

LOCAL COMPANY – LOCAL PEOPLE – LOCAL STOCKHOLDING Customers can be assured that when they contact the office, they will be dealing with people that understand the needs of their laboratory and are familiar with the Irish laboratory market.

Highly experienced field sales and customer service teams were handpicked to give Fisher Scientific’s customers the confidence in knowing that they will receive the attention they would expect from a

CHOICE, QUALITY

AND

VALUE

Fisher Chemical provides customers with choice, quality and value from the world leader in serving science. It gives users confidence in the specification of the chemicals and reagents, 18

COVER STORY

ONLINE PRESENCE The Fisher Scientific web site is recognised as one of the best within the lab supplies industry. Here are just a few of the reasons for visiting www.ie.fisher.com.

Techzone is the on-line technical support area. This is being constantly updated and added to ensure users can access information that will help them to solve issues, whether it be the most suitable product for an application or how to find the nearest suitable replacement for another product.

Users can download MSDS’s, Certificates of Analysis, and protocols, chemical modelling and other information designed to make life easier in the lab.

Viewers can study selection tables and product guides and look-up FAQ’s. There are a wealth of special offers and promotions – the Fisher web team aims to keep offers and promotions not just ‘fresh’ but relevant to the user. Users will also find fun competitions, with some great prizes, so it’s not all work and no play.

‘Insight 2’ is the Fisher Scientific on-line catalogue, where the user can browse products, compare, check real-time stock availability and have the ability to view ‘new’ products as soon as they are added to the Fisher product range.

Once registered to use the on-line catalogue, Insight 2, the user can view real time stock availability: the price they see is the one they will pay, so there is no need for them to look up any complicated discount schedule and work the price out. Other benefits for registered uses include order history download and hot lists, just some of the advantages of purchasing on-line at www.ie.fishersci.com.

along with the stability of supply, backed by consistently high levels of stock availability, service and delivery.

Customers can rest assured that all Fisher Chemical products are manufactured, processed and/or tested in Loughborough, UK. ISO9001: 2000 certification ensures that customers can have confidence that when Fisher Chemical products arrive at their bench, they will meet the specification detailed in the current catalogue or a specification agreed with the customer, prior to ordering.

A RECENT ADDITION TO THE FAMILY: THE 2008/2009 FISHER SCIENTIFIC LIFE SCIENCE CATALOGUE With over 1,200 pages, the 2008/2009 Fisher Scientific Life Science Catalogue is a must for anyone involved in the life sciences, with a comprehensive selection of more than 17,500 essential life science products, 2,000 of which are brand new.

Always aware of the need for customer service and support, this catalogue is even more user friendly, with product groups organised into application areas, including: Cell Isolation, Cell Culture, Microbiology, Nucleic Acid, Protein Purification, Amplification and Expression (including PCR, RTPCR and qPCR techniques), Electrophoresis, Modification, Analysis and Characterisation. A whole new section dedicated to Healthcare has been included, to satisfy the needs of the busy clinical laboratory.

The equipment and consumables are complemented by a complete range of bioreagents and kits suited to the applications covered within the catalogue. This format enables users to easily find and view specific products relating to particular techniques and applications.

FOR

FURTHER INFORMATION, CONTACT:

Fisher Scientific Ireland Suite 3, Plaza 212, Blanchardstown Corporate Park 2, Ballycoolin, Dublin 15.

Tel: (01) 885 5854 Fax: (01) 899 1855 Email: fsie.sales@thermofisher.com Web: www.ie.fishersci.com

19

Measom Freer

23/09/2008

11:59

Page 1

R&D

18/09/2008

14:41

Page 1

RESEARCH & DEVELOPMENT

TOP OF THE R&D LEAGUE

M

oney invested in pharmaceutical research and development (R&D) eventually provides patients and physicians with more and better treatment options to best meet individual patients’ needs.

Globally, the pharmaceutical industry accounts for no less than 19% of business R&D expenditure and 5.8% of EU manufactured exports. It is the sector with the highest ratio of R&D investment to net sales (15.9%), employing more than 640,000 people in Europe, of which 107,000 work in R&D units.

This huge investment is necessary as the discovery, development, testing and gaining of regulatory approval for a new medicine is a highly complex, lengthy, risky and expensive process. In fact, several studies now put the cost of researching and developing a new medicine at €1 billion. But as the cost continues to increase, so do attrition rates. On average, only 1 out of 5,000 to 10,000 promising substances will survive extensive testing in the R&D phase to become approved as a quality, safe and efficient marketable product.

The Pharmaceutical industry invests more in R&D than any other sector, but Europe is beginning to lose out to the US and Asia, according to Ronan Collins, Communications Manager, Irish Pharmaceutical Healthcare Association Ltd.

ly with the APC to identify new drug targets for the treatment of debilitating GI disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).

CLINICAL TRIALS The pharmaceutical industry is also involved in a range of clinical trials in Ireland. In 2006, the Irish Medicines Board approved 122 clinical trial applications in Ireland.

According to ICORG, the AllIreland Co-operative Oncology Research Group which enables Irish patients to gain early access to new cancer treatments, Ireland’s pharmaceutical industry provided medicines worth over €3.5m to Irish cancer patients through the various clinical trials they were involved with in 2007.

This demonstrates how valuable the pharmaceutical industry is to Ireland, its health and economy.

EUROPE LOSING GROUND However that contribution cannot be taken for granted. For over a decade, Europe has gradually lost ground as a research base, with a steady transfer of R&D activities to other parts of the world, in particular the US, where the environment is more supportive of pharmaceutical innovation.

Between 1990 and 2007, R&D investment in the United States grew 5.2 times whilst in Europe it only grew 3.3 times. There is rapid growth in the research environment in emerging economies such as China and India. The current tendency to close R&D sites in Europe and to open new sites in Asia will show dramatic effects in the next few years if nothing is done to maintain the pharmaceutical discovery expertise in the EU. Europe needs to be serious about making innovation work. It is our belief that if Europe rewards and stimulates innovation, industry will not only be able to improve healthcare in Europe, bringing new innovative medicines faster to European patients, it will also contribute to the Lisbon objective of economic growth, to more and better jobs, and therefore guarantee high living standards for current and future generations of Europeans.

THE IRISH EXPERIENCE In Ireland, pharmaceutical R&D ranges from basic research to translational research. Much of this investment is spent in collaboration with academic institutions with the support of Government agencies.

GlaxoSmithKline, Wyeth, Servier Laboratories, BMS and several other companies have developed partnerships with universities, the most notable being TCD, UCC, NUI, Galway and DCU. Agencies supporting these partnerships include Science Foundation Ireland (SFI) and IDA Ireland.

For example, the Alimentary Pharmabiotic Centre (APC) at UCC, which is supported by SFI, has established a joint research partnership with GlaxoSmithKline.

Researchers from GSK’s Neurology and Gastro-Intestinal (GI) Centre of Excellence for Drug Discovery work close21

Ireland

funds great research... maybe it’s your turn!

Science Foundation Ireland, (SFI) the national foundation for excellence in scientific research is investing in academic researchers and research teams who are most likely to generate new knowledge, leading edge technologies, and competitive enterprises.

SFI has a flexible grants and awards portfolio and several times a year issues calls for proposals from scientists and engineers. SFI also accepts unsolicited proposals throughout the year. SFI’s award programmes include:

Principal Investigator Programme for outstanding researchers, normally ranging between €50,000 - €250,000 per year for a three to four year period.

Research Professor Recruitment Awards for outstanding researchers, with particularly distinguished international reputations, awards normally ranging up to €500,000 per annum for up to two years.

E.T.S. Walton Visitor Awards supporting leading international scientists who visit Ireland to undertake research for up to one year, normally ranging up to €200,000.

President of Ireland Young Researcher Awards (PIYRA) attracting to Ireland and supporting Irish researchers within five years of completing their PhD, normally up to €1 million over five years.

Undergraduate Research Experience & Knowledge Award (UREKA) supports active research participation by undergraduate students during the Summer.

Apply for an SFI award or learn more about our programmes at www.sfi.ie Science Foundation Ireland, Wilton Park House, Wilton Place, Dublin 2, Ireland. Tel +353 1 607 3200 fax +353 1 607 3201 email info@sfi.ie

Sci-fi ad (A4).indd 1

05/03/2008 09:27:40

SFI

18/09/2008

15:23

Page 1

S C I E N C E F O U N D AT I O N I R E L A N D

RESEARCH FOR IRELAND’S ECONOMIC FUTURE The vital role of Science Foundation Ireland in delivering on the Government’s Strategy for Science, Technology and Innovation.

T

he Irish Government has made a major commitment, through the substantial investment set out in the National Development Plan (NDP) 20072013, and the Strategy for Science, Technology & Innovation (SSTI) 2006-2013, to making the transition to a knowledge-economy by funding world-class research in Ireland. Building on previous strategies, it provides for an investment of €8.2 billion to 2013 which will: • • • • •

Double the number of postgraduates; Promote greater commercialisation of ideas and knowhow of universities and public research institutions; Increase participation in the fields of science; Increase translational research activity; Allocate significant resources to supporting enterprise R&D, in order to double corporate R&D spend by 2013 with a Business Expenditure in Research & Development (BERD) target of $3.9 billion.

ing over 940 Life Science researchers with Ireland, in such diverse areas as Agri-Food, Bioinformatics/Systems Biology, Molecular & Cell Biology, Immunology, Microbiology’ Neuroscience, Sensors/Devices and Pharma-Chem.

The aim of the SSTI is to ensure that Ireland remains a key location for leading edge research and development, and the quality jobs it can deliver.

Science Foundation Ireland (SFI) is investing in academic investigators and research teams, who are most likely to generate new knowledge, leading edge technologies and competitive enterprises in the fields of science and engineering which underpin the broad areas of: • • •

THE ULTIMATE GOAL The ultimate goal of the investment in SFI is that economic benefit should, in due course, arise from the actions and projects funded. Those who are performing research at the frontiers of knowledge will inevitably discover some new prospect and some of these will be intellectual property, including items that are of a patentable nature. Inventions and insights from top class researchers have been at the core of the expansion of industry in the US and elsewhere and the same should be true of Ireland.

The steps from invention through to commercial activity, however, may be different than those normally occurring in major industrial companies. Compared to industrial research, there is a longer time-lag between frontiers research and economic output and we have to recognise this.

It must be noted that the outcome of frontiers research is richer and more diverse, not concentrated on a single product but rather a multiplicity of products and processes. We need, therefore, to be patient, understanding and flexible in assessing the Brains to Business process. In this process, SFI works very actively with IDA Ireland and Enterprise Ireland. Indeed, the increased R&D investment reported by IDA is frequently the consequences of seed funding by SFI.

Biotechnology Information and communication technology Sustainable energy and energy efficient technologies.

HIGH QUALITY RESEARCH ENVIRONMENT Now seven years on from its first grant award, SFI is moving into a new phase of implementation as the organisation focuses on delivering the ambitious targets set down in the SSTI. Since its establishment in 2001, SFI has approved over 1,800 awards across all its programmes, representing a substantial investment commitment of over €1.04 billion as it continues to build a high quality research environment in Ireland.

Ireland is now a place where an active and successful researcher has access to grants that are higher than those available in most countries. To-date in the life sciences area, SFI has made award commitments of over €324m, fund23

BSB .25

23/09/2008

17:15

Page 1

Manotherm Magnehelics Meters Matter

Manotherm Limited 4 Walkinstown Road, Dublin 12 Tel: 01-452 2355 Fax: 01-451 6919 Email: info@manotherm.ie Web: www.manotherm.ie Co. Down Tel: 028 4066 9936 Email: sales@manotherm.co.uk

SUPPLIERS OF:-

ACETATE ESTERS ACIDS & ALKALIS ANTIFREEZE / GLYCOLS ETHANOL ETHANOLAMINES EXCIPIENTS

A LARGE RANGE

FATS & WAXES FRAGRANCES & FLAVOURS GLYCOL ETHERS / ESTERS GLYMES HYDROCARBON SOLVENTS KETONES OF

PETROLEUM JELLIES / WHITE OILS PHARMACEUTICAL SPECIALITIES POLYALKYLENE GLYCOLS POLYETHYLENE GLYCOLS SALT - ALL GRADES SOLVENTS

MATERIALS CAN BE SOURCED TO YOUR SPECIFICATION

CARBON CAN NOW OFFER A SELECTION OF SOLVENTS IN 200 LITRE DRUMS/ IBC'S EX STOCK FROM OUR SOLVENT STORAGE AND DRUMMING FACILITY, IN RINGASKIDDY, CORK Whatever your requirement please contact:- Carol Deegan Carbon Group, Ringaskiddy, Cork Mobile: 086 2612 485 Office Tel: 021 437 8988 Fax: 021 437 8950 Email: cdeegan@indigo.ie Email: sales@carbon.ie Website: www.carbon.ie

UK lo-cal number: 0870 850 4831

SFI

24/09/2008

09:47

Page 2

S C I E N C E F O U N D AT I O N I R E L A N D

Teagasc, Alimentary Health and their partners Proctor & Gamble and GlaxoSmithKline (GSK).

The primary objective of Biomedical Diagnostics Institute (BDI), based in Dublin City University, is the development of novel diagnostic devices, enabling earlystage diagnosis and monitoring of major diseases. These devices are targeted for use at the point-of-care and will ultimately enable efficient coupling of diagnosis and treatment (theranostics). The BDI industry partners include: Becton Dickinson and Co., Analog Devices Inc., Hospira Inc., Inverness Medical Innovations Inc., Enfer Technologies Ltd, and Amic AB. The REMEDI was established in National University of Ireland Galway in 2003 to conduct research in regenerative medicines, an emerging field that combines the technologies of gene therapy and adult stemcell therapy.

REMEDI’s industrial collaborators include Medtronic Vascular (Galway).

FOSTERING STRONG LINKS

WITH INDUSTRY

In addition to working with the other agencies, it is crucial for SFI and its funded researchers to develop strong links with industry. It will be key industry partners who pose the questions and, through partnership with academic researchers, find the solutions to technological, environmental, medical and economical issues. It is these industry partners who, in association with SFI-funded projects, will commercialise the outputs of the research. This is where the economy benefits and Ireland moves up the value chain.

Smaller incremental changes in the existing operations will also follow, thereby increasing the competitiveness of business in Ireland.

Significant numbers of SFI funded researchers are actively engaged in collaboration with industrial partners.

SFI’s nine Centres for Science, Engineering and Technology (CSETs) and 12 new Strategic Research Clusters (SRCs) are at the leading edge of this process by collaborating with multinational companies such as GlaxoSmithKline, Proctor & Gamble, Eli Lilly, Merck Sharp & Dohme, Schering Plough, Pfizer, Abbot, Becton Dickinson, and also with smaller Irish companies. IDA Ireland and Enterprise Ireland play an important role together with SFI in encouraging this collaborative process.

Some examples of these collaborative SFI CSETs in the Life Sciences include: The Alimentary Pharmabiotic Centre (APC) in University College Cork (UCC): its research is focused on the exploration and exploitation of gut microbiota in health and disease. The APC has grown in scope, scale and international stature since its launch four years ago as an SFI CSET. The APC’s collaborative partners include

BUILDING

THE

TALENT POOL

The Irish Government’s Strategy sets down the goal of seeing Ireland recognised as an internationally renowned location for excellence in scientific research. In order to achieve this, we need to continue to build the talent pool; Ireland needs to ensure that there are sufficient researchers available to serve the knowledge-driven economy.

Over the next seven years, a key objective of the Irish Government’s Strategy is to double the number of PhD graduates. To deliver this, SFI will increase the number of supported Principal Investigators by 30 per annum up to 2013. SFI has developed a suite of competitive award programmes to build this capacity in the Irish research system.

Over the coming years, SFI will continue its efforts to build world-class research teams, increase the number of high quality researchers and therefore contribute to increasing the output of PhDs, which is a key objective of the Strategy. SFI will be to the forefront in implementing initiatives over the coming seven years, which will provide a solid basis for Ireland's future economic development.

See www.sfi.ie for more details 25

Labs

18/09/2008

14:41

Page 1

L A B O R AT O R I E S

L ABS ARE VITAL LAUNCHED IN DUBLIN The recently launched ‘Labs are Vital’ programme will promote the work of Ireland’s 3,000 laboratory professionals. ‘

L

“The 3000 laboratory professionals working in Ireland make a very significant contribution to our health care system, said Kevin O’Connell, President of the Academy of Medical Laboratory Science (AMLS). “From early diagnosis, to effective treatment, to maintaining affordable costs – all rely on the continued vitality of our clinical laboratories.

‘Labs are Vital’ is an important initiative which will help promote better understanding of the work of laboratories and will also facilitate peer-to-peer engagement on issues affecting the profession. The Academy of Medical Laboratory Science is delighted to be a partner in the ‘Labs are Vital’ programme.”

Dolores Quinn, Marketing and Communications Manager, Abbott Diagnostics, echoed his enthusiasm: “‘Labs are Vital’ is a programme whose success is driven by the active involvement of laboratory professionals and their professional organisations. It embraces new media, including social networking sites such as Facebook.com, to create awareness of their work and the exciting career opportunities which exist in the profession. It also supports the profession in promoting their work within the wider health care system. We are delighted with the enthusiastic response from the Academy and other professional bodies and we look forward to seeing ‘Labs are Vital’ grow from strength to strength in Ireland.”

Further information is available on www.labsarevital.com

abs are Vital’ is an exciting new initiative dedicated to creating greater awareness and appreciation of the importance of laboratory professionals in Ireland’s healthcare system. Every day, laboratory professionals provide critical information that saves lives and helps control the costs of care in our hospitals. It is estimated that 60-70% of health care decisions are influenced by laboratory run tests.

‘Labs are Vital’ will provide a unique platform for professional associations such as the Academy of Medical Laboratory Science (AMLS) to work together to: • Highlight the value of the laboratory professional, both within the healthcare system and to the general public; • Address the issues that laboratories face today, from workforce changes to reimbursement strategies and laboratory utilisation; • Serve as a community for laboratory professionals to exchange ideas and suggestions, working as a catalyst for positive change; • Promote careers in laboratory science among students in Ireland.

Launched in the United States by Abbott in 2006, ‘Labs are Vital’ is successfully promoting the valuable work of laboratory scientists in the United States, the United Kingdom, the Netherlands and now in Ireland, where Abbott employs more than 3,400 people across seven manufacturing sites, including the Diagnostic Plants at Sligo and Longford.

LANCASTER LABS EXPANDS IN IRELAND LANCASTER Laboratories, one of the largest commercial analytical laboratories in the US, is expanding its operation in Dungarvan, Co. Waterford. This investment follows Lancaster’s acquisition in 2007 of Microchem Labs, an Irish company. It will result in the creation of 100 new high level positions over the next five years, with the support of IDA Ireland. The majority of these positions will require people at PhD, Masters and graduate level.

Lancaster Labs is a leading provider of a comprehensive array of scientific and validation services required by the US Food and Drug Administration (FDA).

Following the acquisition of Microchem in Dungarvan, which will also be known as Lancaster Laboratories Europe, it has greatly enhanced its ability to support the requirements of companies in Europe and Asia. The services currently offered by Microchem will complement the pharmaceutical, biopharmaceutical, medical device and environmental testing services at Lancaster Laboratories.

Pictured at the launch of ‘Labs are Vital are (l-r): Alex McAllorum (8) and Leah Hennessy (9).

26

Univar

23/09/2008

14:57

Page 1

536 Grants Crescent, Greenogue Business Park, Rathcoole, Co. Dublin Tel : + 353 1 4019800 Sales Office : + 353 1 4019817 E mail : pharma.sales@univareurope.com www.univareurope.com

Univar is Ireland’s leading source of high quality ingredients to the pharmaceutical sector. Our brand new site has been designed to meet the regulatory compliance demands of our pharmaceutical customers.

We are serious about safety and we are committed to making a positive impact on environmental issues in handling fine chemicals.

Univar is the partner of choice for many of the world’s leading pharmaceutical ingredient manufacturers.

Whether you are looking for API’S, EXCIPIENTS, PROCESS CHEMICALS, SOLVENTS, OR INTERMEDIATES we can provide technical and regulatory support.

To discuss your specific needs please contact our sales office at +353 1 4019817

Need to re-engineer your career?

What do you do?

Specialising in Pharmaceutical / Scientific / Technical / Logistics Manpower offers you dedicated Scientific & Engineering consultants. Professionals who can truly understand your specific skills and know where the best opportunities for your career lie.

With a Manpower consultant who specialises in Scientific & Engineering recruitment, you can uncover what you really want out of your career. And more importantly, where to find it.

Call Manpower quoting the reference PCM on 01 - 6455200 or email ScientificEngineering@manpower.ie

Manpower Ireland Ltd cares about your privacy and is committed to processing your personal information in accordance with our Global Data Privacy Principles and the standards of fair information practices. For further information please visit: http://www.manpower.ie/user_agreement/data_privacy.asp

Univar

26/09/2008

15:53

Page 1

PHARMACEUTIC AL INGREDIENTS

PHARMA INGREDIENTS FOR SUCCESS Univar Pharma Ingredients is a world leader in pharmaceutical and chemical distribution, and its new site at Rathcoole, Co. Dublin, sets the standard for its European operations.

U

nivar is best known as a world-leader in chemical distribution, serving customers from industries that range from pharmaceutical through to coatings and chemical manufacturing. The pharma industry, however, has been a significant focus area for the company in recent times and Univar Pharma Ingredients are determined to build further on their already highly successful pharma ingredients business, in line with their European Pharma industry approach.

SETTING

THE

STANDARD

FOR

EUROPE

The new site at Greenogue, Rathcoole Co. Dublin sets the standard. This outlet has become a blueprint for Univar facilities across Europe. Thomas Butler, Operations Manager at Univar Ireland, gave PharmaChem Ireland a tour of the company’s dedicated pharma ingredient storage facility in Rathcoole. Thomas and his team ensure every caution is taken in how products are received, stored, and then distributed around the country.

“We designed the site around the needs of pharmaceutical and food customers,” explains Thomas. “This stands to reason, as there has been colossal inward investment in this business.”

The management and staff at Univar’s headquarters in Rathcoole, Co. Dublin.

UNIVAR PHARMA INGREDIENTS “Univar Pharma Ingredients represents a significant por-

tion of the business in Ireland,” continues Frank McLaughlin, Marketing Manager. “Our pharmaceutical business is the sector where further strategic growth is targeted over the coming years.”

Univar’s expertise and long history in the pharmaceutical ingredients market allows them to offer customers a unique combination: global cost effective supply of a broad range of ingredients with specific quality and regulatory standards required by pharmaceutical manufacturers.

Univar distributes an unrivalled variety of Pharma ingredients, including API’s, excipients, process chemicals, intermediates and vitamins.

“In Ireland, Univar Pharma Ingredients work closely with world leaders and innovators such as DMV Fonterra, BASF, Shell, Jungbunzlauer, Ineos and Purac,” notes Frank McLaughlin. “We want to be with only the best.”

If proof of Univar’s strong pharma ingredient offering 28

Univar

25/09/2008

15:25

Page 2

PHARMACEUTIC AL INGREDIENTS

Univar’s new site at Greenogue, Rathcoole, Co. Dublin, has become a blueprint for Univar facilities across Europe.

was needed, look no further than its customer base. The common denominator for every customer is a dedicated and ‘best in class’ level of service, expertise, and technology – Univar supports its business not just in Ireland but throughout Europe.

Keeping an eye on trends is crucial for the prolonged success of Univar Pharma Ingredients. Through watching the market, they distribute products that are maintained to the highest standards, through vendor approval and site audits.

Indeed, Univar Ireland openly welcomes and encourages both customer and supplier visits to their facility.

COMMITMENT

TO

Indeed, Univar’s global reach is an additional benefit for its customers. Univar is the world’s leading chemical distribution company, with a turnover in excess of $8 billion.

The business is owned by venture capitalists CVC. “A lot of our relationships are long term,” explains Frank McLaughlin. “We have a clearly defined growth strategy: we know where we are going and why we are going there.”

HIGHLY TRAINED STAFF Crucially, personable, knowledgeable, and professional people lead Univar Ireland’s business. Although the pharma manufacturing industry is consumed by issues that range from technology to supply chain to globalisation, human relationships play a major role in the success and future direction of the business. Univar Pharma Ingredients provides more than just products: they offer new business opportunities, creativity, and windows into new technologies. Univar’s standing is as a result of its employees, suppliers, facilities, and its understanding of, and roots in, the market.

In a fast moving, innovative, and rapidly changing sector, Univar Pharma Ingredients not only provide the answers, they also have the solutions.

SAFETY

With such market focus comes a commitment to safety that surpasses current industry standards, including their inhouse ‘U+ Serious About Safety’ Programme.

When a customer buys from Univar Pharma Ingredients, they are not just buying a product, they are buying a service; not just a reputation, but also a guarantee that the product has been verified.

For more information, contact: Univar Pharma Ingredients, 536 Grants Crescent Greenogue Business Park Rathcoole, Co Dublin.

Tel: (01) 4019800.

Fax: (01) 4019412.

Email: pharma.sales@univareurope.com Web: www.univareurope.com

29

Why use an accredited Laboratory, Certification or Inspection Body?

Reduce risk - choose a proven, competent body Accreditation by the Irish National Accreditation Board (INAB) means that laboratories, certification and inspection bodies have been assessed against internationally recognised standards to demonstrate their competence, impartiality and performance capability.

INAB ACCREDITED CERTIFICATION BODIES Reg No: 6003 Bord Bia Quality Assurance Board (Dublin) 5007 Business Quality Assurance International (BQAI)Ltd. (Galway) 8002 Certification Europe Ltd (Dublin) 5006 Certification Europe Ltd (Dublin) 3001 Certification Europe Ltd (Dublin) 3501 Certification Europe Ltd. (Dublin) 5005 EQA (Ireland) Ltd (Dublin) 7001 ERS (Meath) 6002 IFQC Ltd (Louth) 6001 NSAI (Dublin) 5001 NSAI (Dublin) 6004 Verifier Services Ltd (Dublin)

INAB ACCREDITED INSPECTION BODIES 9007 AD Analytical (Dublin) 9003 BOC Gases Ireland Ltd. (Dublin) 9005 Certification Europe Ltd (Dublin) 9006 Clean Technology Centre (Cork) 9002 Hibernian General Insurance Ltd (Dublin) 9001 Industrial Pressure Testing Ltd. (Cork) 9004 OHSS Ltd (Co Dublin) 9008 SWS Auditing Services (Cork)

INAB ACCREDITED LABORATORIES

018 AGB Scientific Ltd. (Dublin) 157 Advanced Micro Services (Cork) 126 AGB Scientific Ltd (Dublin) 175 Anecto Ltd (Galway) 075 Aqualab (Donegal) 189 Ascon Ltd. (Co Kildare) 029 Aughinish Aluminia Ltd. (Limerick) 149 Ballina Beverages (Mayo) 005 BHP Laboratories Ltd (Limerick) 183 Bodycote Consultus Ltd. (Cork) 153 Bon Secours Hospital (Cork) 116 Bord Iascaigh Mhara (Dublin) 083 Bord Na Mona Environmental Ltd. (Kildare) 178 Bristol-Myers Squibb Cruiserath (Dublin) 193 Building Envelope Technologies Ltd (Wexford) 001 Calibration Specialists Ltd. (Limerick) 186 Calibration Technology Ltd. (Limerick) 155 Cavan County Council (Cavan) 171 Central Meat Control Lab (Kildare) 138 City Analysts (Dublin) 159 Claymon Laboratories (Co Dublin) 174 Coillte Laboratories (Wicklow) 108 Complete Laboratory Solutions (Galway) 088 Compliance Engineering Ireland Ltd. (Meath) 016 Cork County Council (Cork) 092 CTL Tástáil Teo. (Galway) 141 Dairy Science Laboratory (Kildare) 007 Dairygold Feed Laboratory (Cork) 188 Davidson & Hardy (Laboratory Supplies) Ltd. (Dublin) 160 Drogheda Concentrates (Louth) 079 Dublin City Council (Dublin) 177 Edenderry Power Operations Ltd (Offaly) 142 Eli Lilly (Cork) 166 Enfer Micro Laboratories Ltd (Tipperary) 181 Enfer Testing Ltd. (Kildare) 172 Enforce Laboratories Ltd (Cork)

185 Enva Ireland Ltd (Cork) 111 Environmental Laboratory Services (Cork) 113 Environmental Protection Agency (Monaghan) 145 Environmental Protection Agency (Mayo) 117 Environmental Protection Agency (Cork) 119 Euro Environmental Services (Louth) 077 Flow Meter Systems Ireland Ltd. (Co Cork) 137 Forensic Science Laboratory (Dublin) 044 GE Sensing EMEA (Co Clare) 162 GeoTesting Ltd (Kildare) 047 Hensey Glan-Uisce Teo (Galway) 152 Highway Testing Laboratory (Galway) 147 Icon PLC (Dublin) 179 Identigen Ltd (Dublin) 133 IGSL Ltd (Kildare) 031 Independent Micro Lab Ltd. (Laois / Waterford) 151 Irish Equine Centre Microbiology Unit (Kildare) 128 Irish National Greyhound Laboratory (Limerick) 164 Isotron Ireland Ltd. (Offaly) 066 JVA Analytical Ltd. (Dublin) 130 Marine Institute (Co Galway) 043 Mason Technology Ltd (Dublin) 191The Mater Private Healthcare Group (Dublin) 161 Metrology Systems & Services Ltd (Co Cork) 163 McAllister Devereux Keating (Cork) 030 Medical Bureau Of Road Safety (Dublin) 187 Metlab Int. Ltd. (Cork) 004 Microchem Labs (Waterford) 182 Monaghan Veterinary Laboratory (Monaghan) 195 Mullingar Midland Regional Hospital (Westmeath) 120 MTS Ltd. (Carlow) 184 Neptune Laboratory Services Ltd (Galway) 176 Occupational Hygiene & Safety Services Ltd (Co Dublin) 173 OMAC Laboratories Ltd. (Galway) 121 Pesticide Control Laboratory (Kildare) 081 Public Analyst’s Laboratory (Cork) 099 Public Analyst’s Laboratory (Dublin) 009 Public Analyst’s Laboratory (Galway) 101 Public Health Laboratory (Dublin) 096 Public Health Laboratory –HSE (Limerick) 098 Public Health Laboratory – HSE (Sligo) 097 Public Health Laboratory - HSE (Galway) 094 Public Health Laboratory – HSE (Waterford) 087 Public Health Laboratory – HSE (Cork) 089 Q-Lab Ltd. (Wexford) 086 Radiological Protection Institute Of Ireland RPII (Dublin) 091 Radiological Protection Institute Of Ireland RPII (Dublin) 180 Reagecon Diagnostics Ltd (Clare) 012 Reagecon Diagnostics Ltd. (Clare) 190 Roadbridge Limited (Limerick) 165 Roadstone Dublin Ltd. (Dublin) 127 Roadstone Dublin Ltd. Slane Laboratory (Meath) 194 Southern Scientific Services Ltd (Kerry) 144 Schering Plough (Avondale) Company (Wicklow) 196 SM Morris Ltd (Wicklow) 146 State Laboratory (Kildare) 192 St Vincent’s Hospital Healthcare Group (Dublin) 112 Transtest Equipment Ltd. (Co Kildare) 106 T.E. Laboratories Ltd. (Carlow) 038 Teagasc (Dublin) 169 The Drug Treatment Centre Board (Dublin) 150 TMS Environment Ltd (Dublin) 170 Waterford Regional Hospital – HSE (Waterford) 064 Wyeth Nutritionals Ireland (Limerick)

Log on to WWW.INAB.IE for current accreditation status and a full list of members scopes of accreditation.

Inad A4.indd 1

23/09/2008 17:07:47

INAB

18/09/2008

14:32

Page 1

ACCREDITATION

AND

S TANDARDS

THE BENEFITS OF ACCREDITATION The Irish National Accreditation Board (INAB) is the national body with responsibility for accreditation in accordance with the relevant International Organisation for Standardisation ISO 17000 series of standards and guides and the harmonised EN 45000 series of European standards.

A

ccreditation is an often misunderstood concept, but it is one of the cornerstones of both consumer confidence and international trade. Frequently confused with certification or standard setting, accreditation actually exists somewhere between these two levels of checks and measures: approving the management of standards which are created at an official level, but applied at a local level.

Standards are set by national standards bodies, although standards are global, and the National Standards Authority of Ireland is a member of the European Committee for Standardisation (CEN) and the International Standards Organisation (ISO). The standards are agreed by all stakeholders of the business, and accreditation is not involved in setting those standards.

Instead, it is about measuring how effectively those standards are applied.

In this context, accreditation is different to academic accreditation. It is there for both the end user and for industries and companies, and it is a major element in the business carried out by what are known as Conformity Assessment Bodies – whether these bodies are inspecting, certifying or testing a service or a product.

Accreditation began in Ireland in 1985 in laboratories, but it has broadened its remit into areas as diverse as certification of food and energy efficiency. And it is now being used more and more to facilitate trade between member states.

The EC realised that there was a risk of one member state insisting on testing the products that it imported, so they needed a system where there was international acceptance of the testing that was done, a formal approval system.

has been consistent growth in accreditation over the past 22 years. It is being applied in a whole range of areas which you might not have thought of years ago. But, given that 20% of the European market is regulated, and 80% is not, it is actually the 80% voluntary market which is attracted to accreditation because it needs to be able to demonstrate its competence.

This assessment of competence is a key element, in that the work of accreditation is about assessing the competence of the bodies whose business it is to check how the standards are applied.

A laboratory which tests water for lead content could be using an international standard, but INAB have to the check how competent that laboratory is at applying that standard.

Because INAB is a small organisation, it utilises peer experts to carry out these checks: it is a system of managing the assessment process through peer expertise, and INAB can call on a wide network of experts worldwide.

QUALITY MANAGEMENT SYSTEMS A familiar area covered by accreditation is that of quality management systems, where a company has to ensure consistency in its production processes – (the standard is known as ISO 9001). In order for companies to demonstrate that they are complying with the standard, they must be certified by a certification body. This body certifies compliance with the standard – accreditation assesses the competence of the body to be able to certify compliance with the standards.

Accreditation is seen as the last level of control over conformity assessment. Laboratories, inspection bodies or certification bodies are measuring the conformity of products or services. They compete with each other, and are generally dealing with a huge volume of work. It is necessary to have an accreditation body which levels the playing pitch and assesses how bodies maintain those standards. The Irish National Accreditation Board fulfils this role.

See www.inab.ie for more information.

DEMONSTRATING COMPETENCE To date, accreditation has become far more widely used across a variety of sectors, although surprisingly, this increase is not being primarily driven by regulation. There 31

NITL

18/09/2008

15:18

Page 1

S U P P LY C H A I N

ADDING VALUE THROUGH EXCELLENCE Edward Sweeney, National Institute for Transport and Logistics (NITL) writes on enhancing shareholder value in the Pharmaceutical industry: the supply chain dimension.

T

he international pharmaceutical business environment continues to develop at a rapid rate.

Increasing interactions between economies, particularly between North America, Europe and Asia, have raised many important issues regarding transport infrastructure, logistics and broader supply chain management (SCM). The potential exists to further enhance shareholder value through enhanced trade, provided that these issues are addressed in a logical and systematic manner.

Ireland is a key global location for the pharmaceutical industry. Currently 13 of the top 15 companies in the world have substantial operations in Ireland, with six out of 10 and 12 out of 25 of the world’s top selling drugs produced here.

The majority of products are manufactured for global markets.

SCM EXCELLENCE It must be recognised that a product is delivered to the ultimate customer through a series of complex interactions with several companies along the way. The manufacturer’s ability to give the customer what they want, when they want it, at the price and quality that they expect is not just determined by the efficiency and effectiveness of the manufacturer’s own operation. Inefficiencies anywhere in the supply chain will reduce the chances of the manufacturer successfully competing against other suppliers.

Without a proper focus on total supply chain management, therefore, a company will never achieve true competitive advantage.

The increasingly international nature of markets and companies has resulted in many companies becoming part of large and complex global supply chains. In addition, the potential benefits associated with emerging electronic commerce technologies provide the potential to simultaneously improve customer service levels and to reduce supply chain costs. These factors have sharpened the focus on the need for improvements in all aspects of supply chain performance.

So what are the characteristics of SCM in companies that might be regarded as world class? The following four elements appear to be of critical importance for most companies in most sectors:

-

Identification and measurement of customer service because customer service ‘sets the spec’ for supply chain design.

Integration of supply chain activities and information because many supply chain NVAs are caused by fragmented supply chain configurations.

SCM regarded as a senior management function because SCM is a strategic activity.

Establishment and measurement of supply chain key performance indicators (KPI’s) because what gets measured gets done!

Recent research by NITL indicates that while pockets of excellence undoubtedly exist, there is serious room for improvement. A survey of 776 companies in the Republic of Ireland (including many in the pharma sector) in relation to the factors outlined above showed that: • Approximately 50% measure customer service formally and those have very limited measurements; • Companies score low in relation to having the latest supply chain information and communications technology (ICT) and having them integrated across the supply chain; • Less than 10% have any formal SCM position; • Few companies had clearly defined SCM KPI’s.

32

NITL

18/09/2008

15:18

Page 2

S U P P LY C H A I N

Furthermore, a number of possible barriers to SCM excellence have been identified and will be explored as part of the ongoing research and associated analysis. These include:

ABOUT THE AUTHOR Edward Sweeney is Director of Learning at the National Institute for Transport and Logistics (NITL), based at the Dublin Institute of Technology (DIT). NITL was established in 1998 as Ireland’s ‘Centre of Excellence’ in supply chain management. Since then, it has provided a range of education, training, consultancy and research supports to companies in Ireland and abroad.

At NITL, Edward is responsible for the development and implementation of the integrated supply chain management (SCM) development programmes and carries out research and consultancy work on behalf of NITL client companies.

He is an engineer by background and has worked and lectured in over 20 countries in Europe, North America and Asia. His work has been widely published and he is a regular contributor to business and academic conferences and seminars throughout the world. His most recent book, ‘Perspectives on Supply Chain Management and Logistics: Creating Competitive Organisations in the 21st Century’, is available through Blackhall Publishing.

• Inefficiencies are often built into the supply chain.

• Communication structures are ineffective and exchange of information poor.

• Culture is inappropriate.

• There is an excessive reliance on forecasting and stockholding.

• Problems are often managed, rather than their causes eliminated.

CONCLUDING COMMENTS The potential exists across the pharma industry to significantly enhance shareholder value through the adoption of SCM thinking. The regulatory environment in which the industry operates brings its own particular challenges but these are not insurmountable: rather, they require that creative SCM strategies be developed, and then executed superbly, with strong attention to detail.

33

Process Analytical & Diagnostics

18/09/2008

17:11

Page 1

P R O C E S S A N A LY T I C A L T E C H N O L O G Y

PREPARING FOR THE FUTURE Process Analytical Technology (PAT) will revolutionise the way pharmaceuticals are made and will forever change the face of the industry, according to ABB, who maintain that PAT improves asset uptime and availability for pharmaceutical unit operations by up to 40%.

P

harmaceutical manufacturers have been providing medicines for more than 60 years using tried and tested formulations and manufacturing and quality management processes. In recent years, new innovations in measurement, control and IT technologies have helped them to manage their processes more efficiently, with higher productivity as a result. In addition to these innovations, a specific initiative has also been making its presence felt. Known as the Process Analytical Technology (PAT) Initiative, its goal is to understand and better control the entire manufacturing process within the pharmaceutical industry.

Processes are actively managed to achieve a high degree of repeatability and efficiency, and quality assurance becomes continuous and real-time activity. ABB is working in partnership with its customers to deliver a systems approach to PAT. From measurements to process improvement, ABB supports PAT implementation and the delivery of real business benefits.

needs of research and development, manufacturing and quality processes within the business.

Using PAT, ABB offers a unique industrial solution so that its customers in the Life Sciences industry can enhance their processes to deliver the benefits of PAT, from process investigation right through to achieving operational excellence.

WHAT IS PAT? Process Analytical Technology (PAT) is a system for designing, analysing, and controlling manufacturing processes based on an understanding of the scientific and engineering principals involved, and identification of the variables which affect product quality. The PAT initiative is based on the FDA (The US Food and Drug Administration) belief that: “quality cannot be tested into products; it should be built-in or should be by design.”

The primary goal of PAT is to provide processes which consistently generate products of a predetermined quality.

Effective PAT implementation is founded on detailed, sciencebased understanding of the chemical and mechanical properties of all elements of the proposed drug product.

In order to design a process that provides a consistent product, the chemical, physical and biopharmaceutical characteristics of the drug and other components of the drug product must be determined. The role of on-line advanced measurement systems is pivotal to realising the benefits of PAT. However, the transformation of process performance to provide greater efficiency and cost effectiveness, in addition to assured quality, requires much more than the application of measurement technologies. Realising such gains also requires an integrated measurement, control, workflow management and information environment which meets the

THE BENEFITS OF PAT In a nutshell, the benefits of PAT can be summed up in the following sentences: PAT improves asset uptime and availability for pharmaceutical unit operations by up to 40%. Costs are reduced by up to 30%, while fundamental product quality is maintained. How this is achieved is outlined in the following paragraphs.

BETTER PROCESS UNDERSTANDING: The physical and chemical processes involved in the manufacture of pharmaceuticals are complex and not well understood. However, during both the development and manufacturing stages, PAT-enabled processes provide access to information rich data, in real-time, which can be “mined” to find the critical quality parameters through multivariate analysis. Once these are determined, it is then easier to establish accurate control schemes for the relevant process parameters, so that a more robust process can be established in a shorter timeframe and right-first time production is ensured.

34

Project3

25/09/2008

15:44

Page 1

ABB has arrived with a PAT solution.

End to end solution for PAT implementation.

A system for taking advantage of the FDA’s PAT guidance has arrived!

ABB’s IndustrialIT for PAT is a fully integrated PAT solution that supports online process verification, continuous process improvement and PAT based product release. The system communicates with ABB and/or third party analyzers, DCS systems, databases and other manufacturing support systems. The system is scalable, able to support systems ranging in size from a development laboratory to a full production facility. To complete the total PAT solution, ABB offers consultancy, engineering and project management services for the system that meet GAMP4, ICH Q8 and ICH Q9 guidance. From analyzers and automation to services and support, only ABB stands ready to implement a total PAT solution for your process today! Call ABB to take delivery of your PAT solution.

For more information, visit us at www.abb.com/lifesciences, abb.com/analytical or email pharmaceutical.info@us.abb.com

© Copyright 2007 ABB USCS 1204

Process Analytical & Diagnostics

23/09/2008

16:50

Page 2

P R O C E S S A N A LY T I C A L T E C H N O L O G Y

REPEATABLE BATCH TRAJECTORY: Quality control requires a highly detailed level of process understanding. ABB offers a combination of advanced and regulatory control based on robust process models that deliver verifiable results. The PAT solutions detect and manage critical control points in the process so that deviations from a required profile are correctly managed and fed back into the high performance control zone.

REDUCTION IN OVERALL CYCLE TIME: • • • • •

Processing to a quality-based endpoint is a key part of the PAT quality assurance regime. This eliminates wasted cycle time associated with processing using a fixed time-based endpoint, including subsequent reprocessing time, and provides a streamlined workflow through the facility.

Data storage Data mining System integration Connectivity with manufacturing and business systems Advanced Process Control (APC)

ANALYTICAL AND MEASUREMENT TECHNOLOGIES: THE PLATFORM FOR PAT

REDUCTION IN QUALITY ASSURANCE (QA) COSTS: Reduction in Out of Specification (OOS) events and consequent investigation leads to significant cost savings. PAT enabled unit operations reduce the reliance on laboratory testing and associated lead times, thus reducing the overhead costs associated with product quality.

At the heart of any PAT system is a series of measurements made on real processes under realistic manufacturing conditions. Data from conventional process measurement systems (eg, temperature, pressure and flow) give some insight into manufacturing processes so as to achieve a basic level of process understanding.

However, manufacturing processes are usually too complex for simple approaches to be effective in achieving process understanding and control. An in-depth degree of understanding and tight control can only be achieved by employing the correct technologies to measure relevant process parameters. These technologies are often based on chemical composition and/or physical form measurements, ie analytical techniques.

ABB has top class analytical technologies, from FTIR/NIR spectroscopy right through to mass spectrometry and Gas chromatographs. Fully integrated into ABB’s Industrial IT (IIT) concepts, the systems have unparalleled connectivity capability and provide a robust measurement platform for all PAT applications. Connected to the IIT information backbone, the process data developed can be used in everything from advanced control to process troubleshooting.

IMPROVEMENT IN OVERALL EQUIPMENT EFFECTIVENESS (OEE): OEE is the industry accepted tool to measure and monitor production performance. It can be applied at the machine, manufacturing cell or plant process level. Making cycle times repeatable and reducing in-batch down-time through improved control and early fault detection delivers a more flexible agile asset with much improved OEE.

ABB’S PAT CENTER OF EXCELLENCE (COE) Following the need to offer an integrated approach to PAT, ABB created a CoE in 2004. Its mandate is to develop ABB products and services which will enable customers to reap the benefits of PAT. The PAT CoE builds on ABB Analytical’s experience of providing Pharmaceutical PAT Fourier Transform Infrared) (FTIR) and Fourier Transform Near Infrared (FT-NIR) analysers to the market for the past 10 years, as well as ABB’s position as a leader in Automation and Control, in particular with its 800xA platform.

The PAT CoE leverages ABB’s global resources, which include experienced research and development personnel, application specialists, chemometricians, process engineers, IT engineers, senior validation consultants and advanced process control specialists. Its mandate covers the entire range of PAT applications: • Initial integration with Manufacturing • Excellence programs • Multivariate analysis • Basic and advanced analysers • Data gathering

FT-IR/NIR ANALYTICAL SOLUTIONS FT-NIR is, by far, the most widely used and proven analytical technology for PAT applications. ABB has 10 years of experience in supplying off-line, at-line and on-line FTIR/NIR PAT solutions to the pharmaceutical industry and is a preferred supplier of most of the leading companies. Turnkey analytical solutions are provided for research and development for scale-up, drug substance, and drug product manufacturing. Typical drug substance solutions include: • Reaction monitoring • Fermentation monitoring • Crystallisation monitoring • Dryer monitoring • Solvent Recovery monitoring 36

Process Analytical & Diagnostics

23/09/2008

16:50

Page 3

P R O C E S S A N A LY T I C A L T E C H N O L O G Y

PAT solution for the scaled-up process

DATA STORAGE - PAT DATA MANAGER: The management of PAT data is highly complex, not only because the flow of information is enormous, but because it also includes a mix of data formats (spectral, vector and scalar data) that makes it difficult for standard historians to handle. Furthermore, the centralisation of PAT data is not sufficient as it needs to be combined with the batch information coming from the process control system (PCS) and the business systems.

ABB’s PAT data manager is unique in that it stores all the data in a single distributed database and can handle huge flows of both scalar and vector data coming from the analysers, the PCS and SCADA systems. It handles the batch structure data, the vector and scalar data, alarms and events, as well as a complete audit trail. It can also exchange data with other third party historians.

Typical drug product applications are: • Raw material identification • Blend monitoring • Spray coating monitoring • Fluid bad dryer monitoring • Solid dosage form content uniformity • Moisture in lyophilized solids Even though the available analytical technology fulfills a wide variety of measurement needs, there is still a very wide Information Technology gap which is preventing the industry from efficiently gathering and using this data in real-time for process understanding and control. To be more specific, most of the advanced PAT analysers currently available do not share a common user interface and data format, and do not offer the connectivity required to efficiently exchange this data with plant and business systems. Furthermore, the data is highly scattered and is not available in real-time in a central location.

DATA MINING, VISUALISATION, MULTIVARIATE ANALYSIS, AND BATCH MANAGEMENT: The IndustrialIT for PAT suite includes a wide range of modules to provide an operator workplace, central method configuration, multivariate analysis batch configuration and management, as well as asset management for analytical and process equipment. The system also has the ability to connect to third party commercial multivariate analysis tools for offline and real-time predictions.

CONTROL THE INDUSTRIAL IT FOR PROCESS ANALYTICAL TECHNOLOGY SUITE:

Controlling processes in a flexible and repeatable manner requires process understanding to be realised within regulatory and advanced control environments, while at the same time taking advantage of a range of process models. This is facilitated by dynamic solutions – predict, control and inferential measurement platforms which integrate with operator interface, and regulatory control and process data management components.

To address these drawbacks, ABB is currently developing an Industrial IT PAT suite that features an integrated IT platform using proven analytical and automation core components. This platform is based on the award winning 800xA Industrial IT Automation technology).

The concept is based around a flexible, modular, scaleable and open architecture which uses OPC – a standard communication protocol – to exchange data between modules.

THE WAY FORWARD PAT provides an opportunity to move from the current “testing to document quality” paradigm to a “continuous quality assurance” paradigm that can improve a company’s ability to ensure that quality has been “built-in” or is “by design”. Not only that, but it gives companies a greater insight and understanding of their processes; it provides the potential for significant reduction in production (and development) cycle times; and it minimises the risk of poor process quality.

PAT will revolutionise the way pharmaceuticals are made and will forever change the face of the industry. This is why ABB’s investment in PAT is the single biggest development initiative in Life Sciences, and it also presents the company with an exceptional opportunity to become the market leader in Life Sciences.

FTSW800 – ANALYSER CONTROL PROCESS SOFTWARE FOR DATA ACQUISITION This flexible, open architecture process analyser software is designed for implementing analytical methods and control sequences. It offers a single platform for the local control of multiple analysers from spectroscopy (IR, UV-VIS, Raman etc) to other advanced analyser types (particle size, acoustics, HPLG, mass spectroscopy etc). In addition, it provides unified engineering and operator interfaces as well as tools for multivariate analysis and predictions.

37

kells stainless

18/09/2008

16:49

Page 1

S TA I N L E S S S T E E L V E S S E L S

KELLS STAINLESS CELEBRATES 20TH ANNIVERSARY

O

n June 19, 1988, Kells Stainless Ltd opened its doors for business and this year, the company celebrates 20 years in operation. Although on a newly purchased five-acre site and with a new name, Kells Stainless personnel already had 18 years of Stainless Steel fabrication experience gained from working with Bailie Engineering, a Stainless tank fabrication company which was based in Bailieborough, Co. Cavan.

Founded by key personnel from the former Bailie Engineering facility and using plant and equipment purchased from the engineering site, Kells Stainless hit the ground running and immediately became a major player in the growing Stainless Steel Vessel manufacturing industry.

Flexibility to manufacture Tanks, Vessels and Modular Skid Assemblies for a wide range of industries from Chemical, Food & Beverage to Pharmaceutical and Biotech, has meant that Kells have been able to build up long term working relationships with their clients and customers all over the world.

INTERNATIONAL CLIENT BASE Kells have a 40% export market that is supported by a Sales and Design office based in the UK and have recently exhibited at Interphex Asia in Singapore, with a view to growing their worldwide market, especially within the Pharmaceutical & Biotech sectors.

Recent investment in state of the art fabrication equipment and a new 1,000 square metre Clean Factory Acceptance Test facility, paves the way for future growth for Kells, and provides them with the ability to meet specific customer requirements and to copperfasten Kells Stainless’ position as a complete Process Engineering Solutions provider.

For more information go to www.kellsstainless.com or e-mail info@ksl.ie.

MEETING CHALLENGES Key to Kells’ success over the years has been their ability to predict changes in industry trends and to implement internal changes within the organisation to meet every new challenge. These challenges have required substantial investment in personnel, premises, plant and technology and this has kept Kells ahead of their competitors and they continue to lead the way in having strong industry recognition of quality product and performance.

38

Conterfeit

18/09/2008

14:38

Page 1

COUNTERFEIT MEDICINES

SECURE SUPPLY CHAIN TO COMBAT COUNTERFEITERS Counterfeit medicines pose a growing threat to European patients’ health, writes Ronan Collins, Communications Manager, Irish Pharmaceutical Healthcare Association Ltd.

T

oday, international traders take advantage of more open borders and new technologies such as the Internet to conduct their criminal business without any scruples for people's health. Though traditionally rare in Europe, this growing threat needs to be tackled, in particular, by making the entire European pharmaceutical supply chain as tight and secure as possible.

Counterfeit medicines are any medicines and active pharmaceutical ingredients (APIs) that are deliberately and fraudulently mislabelled by unauthorised parties with respect to source and/or composition and/or therapeutic quality. They have been found to contain toxic substances, no active ingredient, or the wrong amount of it. Life-saving medicines are increasingly targeted, including medicines to treat cancer and heart disease, psychiatric disorders, and infections.

Counterfeiting is attractive because it is a lucrative activity with little risk of being caught. Globalisation has lead to relaxed barriers to trade, thus facilitating the circulation of counterfeit products and a plethora of actors are now operating internationally or through the Internet and therefore outside the jurisdiction of national regulators.

ficking in counterfeit medicines are required immediately.

The World Health Organisation (WHO) estimates that 8-10% of the medicines in the global medicine supply chain are counterfeit, reaching as high as 25% in some countries.

The largest counterfeit market with close proximity to the EU is Russia, where it is estimated that 12% of medicines are counterfeit (Source: Association of International Pharmaceutical Manufacturers (AIPM) and the Coalition for Intellectual Property Rights (CIPR) 2002).

An in-depth report by the European Alliance for Access to Safe Medicines (EAASM) entitled the Counterfeiting Superhighway (www.eaasm.eu/Media_Centre/News/The_Counterfeiting_Super highway), examining internet pharmacies and lifesaving medicines purchased online, revealed that a frightening 62% of medicines purchased online are fake or substandard. These include medicines indicated to treat serious conditions such as cardiovascular and respiratory disease, neurological disorders, and mental health conditions.

DETERMINED ACTION IS NEEDED It is time for Europe to act as the driving force in the fight against this deadly crime. Organised crime gangs are operating on an international scale and playing with human lives in the name of profit, and these must be dismantled through determined action, systematic prosecution and appropriate sanctions (civil and penal). Penalties in place in Member States today are inadequate.

Patients must also be encouraged to purchase prescription medicines through authorised distribution channels only.

Only then can patients be guaranteed to be getting a genuine pharmaceutical product.

Proposals for tougher EU legislation are expected before the end of 2008, as part of a new ‘pharmaceutical package’ being developed by the European Commission. Options outlined by the Commission in its public consultation document in March 2008 include obligatory product sealing and a ban on medicine repackaging.

The need for action is urgent, no further time can afford to be lost if patients’ lives are to be protected.

THE SCALE OF THE PROBLEM EU statistics released in May 2008 show that over 4m medicinal products (articles) were seized at EU customs borders in 2007. This was an increase of 51% on the 2006 figure. While Internet-based sales are the main source of counterfeit medicines, these products are being encountered at all stages of the supply network: manufacture, distribution and entry through wholesalers, pharmacists and the black market.

The lack of integrity in the supply chain is seen as a facilitating factor. There is no accurate data on the scale of counterfeits in the pharmaceutical sector because they are mainly sold and used in unofficial and uncontrolled settings, thus making them difficult to detect. Or where controls and regulations do exist, reporting is sporadic and not centralised.

Strong EU measures to tackle this growing threat, including a ban on medicine repackaging, a harmonised EU-system of identification of medicines, and heavier penalties for traf39

GS1

23/09/2008

09:57

Page 1

TRACEABILITY

CUTTING DOWN ON MEDICAL ERRORS The EPC Global Network is a technology solution for its time, with proven benefits for the healthcare sector, according to Jim Bracken, Chief Executive Officer, GS1 Ireland.

P

atient Safety issues such as medication errors, counterfeit medicines and the inability to achieve complete traceability of surgical instruments and implants have challenged the key stakeholders in the healthcare sector in recent years. Industry has been searching for practical solutions to deal with the growing threat of counterfeits and the more effective management of product recalls.

Concern about patient safety issues has also forced regulators at national and regional level to respond with new laws requiring more effective tracking of products within the supply chain, from manufacturer to patient, and in the case of implants and instruments, throughout their entire lifecycle.

Healthcare providers are crying out for solutions that will help them to reduce the risk of medical errors. Funding providers to healthcare, both Government and private, are looking for information systems which will give them greater control in order to achieve better value for money.

THE BENEFITS

OF

SECURE NETWORKS

So how will secure networks based on the EPC global architected standards deliver on the range of requirements outlined above? Well essentially it will for the following reasons: - All pharmaceuticals and medical devices will carry GS1 Data Matrix bar codes and/or RFID tags, which will provide access to the following common data content – GTIN (Global Trade Item Number), serialisation (unique ID per unit/patient pack), batch number and expiry date.

- Electronic patient record data held in various databases, such as GP, Laboratory and Radiology Systems and at other treatment centres, will be made available to the point of care via the Network using the EPCIS. - The Network will provide secure access (for trusted parties only) to the following data:

PEDIGREE L AWS Once again, the US has led the way with pedigree laws which require a chain of custody across the entire pharmaceutical supply. The early laws, for example the Florida pedigree, did not refer to any form of electronic documentation but rather naively envisaged paperwork passing from manufacturer through many other supply chain partners, with each one being required to sign their acceptance and accountability.

Fortunately these new demands coincided with the advent of GS1’s RFID division, EPCglobal. As a consequence, the manufacturers became heavily involved in defining requirements for deploying RFID and Bar Codes in order to deliver an electronic or ePedigree solution. In essence, there was no other practical way to meet such onerous regulation. A key reason for choosing EPCglobal was not just the RFID technology but also its concept of the EPC Network. The network architecture allows the sharing of critical data via a secure intranet between trusted parties across the entire supply chain: as you might say it’s not the technology, it’s the data, stupid.

The illustration shows how the network operates.

1. The product master data.

2. Manufacturing information – batch and expiry etc.

3. A complete lifecycle for stakeholders such as the IMB (Irish Medicines Board), especially important in the case of a product recall. The latter feature will be achieved because each time a tag or data matrix bar code is captured along the supply chain, this will provide a time and date stamp as well as location confirmation.

40

GS1

23/09/2008

09:57

Page 2

T R A C E A B I L I T Y / PA C K A G I N G I R E L A N D 2 0 0 9

SUPPLY CHAIN INTEGRITY

Some of the other benefits of these secure networks include:

By recording every transaction between all the parties across the entire supply chain, from manufacturer to patient, it will be possible to identify if product goes missing and where and also to provide a means of product authentication before a product is dispensed in a pharmacy. This capability will help to prevent counterfeit products entering the normal pharma supply chain, an all too regular occurrence in recent times.

MEDICAL ERRORS It is widely accepted that hospital patients have a 1 in 9 chance of experiencing an adverse event. This can be anything from minor incidents to serious failures causing death or significant harm to the patient. Medication errors already account for over 20% of all medical errors and continue to increase. With real time availability of clinical data, coupled with the ability to scan patient packs containing product ID, batch and expiry information, it will be possible to attack 90% of the root causes of the problem (56% arises at the prescribing/ordering stage and a further 34% at the point of medication).

PRODUCT RECALL At present, it is impossible to effect 100% recall of a product withdrawn from the market. On average, more than 33% of products are never recovered. Furthermore, the costs of managing a single recall run in to tens of millions of euro.

With the visibility provided by the network, virtually 100% of products subject to recall could be located and withdrawn.

MEDICAL DEVICE TRACEABILITY

RE-IMBURSEMENT FRAUD

In a similar way, the current medical errors (involving instruments and devices – infection caused by cross contamination due to unclean instruments and inability to track individual implants to particular patients) could be greatly reduced through improved Track & Trace capability due to having certainty of identification through scanning and linking to patient records. Given that some implants today have a life expectancy of 15 plus years, the accuracy of identification of the device to the patient is critical.

Many European Governments have attempted to counteract this fraud, where the patient is provided with a cheaper (generic) drug in place of the branded one prescribed, but the Re-imbursement body is charged with the more expensive item. By having each patient pack bar-coded or tagged with a unique identifier, simply by scanning the code, an audit trail will be established and fraudulent overcharging will be identified and stopped

PACKAGING IRELAND 2009 EUROPEAN packaging show specialist easyFairs, which organises around 20 packaging shows across Europe, brings the inaugural easyFairs Packaging Ireland to the RDS, Dublin, on June 17 and 18, 2009, heralding an exciting opportunity for pharmaceutical companies to discover innovative new packaging solutions.

The show will mirror the easyFairs model of cost- and time-effective shows for people who want to do business. It’s a no-nonsense formula that’s proved popular in the UK – the expo held at Birmingham’s NEC in March attracted 360 exhibitors and a record 3,925 visitors – and the Continent.

Many leading packaging companies such as Ashtown, Greiner and pharma specialist Catalent Ireland have already committed themselves to easyFairs’ Packaging Ireland.

The event will showcase the latest packaging design innovations, eco-friendly materials and sustainable packaging solutions, plus packaging machinery, printing systems, robotics automation, and converting technology.

Peter Heath, Managing Director of easyFairs UK, said: “Ireland demands its own packaging show, a place where the thriving packaging community can meet key buyers and decision makers. I’m confident easyFairs’ Packaging Ireland can grow to become as successful as our shows in the UK and Europe. I envisage the show will comprise mainly Irish exhibitors, with small, niche suppliers exhibiting alongside

larger companies, but also appeal to many European packaging suppliers who exhibit at easyFairs’ editions elsewhere.”

And he believes the low-cost, low-fuss easyFairs formula will prove particularly attractive during today’s challenging economic climate: “At times like this, companies are focused on getting an even better return on their investment. easyFairs’ packaging shows enable exhibitors to do business, develop new contacts and make sales at a fraction of the cost of a traditional trade show.”

- For further information and stand bookings, contact Marc Benoit on +0044 208 622 4421 (e-mail: marc.benoit@easyfairs.com) 41

Goliath

18/09/2008

16:12

Page 1

P A C KA G I N G

GOLIATH: THE PACKAGING GIANT Goliath Packaging Systems Ltd sources, supplies, installs and offers after-sales service on a comprehensive range of end-of-line packaging, materials handling, and washing equipment to the Irish pharmaceutical and chemical marketplace.

W

Goliath is the Irish partner to a number of ith direct industry experience internationally known packaging equipment gained through many years of suppliers. The capabilities of the more important successful project delivery in of these international partners (to the Ireland, the expertise of its interPharmaChem sector) are highlighted below. national partners/suppliers and the skills of its factory trained staff, Tipperary-based Goliath Packaging Systems Ltd is perfectly positioned to FILAMATIC meet the demands of its customers in the pharmaceutical and chemical sectors.

Filamatic has designed and manufactured liquid The company recognises the importance of the filling equipment for over 50 years. Servicing the PharmaChem sector to the Irish economy and pharmaceutical, biotech, diagnostic, healthcare, concentrates on this critical market segment via specialty chemical and food industries, Filamatic its trading division, Goliath Pharma. provides a wide range of equipment that can be The Goliath Pharma product range consists customised to suit a client’s unique application of the following distinct items; and/or budget. Each unit is custom built to proNewman Labelling Systems has • Liquid Filling Systems vide increased throughput and faster changeover, been a world leader in the supply • Shrink Wrapping & Over Wrapping while reducing downtime and increasing overall of pharmaceutical labelling sys• Case Erecting, Case Packing & Bag-in-Box tems for over 60 years. equipment effectiveness.

Lining Systems Filamatic offers a comprehensive equipment • High Speed Labelling Systems portfolio from easy to use semi-automatic benchtop units to fully • Case Sealing automatic, integrated packaging systems. The semi-automatic • Conveying Systems benchtops are ideal for start-up companies, R&D departments, • Pallet Inverting (Fixed, Mobile & Automatic In-line) short production runs and budget conscious projects. The auto• Pallet Stacking / Handling matic range includes Monobloc, In-Line and Molten Product • Scissors & Vacuum Lifting Systems Fillers plus In-Case Filling/Capping Systems. The automatic fill• Materials Handling Systems ing system range can also incorporate a variety of functions • Pallet Elevating Systems including sorting, plugging, stoppering, crimping, capping, • Palletising Systems (Gantry, Articulated Arm & Layer) induction sealing and/or labelling as necessary. With precision • Stretch Wrapping filling pumps that can accommodate free-flowing, semi-viscous • Strapping Systems (Case & Pallet) and viscous products, Filamatic equipment is designed to work • Washing Systems (Pallet, Box, Tray, Drum, Bottle & IBC) with an array of container types such as bottles, vials, tubes and • AGV Transport pails.

• Warehouse Management Systems (WMS)

PESTER In addition, the following complementary (ancillary) items are provided by Goliath in order to offer a fully integrated turn-key service; • Weighing Systems • X-Ray / Metal Detection

Pester is a leading international manufacturer and supplier of shrink wrapping, case packing and palletising equipment with a particular focus on the pharmaceutical industry. In business since 1888 and with over 280 employees, the company ensures that all customers’ packaging requirements are satisfied with machines of the highest reliability and quality.

With Irish references at P & G, Braun Oral-B, IVAX, Genzyme, GSK and Pfizer, amongst others, Pester has proven itself to be one of the best international providers of validated equipment in this specialist field.

Goliath also offers a Project Management / Packaging Consultancy Service to assist in the early determination of customers’ particular packaging equipment requirements.

Goliath serves the following segments of the Irish market: Pharmaceutical; BioTech; Chemical; Healthcare; Medical Devices; Contract Packing etc.

42

220 x 307mm:Layout 1

18/09/2008

16:56

Page 1

Shrink Wrapping

Bag-In-Box

Banding

Case Sealing

Liquid Filling

Conveying

Case Erecting

Labelling Systems

Case Packing

Check Weighing

Leaflet Dispensing Metal/X-Ray Detection

sales

●

installation

●

service

T: 067 37893 F: 067 34794 M: 087 1222816 info@goliath.ie www.goliath.ie BEECHWOOD, NENAGH, CO. TIPPERARY Pallet Inverting

Palletising

Scissors Lifting

Stretch Wrapping

Vacuum Lifting

Strapping

Reel Handling

AGV Transport

Drum Handling

Washing Systems

Pallet Elevation

Warehousing

sales

●

installation

●

service

Goliath

18/09/2008

16:12

Page 2

P A C KA G I N G

The comprehensive product range incorporates both semi and fully automatic systems, plus mobile and fixed options. Today, with a strong base in Europe and over 2,000 global installations, Toppy has proven itself to be a reliable partner for safe and costeffective pallet exchange and is one of the most important global players in this specialist field.

MJ MAILLIS MJ Maillis UK, a part of the global Maillis Group is expert in the supply of automated/integrated strapping and wrapping systems. Based in Nottingham, MJ Maillis has enjoyed many years of successful project delivery, with over 2,000 installations.

With wide ranging packaging expertise and an outstanding choice of high quality semi-automatic, automatic and high speed strapping and stretch wrapping solutions, MJ Maillis is superbly placed to meet all clients’ complete end-of-line packaging needs.

Soco System provides a complete range of end-of-line packaging equipment, via Goliath Packaging Systems Ltd.

NEWMAN L ABELLING SYSTEMS Newman Labelling Systems has been a world leader in the supply of pharmaceutical labelling systems for over 60 years and has built up an enviable reputation for high quality labelling equipment to meet the specific regulatory demands of the international pharmaceutical industry. The secret behind Newman’s success can be attributed to a combination of accuracy and reliability of equipment, quality and speed of validation, quality of after-sales service, engineering capability, staff experience and the stability of the company.

Newman’s products are designed and built to meet and surpass the rigorous quality requirements of the pharmaceutical industry. In addition, the company provides full validation service to FDA, European and other national and international standards, enabling easy progress through the necessary qualification procedures.

JBT Automated Guided Vehicle Systems by JBT (formerly FMC Technologies) provide automated material movement for customers in a variety of industries including pharmaceutical, chemicals/plastics, warehouse/distribution and manufacturing. JBT is a world leader in AGV supply, with over 20 years’ experience.

JBT engineers develop the most cutting edge AGV technology, in order to continue to provide guided vehicle solutions to the most unique materials handling challenges.

SUMMARY

SOCO SYSTEM

Goliath understands the specific needs of the PharmaChem sector. From liquid filling, shrink wrapping, case-packing, labelling, palletising, inverting to high speed washing, via partnerships with the above international companies, Goliath has positioned itself as a major provider of packaging equipment to this discerning sector.

Centrally located in Nenagh, Co. Tipperary, Goliath is less than two hours from all of major markets, while trained engineers maintain spare parts and service all equipment installed with annual service contracts (reactive / preventative) available as preferred.

Based in Denmark and founded in 1964, Soco System provides a complete range of end-of-line packaging equipment to the PharmaChem sector. Incorporating carton erecting, pick & place, sealing, conveying, palletising and stretch wrapping solutions, amongst others, the company enjoys turnover in the region of €30m per annum.

NEWSMITH The Newsmith name is synonymous with robust and reliable washing systems, designed for the particular requirements of the PharmaChem industry. Newsmith have been manufacturing washing equipment since 1968 and have supplied hundreds of systems to the PharmaChem sector, including Irish references at Organon, Pfizer, UCD and UCC, amongst others.

The Newsmith range includes the Series 80 Rack Washers (laboratory sector), Dynajet Cabinet Washers (trays, containers, pallets on trolleys), Rotary Bin Washers and high speed Conveyorised Systems (trays, drums, pallets, IBC’s etc).

CONTACT DETAILS To discuss your particular packaging equipment needs, please contact Goliath as follows; Goliath Packaging Systems Ltd Contact: George O’Leary, Director Beechwood, Nenagh, Co. Tipperary, Ireland.

Tel: (067) 37893 Fax: (067) 34794 Mobile: 087 1222816 E-mail: info@goliath.ie / service@goliath.ie Web: www.goliath.ie

TOPPY Toppy, based in Italy, specialises in providing a complete range of pallet inverting, retrieval, transfer and exchange equipment.

44

Toyota/Plastic Providers

23/09/2008

17:18

Page 1

Flygt. The New Generation N-Pumps.

They might just live forever.

Chances are, that every day you run your pumping operation, your costs are creeping up and up: maintenance, servicing, the cost of replacement.

So the New Generation N-Pumps could bring a brighter start to your day.

The N-technique, patented by Flygt, features a self-cleaning impeller that, together with an integrated relief groove in the pump housing, ensures sustained high hydraulic efficiency and clog resistance.

The N-impeller is designed to prevent clogging and maintain higher pumping efficiency over longer periods.

The Spin-out™ seal protection system prevents particles from damaging the seals.

New, improved cooling means the motors operate more efficiently, and at lower temperatures. And the new Plug-in™ seal system means that if you do have to replace a seal, it’ll take just a few minutes. Have a nice day. Day after day.

Call us for more information, or visit our website.

www.flygt.ie

ITT Water & Wastewater Ireland Limited 50 Broomhill Close, Airton Road, Tallaght, Dublin 24 Tel: 01-452 4444. Fax: 01-452 4795

Higdc\Zg id\Zi]Zg# 7I >cYjhig^Zh <gdje ]Vh WZXdbZ V eVgi d[ IdndiV >cYjhig^Zh 8dgedgVi^dc! [jgi]Zg higZc\i]Zc^c\ l]Vi ^h VagZVYn i]Z ldgaY aZVYZg ^c bViZg^Vah ]VcYa^c\! IdndiV# Cdl IdndiV BViZg^Va =VcYa^c\ <gdje XVc d[[Zg ndj ZkZc bdgZ XdbeaZiZ hdaji^dch ^c adVY^c\! jcadVY^c\! ]dg^odciVa igVchedgi! hiVX`^c\ VcY dgYZg e^X`^c\# IdndiV ]VY VagZVYn hZi i]Z hiVcYVgY# Cdl! id\Zi]Zg l^i] 7I! lZÉgZ eaZVhZY id hZi i]Z WVg ZkZc ]^\]Zg# lll#idndiV"[dg`a^[ih#^Z 9edjWYj0 JeoejW CWj[h_Wb >WdZb_d] ?h[bWdZ Wj JeoejW ?h[bWdZ" A_bb[[d HeWZ" :kXb_d '($ J[b0 &' *'/&(&&

Clinical Trials

18/09/2008

14:42

Page 1

CLINICAL TRIALS

CREATING AN ECLINICAL PLATFORM According to a new report from Datamonitor, the paperless clinical trial could be far closer than you think.

L

ife sciences companies globally are turning to eClinical solutions in a bid to cut costs during clinical trials. On average, life science companies spend between $12-17m yearly on mailings and copies of paper case report forms. With the implementation of eClinical solutions, a company could save anywhere from $10-15m a year on paper and postage alone, according to a new report by Datamonitor.

The report, which investigates technology solutions that will be integral to streamlining the clinical trials process, thus lessening the burden on life science companies, says firms spend nearly $1 billion to bring a new drug to market, of which $500700m is spent on clinical trials. Several pharmaceutical companies and contract research organisations have already developed strategies to use electronic data capture (EDC) for 100% of their trials by 2012. Although there are several roadblocks ahead, Datamonitor believes the adoption of EDC will be rapid through to 2012, at which point it will plateau out. The industry will also see an increase in the adoption of clinical trials management systems (CTMS) as management becomes a greater issue due to the globalisation of clinical trials.

in each treatment arm, which could change mid-trial. eClinical technologies play a vital role in the successful implementation of an adaptive trial. Adaptive trials require continuous analysis and monitoring of unblinded clinical data, which is performed by a group of statisticians and researchers who are not allowed to communicate with the rest of the clinical research team. eClinical solutions empower sponsors, researchers and statisticians with real-time data, enabling them to make critical modifications to the trial.

An eClinical platform does not consist of just an EDC or CTMS solution, but rather a whole suite of systems.

Currently, these systems exist in silos and are connected through point-to-point integrations. To fully leverage the benefits of these technologies, eClinical solutions must be built on an interoperable framework that will enable life science companies to run clinical trials in a more efficient manner, since many redundancies which currently exist in the point solutions would be eliminated. An interoperable platform would allow for greater visibility into the clinical research process, and greater collaboration among various departments and stakeholders within an organisation.

DATA COLLECTION AND MANAGEMENT The adoption of EDC and CTMS solutions will be integral in enhancing and transforming the data collection and management aspects of a trial. An efficient eClinical platform will provide companies with substantial cost and time savings and will play a vital role in changing the research process for the better.

There has been a lot of talk of conducting adaptive trials as a means to accelerate the drug development process.

Through this process, pharmaceutical and biotech companies have the flexibility to analyse study data before the end of the trial and change its design in order to either improve the chances for a better positive result or cancel the trial if the drug appears ineffective.

SLOW ADOPTION OF EDC While clinical solutions, particularly EDC, have existed for more than 20 years, adoption of these systems has been much slower than initially anticipated, due in large part to a lack of support from end-users.

EDC adoption requires a major organisational and process paradigm shift. Many researchers and investigators who are accustomed to the paper-based system are not ready to make that change. Until all stakeholders in the clinical trial process are educated on the true features and benefits of modern clinical technologies, and are willing to make the necessary mental and cultural adjustments, implementation of eClinical solutions will remain sluggish.

BENEFITS OF EDC/CTMS EDC allows for a centralised, standard workflow to easily collect, clean, validate and manage patient data. It provides realtime, permission-based access to high quality data, which is critical to a time-sensitive process in which only a limited userbase may be exposed to the information.

CTMS provides a platform to track and manage all nonpatient information related to a trial. CTMS allows sponsors to maximise clinical supply usage, based on patient enrolment 46

Recruitment

18/09/2008

14:45

Page 1

RECRUITMENT

PHARMACHEM SECTOR REMAINS ROBUST

T

he recent downturn in the Irish economy has hit many manufacturing industries quite hard but the pharmaceutical industry remains robust and seems to be coping well with troubled economic conditions.

The pharmaceutical industry directly employs over 17,000 people in Ireland and 13 out of the top 15 global companies have operations in Ireland. This, combined with 26,000 people in the medical technologies industry, would indicate that opportunities abound for skilled scientists and engineers.

Foreign investment has been critical in Ireland’s development as a global pharmaceutical centre. The IDA has successfully attracted global corporations to Ireland since 1964, when Bristol Myers Squibb opened their Swords plant. Over the intervening 44 years, Ireland has developed into a world leader in the pharmaceutical industry. Given Ireland’s size and location, it has become a major exporter of pharmaceutical products, with export values at €29.7 billion, which account for 40% of Ireland’s manufactured export goods.

The pharmaceutical and chemical sector is coping well, despite troubled economic conditions, according to Berkeley Recruitment.

I RELAND

AS AN

P OTENTIAL P ITFALLS

We have seen there are a good many reasons for optimism in the pharmaceutical side of things: however, there are a number of factors that could alter that. One possible problem is the reduction in the number of science graduates over the coming years and this is being redressed by government and universities. The continued development of economies like China, Singapore and India could destabilise our position as global leader, as these countries may be able to offer more competitive locations for the manufacturing function of these industries.

Although there are a number of threats to the future of the industry, the overall trend would suggest the future of the pharmaceutical industry in Ireland is secure. The length of time the industry has been based in Ireland, the broad range of support functions offered by established companies from a services, infrastructural and technical point of view, coupled by high level of investment, would suggest the future of the industry is strong.

E XPORTER

B RIGHT F UTURE

With a weakening US dollar, strengthening euro, US credit crunch and a plethora of knock-on global economic effects, how will this effect Ireland’s position and competitiveness as an exporter in the world market?

Undoubtedly, other manufacturing industries have been hit hard and have faced shut downs and relocations, but the pharmaceutical industry has remained quite strong. There are many reasons for this, primarily being that the industry is very much knowledge based and is reliant on a highly educated, highly skilled and experienced workforce. The expansion, development and investment in the R&D function by some of the leading pharmaceutical companies would suggest that the long term future of this industry is secure, as companies generally prefer to have their R&D function and manufacturing functions close to each other.

The industry has shown a remarkable robustness and has continually developed and evolved within a changing marketplace over the last 40 years. Initial activity was centred on the production of bulk active materials, but has been followed by investment in finished product, to a situation where many facilities specialise in product development for global markets. This level of adaptability and growth, coupled with a strong knowledgeable work force, would indicate that the industry should continue to grow.

At Berkley Pharmaceutical, we have found that the demand for highly skilled and motivated individuals is still as strong as ever. We are committed to finding the best candidates in the industry and finding the best possible roles to meet and develop their skill set, helping to maintain Ireland’s position as global pharmaceutical leader.

47

SRI

23/09/2008

13:05

Page 1

PHARMACEUTICAL SOLUTIONS

HANDLING & PACKAGING EXPERTS •

Conveying & Materials Handling Systems

•

End of Line Packaging Systems

•

Control & Automation Solutions

With 40 years experience Odenberg offers excellence in best practice design, manufacture, installation & commissioning and after sales service to meet your individual and productivity needs.

Official Integrators for Kuka, PWR and Gudel Robots 2004 Orchard Avenue, Citywest Business Campus, Naas Road, Dublin 24, Ireland.

Tel: + 353 1 413 62 00 Fax: + 353 1 457 02 19 Email: info@odenberg.ie

www.odenberg.ie

Economic Outlook

18/09/2008

16:05

Page 1

ECONOMIC OUTLOOK

TOWARDS A NEW BEGINNING! There may be some belt-tightening ahead, but Ireland has the economic and cultural characteristics to ride out the current storm, according to Helen McGardle, MD, Science Recruitment Ireland.

T

he comfort of having 13 of the top 15 pharma companies with facilities located in Ireland now provides little solace to the sector. The competitive advantage that we offered against other nations (a hardworking, educated English speaking workforce combined with attractive grants and low corporation tax) has been overtaken by EU accession countries with harder working people, cheaper cost bases and even lower corporation tax, rendering our competitive advantage impotent. Add to this the growing bases of China, India and Asia, who previously were distanced in term of politics, geography, language, quality, and technical ability.

Technology has effectively erased these as barriers to doing business in warp-speed time.

So what’s left for Ireland? David McWilliams, our own pop economist, recommended that it was the diaspora in South America that would save us – grandchildren of Irish emigrants who would revitalise the flagging tiger! That was only months ago when we were looking for more workers: by mid ‘08, we are a net exporter of labour.

RATIONALISATION for its deployment is again in the forum of the Government, who are deploying support, both financial and technical, to bring the new dawn, a dawn for Ireland which will be based on its people’s ability to innovate to a new level, offering a knowledge-based economy.

So while we cut prices to maintain some semblance of competitiveness, we accept the ‘doom & gloom’ of the now official ‘recession’, but we do not have to accept this as our lot in the long-term. It is anticipated that those manufacturing entities with big infrastructural investment in Ireland are mandated to be ever-more competitive, but the hope that we will ever again attract large manufacturing facilities, allowing newspapers to trumpet ‘1000 new jobs for …” cannot happen. The standard and cost of the style of living we now enjoy and a newspaper headline like this are mutually exclusive!

So we are ‘transitioning’, and change does not come without pain. Europe has been consistently and vainly looking for us to temper our rise to glory: we stood steadfast in the pursuit of further increases! Well, now we have no option but to comply! Following direction or advice is not our strong point: the carrot has to be replaced by the stick!

So live with it we will, but the spirit will rise to create the next dawn.

Losing jobs is not necessarily an evil, as long the process is controlled and leads to greater efficiencies. The affected individuals may not feel as strategically orientated, but having an unprecedented importation of labour, it would be naive to consider that it could have continued. We are now in a ‘national’ rationalisation. An organisation going through a ‘rationalisation’ is supported and viewed positively by its investors. A national rationalisation can make us lean and better able to compete.

So where is the ‘gold’ for the next generation? If Ireland were to be known for anything, it has to be the ingenuity of its people. Innovation and creativity have been at our centre as a nation and people since early times: our people’s ability to succeed against overwhelming odds.

Our one replicable, sustainable competitive advantage is the ingenuity of the Irish bloodstream. Ireland has put pieces on the Ariana rocket and introduced mobile telephony to countries 10 times its size.

KNOWLEDGE BASED ECONOMY The base for our new beginning we already have: ingenuity, education and hard-working people. The opportunity 49

uni research

18/09/2008

14:50

Page 1

RESEARCH & DEVELOPMENT

INVESTING IN THE FUTURE Ireland’s universities are at the forefront of research in the healthcare and pharmaceutical sector, with some notable international achievements.

I

rish universities are not just centres of learning: they also provide facilities that are of real, tangible benefit to businesses in their drive to increase competitiveness through innovation, nowhere moreso than in the field of life sciences, with knock-on effects for the pharmaceutical and chemical industries.

The strengths of the university in research have greatly benefited from a strong focus in key areas of excellence and these include immunology, where Trinity has contributed significantly at a global level.

For example, research performed by the institute has identified the genes responsible for childhood eczema and identified new genes for coeliac disease. In addition, work has identified genes that contribute to the immune response to major infectious agents, such as TB, malaria and viral hepatitis.

The Biosciences at Trinity are developing rapidly, in terms of quality and scale.

TCD has started the Biosciences complex building project, which will be complete by 2010, delivering up to 33,000 square metres of research and research-related teaching space.

UCD At University College Dublin, NovaUCD supports innovation and technology transfer at the college.

NovaUCD has supported a number of commercial ventures involving the licensing of UCD technology to establish new companies.

Notable successes include the development and licensing of a BSE test, which to date has generated €2m in royalty income for UCD. The Technology Research for Independent Living (TRIL) Centre is a coordinated collection of research projects addressing the consequences of ageing. The TRIL Centre’s mission is to discover and deliver technology solutions which support independent ageing, ideally in a home environment. Bringing together Intel researchers with interdisciplinary researchers from University College Dublin, Trinity College Dublin and National University of Ireland, Galway, the TRIL Centre is one of the world's largest R&D collaborations on this important topic, and has made Ireland an international centre of excellence for this work.

DCU Meanwhile, Dublin City University (DCU) recently launched its Contract Researchers’ Association (DuCRA).

DuCRA endeavours to represent its members through discussion and dialogue with all appropriate third parties with the aims of improving the professional working environment of research staff and to enhance the university's research environment for the benefit of all.

DuCRA recently launched a policy document, entitled ‘Building Sustainable Research Careers in a Knowledge Based Economy’. This policy document argues that to create a sustainable, world-class research infrastructure in Ireland, the issue of sustainable researcher careers must be dealt with at a national and an institutional level. This will require a change in the thinking of many stakeholders in government agencies, funding bodies, university management and academic investigators alike, changes in the way research in Ireland is funded and the development of a formalised researcher career structure which is supported by all these stakeholder groups, according to DuCRA.

TCD Trinity College Dublin has also made huge advances in medical research. The Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN) is regarded internationally as a flagship nanoscience Institute.

The activity at CRANN is the main driver for Ireland to be ranked 6th globally for research impact. CRANN has a total research staff of 150 people.

50

PC_Chemical Suppliers '08 WIP.qxd

23/09/2008

15:34

Page 1

CHEMICAL SUPPLIERS ACIDS & ALKALIS Albion Chemicals BASF Ireland Ltd Brockley Group Ltd Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Enva Ireland Ltd Fisher Scientific Goulding Chemicals Ltd Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd Scientific & Chemical Supplies Ltd Univar Ltd

BIOCHEMICALS Albion Chemicals BASF Ireland Ltd Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Fisher Scientific Norman Lauder Ltd

BIOCIDES Albion Chemicals BASF Ireland Ltd Camida Ltd Chemco Ireland Ltd

CATALYSTS Albion Chemicals Allchem Performance BASF Ireland Ltd Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd

CHIRAL COMPOUNDS Allchem Performance BASF Ireland Ltd Camida Ltd

Corcoran Chemicals Ltd Norman Lauder Ltd National Chemical Co. Ltd

EXCIPIENTS Albion Chemicals Allchem Performance BASF Ireland Ltd Betco Marketing Ltd Brockley Group Ltd Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd Univar Ltd

FINE CHEMICALS Albion Chemicals Allchem Performance BASF Ireland Ltd Betco Marketing Ltd Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Fisher Scientific Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd

GASES Albion Chemicals BASF Ireland Ltd Corcoran Chemicals Ltd National Chemical Co. Ltd

HETEROCYCLICS Albion Chemicals Camida Ltd Corcoran Chemicals Ltd National Chemical Co. Ltd

INORGANIC CHEMICALS Albion Chemicals Allchem Performance BASF Ireland Ltd

Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Enva Ireland Ltd Fisher Scientific Goulding Chemicals Ltd Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd Scientific & Chemical Supplies Ltd

L ABORATORY REAGEANTS BASF Ireland Ltd Cambio Ltd Carbon Group Corcoran Chemicals Ltd Fisher Scientific Scientific & Chemical Supplies Ltd

MISC. CHEMICALS Allchem Performance BASF Ireland Ltd Betco Marketing Ltd Brockley Group Ltd Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Enva Ireland Ltd Fisher Scientific Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd Scientific & Chemical Supplies Ltd

OILS, FATS AND WAXES Albion Chemicals BASF Ireland Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd

ORGANIC INTERMEDIATES Albion Chemicals Allchem Performance BASF Ireland Ltd

51

Ch

i

lS

li

/T

/JM

CHEMICAL SUPPLIERS

IRISH PHARMACHEM 2008

PC_Chemical Suppliers '08 WIP.qxd

23/09/2008

15:34

Page 2

IRISH PHARMACHEM 2008 CHEMICAL SUPPLIERS

Betco Marketing Ltd Camida Ltd Carbon Group Chemco Ireland Ltd Corcoran Chemicals Ltd National Chemical Co. Ltd Topchem Laboratories Ltd Univar Ltd

ORGANOMETALLICS BASF Ireland Ltd Camida Ltd National Chemical Co. Ltd

REAGENTS BASF Ireland Ltd Cambio Ltd Camida Ltd Chemco Ireland Ltd Carbon Group Fisher Scientific

Norman Lauder Ltd Scientific & Chemical Supplies Ltd Univar Ltd

SILANES Allchem Performance BASF Ireland Ltd Camida Ltd Chemco Ireland Ltd Norman Lauder Ltd National Chemical Co. Ltd P.K. Chemicals Ltd

SOLVENTS Albion Chemicals BASF Ireland Ltd Betco Marketing Ltd Brockley Group Ltd Camida Ltd Carbon Group Chemco Ireland Ltd

Corcoran Chemicals Ltd Dalkia Fisher Scientific Norman Lauder Ltd National Chemical Co. Ltd Scientific & Chemical Supplies Ltd Soltec (Ireland) Ltd Univar Ltd

SURFACTANTS Albion Chemicals Allchem Performance BASF Ireland Ltd Brockley Group Ltd Camida Ltd Carbon Group Corcoran Chemicals Ltd Fisher Scientific Norman Lauder Ltd National Chemical Co. Ltd Univar Ltd

Notes

52

C

S

/

/

PC_General Suppliers '08 WIP.qxd

23/09/2008

15:49

Page 1

GENERAL SUPPLIERS ACTUATORS P.J. Boner & Co. Ltd Festo Ltd Flexachem Manufacturing Ltd Hanlon Oâ&#x20AC;&#x2122;Grady & Co. Ltd Schuf Valve Technology

AERATORS ITT Water & Waste Water Ireland Ltd

AGITATORS CPI Technology Ltd Flexachem Manufacturing Ltd Lianco Odenberg Engineering Ltd WrenTech Ltd

AIR FILTRATION/MONITORING /POLLUTION CONTROL Dalkia Lianco Nederman Ltd Shaw Scientific Ltd

ALARMS P.J. Boner & Co. Ltd Dalkia

ALUMINIUM PRODUCTS Smurfit Kappa Packaging Solutions Cork

ANALYSIS SERVICES Anecto Bord na Mona Environmental Consultancy, Monitoring & Laboratory Services Catalent Pharma Solutions Norman Lauder Ltd

ANALYTICAL EQUIPMENT ABB Ltd Beamex Ltd Calibration Technology Classic Technology Ltd

Fisher Scientific National Instruments Pollution Control Systems Ltd Sartorius Mechatronics UK Ltd Scientific & Chemical Supplies Ltd Shaw Scientific Ltd

AUTOCLAVES Fisher Scientific Goliath Packaging Systems Ltd Scientific & Chemical Supplies Ltd Shaw Scientific Ltd WrenTech Ltd

AUTOMATION Allchem Performance P.J. Boner & Co. Ltd Callaghan Engineering Classic Technology Ltd Eurotherm Ireland Ltd Festo Ltd Flexachem Manufacturing Ltd National Instruments Weber Labelling & Coding

BALANCES Beamex Ltd P.J. Boner & Co. Ltd Calibration Technology Fisher Scientific Irish National Accreditation Board Sartorius Mechatronics UK Ltd Scientific & Chemical Supplies Ltd Shaw Scientific Ltd WrenTech Ltd

BARCODING/L ABELLING/ TRACEABILITY P.J. Boner & Co. Ltd Catalent Pharma Solutions Fisher Scientific Goliath Packaging Systems Ltd GS1 Ireland New Era Packaging Ltd Odenberg Engineering Ltd Weber Labelling & Coding

53

BARRIERS SAFETY Odenberg Engineering Ltd WrenTech Ltd

BIOTECHNOLOGY Callaghan Engineering Cambio Ltd Catalent Pharma Solutions CPI Technology Ltd FDT Consulting Engineers & Project Managers Ltd Fisher Scientific Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Norman Lauder Ltd Lianco Prosys Sampling Systems Ltd Shaw Scientific Ltd

BLENDERS Carbon Group CPI Technology Ltd Fisher Scientific Kells Stainless Ltd Lianco WrenTech Ltd

BLOWERS Lianco

BPRV BS&B Safety Systems Ltd

BURSTING / RUPTURE DISCS BS&B Safety Systems Ltd CPI Technology Ltd Flexachem Manufacturing Ltd

CABINETS Festo Ltd Fisher Scientific Lianco Logstrup (Ireland) Ltd Prosys Sampling Systems Ltd Sartorius Mechatronics UK Ltd WrenTech Ltd

GENERAL SUPPLIERS

IRISH PHARMACHEM 2008

PC_General Suppliers '08 WIP.qxd

23/09/2008

15:49

Page 2

IRISH PHARMACHEM 2008 GENERAL SUPPLIERS

CAD Anecto Callaghan Engineering FDT Consulting Engineers & Project Managers Ltd

CALIBRATION Astech Ireland Ltd Beamex Ltd P.J. Boner & Co. Ltd Calibration Technology Classic Technology Ltd Dalkia Eurotherm Ireland Ltd Flexachem Manufacturing Ltd Irish National Accreditation Board Sartorius Mechatronics UK Ltd

CENTRIFUGES Fisher Scientific GEA Process Technologies Ireland Ltd Sartorius Mechatronics UK Ltd Scientific & Chemical Supplies Ltd Shaw Scientific Ltd

CHEMICAL CONSULTANTS Callaghan Engineering Enva Ireland Ltd Topchem Laboratories Ltd

CHROMOTOGRAPHY Fisher Scientific Norman Lauder Ltd Scientific & Chemical Supplies Ltd

CLEANROOMS Charpak Medical Classic Technology Ltd Dalkia Fisher Scientific Sartorius Mechatronics UK Ltd WrenTech Ltd

CLEANING SERVICES/ EQUIPMENT Goliath Packaging Systems Ltd Nederman Ltd

COLD CHAIN PACKAGING

Cross Technical Solutions Interpac Smurfit Kappa Packaging Solutions Cork

COMPRESSED AIR/ COMPRESSORS Festo Ltd

COMPUTER SYSTEMS Eurotherm Ireland Ltd

CONDENSORS

DESIGN P.J. Boner & Co. Ltd Callaghan Engineering FDT Consulting Engineers & Project Managers Ltd GEA Process Technologies Ireland Ltd

DISPERSERS Lianco WrenTech Ltd

DISTILLATION

Cross Technical Solutions Graham Hart (Process Technologies) Ltd

CONDITION MONITORING Beamex Ltd Classic Technology Ltd National Instruments Smurfit Kappa Packaging Solutions Cork

CONSTRUCTION MANAGEMENT Callaghan Engineering

CONVEYORS Goliath Packaging Systems Ltd Lianco Weber Labelling & Coding WrenTech Ltd

COOLING SYSTEMS Cross Technical Solutions GEA Process Technologies Ireland Ltd

DATA ACQUISITION ABB Ltd P.J. Boner & Co. Ltd Classic Technology Ltd Eurotherm Ireland Ltd GS1 Ireland National Instruments Weber Labelling & Coding Zenith Technologies

DEHUMIDIFIERS Cross Technical Solutions Smurfit Kappa Packaging Solutions Cork

Catalent Pharma Solutions 54

Fisher Scientific Kells Stainless Ltd Soltec (Ireland) Ltd WrenTech Ltd

DRIERS Complas Packaging Ltd GEA Process Technologies Ireland Ltd Lianco Prosys Sampling Systems Ltd WrenTech Ltd

DRUMS/CONTAINERS Carbon Group Complas Packaging Ltd Fisher Scientific Industrial Packaging Ltd Interpac Johnsen & Jorgensen Ltd Norman Lauder Ltd Primepac Ltd Soltec (Ireland) Ltd WrenTech Ltd

EDUCATION & TRAINING Calibration Technology FDT Consulting Engineers & Project Managers Ltd Festo Ltd NITL

EFFLUENT MONITORING/ TREATMENT Astech Ireland Ltd P.J. Boner & Co. Ltd Bord na Mona Environmental Consultancy, Monitoring & Laboratory Services Carbon Group Enva Ireland Ltd

PC_General Suppliers '08 WIP.qxd

23/09/2008

15:49

Page 3

ITT Water & Waste Water Ireland Ltd Pollution Control Systems Ltd Prosys Sampling Systems Ltd Scientific & Chemical Supplies Ltd

ELECTRICAL Callaghan Engineering Classic Technology Ltd Cross Technical Solutions

ELECTRONIC COMPONENTS Cross Technical Solutions

ENERGY EFFICIENCY/ MANAGEMENT Bord na Mona Environmental Consultancy, Monitoring & Laboratory Services Callaghan Engineering Cross Technical Solutions FDT Consulting Engineers & Project Managers Ltd Flexachem Manufacturing Ltd Irish National Accreditation Board Sustainable Energy Ireland

ENGINEERING SERVICES ABB Ltd Axium Process P.J. Boner & Co. Ltd Classic Technology Ltd Cross Technical Solutions Eurotherm Ireland Ltd FDT Consulting Engineers & Project Managers Ltd Festo Ltd GEA Process Technologies Ireland Ltd Kells Stainless Ltd Lianco

ENVIRONMENTAL SERVICES/ EQUIPMENT ABB Ltd Astech Ireland Ltd P.J. Boner & Co. Ltd Bord na Mona Environmental Consultancy, Monitoring & Laboratory Services Cross Technical Solutions Enva Ireland Ltd Environmental Protection Agency FDT Consulting Engineers

& Project Managers Ltd Pollution Control Systems Ltd Soltec (Ireland) Ltd

EVAPORATORS Cross Technical Solutions Fisher Scientific GEA Process Technologies Ireland Ltd Graham Hart (Process Technologies) Ltd Lianco

EXPLOSION PROTECTION / PANELS BS&B Safety Systems Ltd Gunnebo Ireland Ltd Sartorius Mechatronics UK Ltd

EXTRUDERS

FLOW CONTROL P.J. Boner & Co. Ltd Dalkia Festo Ltd Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Manotherm Ltd Hanlon O’Grady & Co. Ltd Sartorius Mechatronics UK Ltd

FLUID HANDLING Consolidated Pumps Ltd CPI Technology Ltd Dalkia Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Hanlon O’Grady & Co. Ltd Viking Pump (Europe) Ltd

FUME CUPBOARDS

Lianco Turboair

FANS Nederman Ltd

FILLING EQUIPMENT Goliath Packaging Systems Ltd Lianco Odenberg Engineering Ltd Sartorius Mechatronics UK Ltd WrenTech Ltd

FILTERS Axium Process Fisher Scientific GEA Process Technologies Ireland Ltd ITT Water & Waste Water Ireland Ltd Nederman Ltd Viking Pump (Europe) Ltd

FILTRATION Allchem Performance Axium Process Enva Ireland Ltd Fisher Scientific GEA Process Technologies Ireland Ltd ITT Water & Waste Water Ireland Ltd Lianco Scientific & Chemical Supplies Ltd

Fisher Scientific Prosys Sampling Systems Ltd Scientific & Chemical Supplies Ltd Shaw Scientific Ltd Turboair WrenTech Ltd

FURNACES Eurotherm Ireland Ltd Fisher Scientific

GAS DETECTION P.J. Boner & Co. Ltd Fisher Scientific

GAUGES P.J. Boner & Co. Ltd Classic Technology Ltd Fisher Scientific Flexachem Manufacturing Ltd Manotherm LtdTORS

GLASSWARE Fisher Scientific Johnsen & Jorgensen Ltd

GRINDING Fisher Scientific Lianco

55

GENERAL SUPPLIERS

IRISH PHARMACHEM 2008

PC_General Suppliers '08 WIP.qxd

23/09/2008

15:49

Page 4

IRISH PHARMACHEM 2008 GENERAL SUPPLIERS

HAZARDOUS WASTE DISPOSAL/TREATMENT Enva Ireland Ltd Soltec (Ireland) Ltd

HEALTH & SAFETY/ FIRST AID Fisher Scientific Scientific & Chemical Supplies Ltd

HEAT EXCHANGERS CPI Technology Ltd Cross Technical Solutions Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Graham Hart (Process Technologies) Ltd Lianco Hanlon Oâ&#x20AC;&#x2122;Grady & Co. Ltd Plate Tek Engineering Ltd WrenTech Ltd

HEATERS Graham Hart (Process Technologies) Ltd Lianco

HOMOGENISERS Fisher Scientific GEA Process Technologies Ireland Ltd Lianco WrenTech Ltd

HOSES CPI Technology Ltd Flexachem Manufacturing Ltd Micro Hydraulics Ltd/Micro Industries Ltd Nederman Ltd

HUMIDITY/HUMIDIFIERS P.J. Boner & Co. Ltd Classic Technology Ltd Cross Technical Solutions Smurfit Kappa Packaging Solutions Cork

HYDRAULICS Micro Hydraulics Ltd/Micro Industries Ltd Viking Pump (Europe) Ltd

INCUBATORS

Fisher Scientific Scientific & Chemical Supplies Ltd Shaw Scientific Ltd

INSPECTION EQUIPMENT ABB Ltd Beamex Ltd P.J. Boner & Co. Ltd National Instruments

INSTRUMENTATION Astech Ireland Ltd P.J. Boner & Co. Ltd Callaghan Engineering Classic Technology Ltd Cross Technical Solutions Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Manotherm Ltd National Instruments Zenith Technologies

IT Callaghan Engineering National Instruments

Gunnebo Ireland Ltd Lianco WrenTech Ltd

MACHINE TOOLS Lister Machine Tools Ltd

MAINTENANCE P.J. Boner & Co. Ltd Cross Technical Solutions Festo Ltd Gunnebo Ireland Ltd Plate Tek Engineering Ltd

MATERIALS HANDLING/ FORKLIFTS/PALLET TRUCKS Goliath Packaging Systems Ltd Henley Forklift Group Ltd Interpac Odenberg Engineering Ltd Toyota Materials Handling Ireland WrenTech Ltd

MECHANICAL ENGINEERING SERVICES

INVESTMENT Science Foundation Ireland (SFI)

L AB EQUIPMENT/SUPPLIES Astech Ireland Ltd Calibration Technology Classic Technology Ltd Fisher Scientific Lianco National Instruments Primepac Ltd Prosys Sampling Systems Ltd Sartorius Mechatronics UK Ltd Scientific & Chemical Supplies Ltd Sealpack Ltd Shaw Scientific Ltd WrenTech Ltd

LEGAL/FINANCIAL/ INSURANCE Matheson Ormsby Prentice

LIFTS & HOISTS Goliath Packaging Systems Ltd 56

Callaghan Engineering Cross Technical Solutions Dalkia FDT Consulting Engineers & Project Managers Ltd Festo Ltd Goliath Packaging Systems Ltd Kells Stainless Ltd Turboair

MECHANICAL & PROCESS ENGINEERING Callaghan Engineering Dalkia FDT Consulting Engineers & Project Managers Ltd Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Kells Stainless Ltd Prosys Sampling Systems Ltd Weber Labelling & Coding

METERS P.J. Boner & Co. Ltd Classic Technology Ltd

PC_General Suppliers '08 WIP.qxd

23/09/2008

15:49

Page 5

Lianco Manotherm Ltd National Instruments

MICROSCOPES

Smurfit Kappa Cork Smurfit Kappa Packaging Solutions Cork

PACKAGING/MACHINERY Goliath Packaging Systems Ltd

Fisher Scientific Scientific & Chemical Supplies Ltd Shaw Scientific Ltd

MILLING Fisher Scientific Flexachem Manufacturing Ltd Scientific & Chemical Supplies Ltd WrenTech Ltd

MIXERS CPI Technology Ltd Fisher Scientific Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd ITT Water & Waste Water Ireland Ltd Kells Stainless Ltd Scientific & Chemical Supplies Ltd WrenTech Ltd

NOISE/ODOUR CONTROL Bord na Mona Environmental Consultancy, Monitoring & Laboratory Services Flexachem Manufacturing Ltd Smurfit Kappa Packaging Solutions Cork

OEM MANUFACTURING B. Braun Medical

PACKAGING/DESIGN Anecto Catalent Pharma Solutions Charpak Medical Complas Packaging Ltd Goliath Packaging Systems Ltd GS1 Ireland Industrial Packaging Ltd Interpac Johnsen & Jorgensen Ltd Norman Lauder Ltd Measom Freer New Era Packaging Ltd Primepac Ltd Sealpack Ltd Smurfit Kappa Ireland

PALLETS Complas Packaging Ltd Smurfit Kappa Ireland Smurfit Kappa Packaging Solutions Cork WrenTech Ltd

PIPES/CORES CPI Technology Ltd Flexachem Manufacturing Ltd Smurfit Kappa Packaging Solutions Cork

PLASTIC CORES / TUBES Smurfit Kappa Packaging Solutions Cork

PNEUMATICS P.J. Boner & Co. Ltd Festo Ltd Flexachem Manufacturing Ltd

POLLUTION CONTROL ABB Ltd Bord na Mona Environmental Consultancy, Monitoring & Laboratory Services Pollution Control Systems Ltd

POWDER HANDLING CPI Technology Ltd Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Industrial Packaging Ltd Interpac Lianco Odenberg Engineering Ltd Prosys Sampling Systems Ltd WrenTech Ltd

POWER SUPPLY ESB Independent Energy Manotherm Ltd

57

PRESSURE MEASUREMENTS/ SWITCHES/VESSELS Axium Process Beamex Ltd Beam Vacuum Systems Ltd P.J. Boner & Co. Ltd BS&B Safety Systems Ltd Classic Technology Ltd Cross Technical Solutions Graham Hart (Process Technologies) Ltd Kells Stainless Ltd National Instruments Prosys Sampling Systems Ltd

PRESSURE RELIEF BS&B Safety Systems Ltd

PROCESS CONTROL Astech Ireland Ltd Beamex Ltd P.J. Boner & Co. Ltd Callaghan Engineering Classic Technology Ltd FDT Consulting Engineers & Project Managers Ltd Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Lianco Logstrup (Ireland) Ltd Manotherm Ltd National Instruments Pollution Control Systems Ltd Weber Labelling & Coding Zenith Technologies

PROCESS & MECHANICAL ENGINEERING CONTRACTORS ABB Ltd FDT Consulting Engineers & Project Managers Ltd GEA Process Technologies Ireland Ltd

PROJECT MANAGEMENT Axium Process Callaghan Engineering Cross Technical Solutions FDT Consulting Engineers & Project Managers Ltd GEA Process Technologies Ireland Ltd Odenberg Engineering Ltd Zenith Technologies

GENERAL SUPPLIERS

IRISH PHARMACHEM 2008

PC_General Suppliers '08 WIP.qxd

23/09/2008

15:49

Page 6

IRISH PHARMACHEM 2008 GENERAL SUPPLIERS

PROTECTIVE CLOTHING/ APPARATUS Albion Chemicals

PUMPS Beam Vacuum Systems Ltd Consolidated Pumps Ltd CPI Technology Ltd Fisher Scientific Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd ITT Water & Waste Water Ireland Ltd Prosys Sampling Systems Ltd Viking Pump (Europe) Ltd

REACTORS CPI Technology Ltd GEA Process Technologies Ireland Ltd Kells Stainless Ltd

RECRUITMENT Berkley Pharmaceutical FDT Consulting Engineers & Project Managers Ltd ICDS Recruitment Consultants Kelly Services Manpower Ireland Science Recruitment Ireland Zenith Technologies

R&D Allchem Performance Cambio Ltd Dalkia FDT Consulting Engineers & Project Managers Ltd Scientific & Chemical Supplies Ltd Topchem Laboratories Ltd

REFRIGERATION/FREEZING Baku GLS Ltd Cross Technical Solutions Dalkia Fisher Scientific GEA Process Technologies Ireland Ltd

RENEWABLE ENERGY Sustainable Energy Ireland

SANITARY TUBING Micro Hydraulics Ltd/Micro Industries Ltd

SCADA/DCS/MIS

Micro Hydraulics Ltd/Micro Industries Ltd Smurfit Kappa Packaging Solutions Cork

STEAM EQUIPMENT Flexachem Manufacturing Ltd

ABB Ltd P.J. Boner & Co. Ltd Cross Technical Solutions Eurotherm Ireland Ltd National Instruments Zenith Technologies

SCREENS

STORAGE/BUNDING Baku GLS Ltd Goliath Packaging Systems Ltd Industrial Packaging Ltd Interpac Johnston Logistics Ltd

TABLETING EQUIPMENT

Lianco

SCRUBBERS Graham Hart (Process Technologies) Ltd

SEALS & GASKETS Axium Process Consolidated Pumps Ltd Flexachem Manufacturing Ltd Micro Hydraulics Ltd/Micro Industries Ltd

SIEVING Lianco Scientific & Chemical Supplies Ltd

SOFTWARE

Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Lianco WrenTech Ltd

TANKS Axium Process Celtic Forwarding Ltd Complas Packaging Ltd CPI Technology Ltd Enva Ireland Ltd GEA Process Technologies Ireland Ltd Kells Stainless Ltd Norman Lauder Ltd Micro Hydraulics Ltd/Micro Industries Ltd WrenTech Ltd

TEMPERATURE CONTROL

Eurotherm Ireland Ltd GEA Process Technologies Ireland Ltd Lianco Zenith Technologies

SOLVENT RECOVERY/ SERVICES ABB Ltd FDT Consulting Engineers & Project Managers Ltd Soltec (Ireland) Ltd

STAINLESS STEEL/ FITTINGS/PRODUCTS Axium Process Festo Ltd Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd 58

Beamex Ltd P.J. Boner & Co. Ltd Classic Technology Ltd Cross Technical Solutions Eurotherm Ireland Ltd Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Manotherm Ltd National Instruments Smurfit Kappa Packaging Solutions Cork

TESTING SERVICES Anecto Classic Technology Ltd Irish National Accreditation Board Norman Lauder Ltd

PC_General Suppliers '08 WIP.qxd

23/09/2008

15:49

Page 7

THERMAL IMAGING/ THERMOGRAPHY Cross Technical Solutions FDT Consulting Engineers & Project Managers Ltd Manotherm Ltd National Instruments

TRANSPORT & LOGISTICS Baku GLS Ltd Celtic Forwarding Ltd C & G Logistics Group Johnston Logistics Ltd KWE (Ireland) Ltd Norman Lauder Ltd

TUBE SETS/DISPOSABLES Micro Hydraulics Ltd/Micro Industries Ltd

VACUUM SYSTEMS Beam Vacuum Systems Ltd CPI Technology Ltd Flexachem Manufacturing Ltd Goliath Packaging Systems Ltd Lianco WrenTech Ltd

VALVES Beam Vacuum Systems Ltd P.J. Boner & Co. Ltd BS&B Safety Systems Ltd CPI Technology Ltd Festo Ltd

Flexachem Manufacturing Ltd GEA Process Technologies Ireland Ltd Lianco Manotherm Ltd Micro Hydraulics Ltd/Micro Industries Ltd Hanlon Oâ&#x20AC;&#x2122;Grady & Co. Ltd Prosys Sampling Systems Ltd Schuf Valve Technology

VALIDATION

Goliath Packaging Systems Ltd Johnston Logistics Ltd Norman Lauder Ltd Smurfit Kappa Packaging Solutions Cork Weber Labelling & Coding Zenith Technologies

WASHING EQUIPMENT Goliath Packaging Systems Ltd

ABB Ltd Astech Ireland Ltd Beamex Ltd Callaghan Engineering Catalent Pharma Solutions Classic Technology Ltd Cross Technical Solutions FDT Consulting Engineers & Project Managers Ltd Sartorius Mechatronics UK Ltd Weber Labelling & Coding Zenith Technologies

VENTILATION Beam Vacuum Systems Ltd Callaghan Engineering

VISION SYSTEMS National Instruments

WAREHOUSE MANAGEMENT Celtic Forwarding Ltd Complas Packaging Ltd Eurotherm Ireland Ltd

Notes

59

WASTE MANAGEMENT/ BALERS/RECYCLING Interpac Norman Lauder Ltd Soltec (Ireland) Ltd

WATER TREATMENT Axium Process Carbon Group Consolidated Pumps Ltd Flexachem Manufacturing Ltd ITT Water & Waste Water Ireland Ltd Logstrup (Ireland) Ltd Pollution Control Systems Ltd Sartorius Mechatronics UK Ltd

WEIGHING Beamex Ltd P.J. Boner & Co. Ltd Calibration Technology Fisher Scientific Sartorius Mechatronics UK Ltd Shaw Scientific Ltd WrenTech Ltd

GENERAL SUPPLIERS

IRISH PHARMACHEM 2008

Industrial Packaging

23/09/2008

16:53

Page 1

Your Local Expert Kelly Scientific Resources is the largest - and fastest growing - provider of scientific talent in the world today. With 100+ locations worldwide, we have developed long term partnerships with some of the biggest names in the scientific industry.

Industrial Packaging Ltd.

Irelands only manufacturer of fibre drums www.industrialpackaging.ie

Kelly Scientific Resources in Ireland supports the scientific community by providing scientists and technicians in both temporary assignments and permanent contracts at all levels.

Kelly Scientific Resources 21 - 22 Grafton St Dublin 2 p. (01) 6793160 f. (01) 6773048 e. ksrdublin@kellyservices.ie

Kelly Scientific Resources Carbery House 67 - 69 South Mall, Cork p. (021) 4905406 f. (021) 4274736 e. ksrcork@kellyservices.ie

Chemists • Microbiologists • Biochemists • Product/Process Developments • Organic Chemists • CRAs • Scientific /Medical Sales • Environmental Technicians • Research & Development • Molecular Biologists • Regulatory Affairs • Validation • Quality Assurance/Quality Control

Fibre Drums Plastic Drums IBCs Security Tags & Seals Small Sample Drums/Containers

Killarney Road, Bray, Co Wicklow Telephone: +353 1 2864010 Fax: +353 1 2864015 Email: sales@industrialpackaging.ie

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 1

COMPANY LISTINGS A

ALBION CHEMICALS Address:

ABB LTD Address:

Belgard Road, Tallaght, Dublin 24.

Tel: (01) 405 7300 Fax: (01) 405 7327 Email: marketing@ie.abb.com Web: www.abb.com Type of Business: Electrical Engineers.

ADC BARCODE SOLUTIONS Address:

Unit 1B, 11 Canal Bank, Parkwest Industrial Park, Nangor Road, Dublin 12.

Tel: (01) 620 9777 Fax: (01) 620 9722 Email: info@adcbarcode.com Web: www.adcbarcodesolutions.com Contact: Marketing Manager: Celine Wogan

AGB SCIENTIFIC LTD Address:

Orion Business Campus, Northwest Business Park, Ballycoolin, Dublin 15.

Tel: (01) 882 2222 Fax: (01) 882 2333 Email: info@agb.ie Web: www.agb.ie www.labshop.ie Type of Business: Lab supplier.

Tel: Fax: Email: Web: Contact:

ALLCHEM PERFORMANCE Address:

Westward House, Montrose Avenue, Slough, SL1 4TN. Tel: (0044) 1753 443322 Fax: (0044) 1753 443323 Email: allchemperformance @acigroup.biz Web: www.allchemperformance.com Contact: Head of Pharma: Khalil Sharif

Tel: Fax: Email: Web: Contact:

The Woodlands, Carrigmore, Ballineen, Co. Cork.

(023) 47333 (023) 47671 info@ aicplasticpallets.com www.aicplastic pallets.com Director: Charles Oâ&#x20AC;&#x2122;Donovan

Tel: Fax: Email: Web: Contact:

Address:

Tel: Fax: Email: Web: Contact:

Hendy Industrial Estate, Hendy, Swansea, SA4 0XP (0044) 1792 883882 (0044) 1792 886049 info@axiumprocess.com www.axiumprocess.com Business Development Manager: Derek Davies

B BAKU GLS LTD Address:

Mervue Business Park, Co. Galway.

Tel: (091) 757 404 Fax: (091) 757 387 Email: sales@anecto.com Web: www.anecto.com Type of Business: Dangerous goods packaging testing laboratory.

Contact: Yvonne Kearney

Dublin 12.

(01) 460 7070 (01) 461 0771 automationsales@atc.ie www.atc.ie Liam Prendergast Sales Manager

AXIUM PROCESS

ANECTO Address:

Tel: Fax: Email: Web: Contact:

Kilrane Business Park, Rosslare Harbour Co. Wexford.

(053) 916 1786 (053) 916 1789 leslie@bakugls.com www.bakugls.com Operations Director: Leslie Devereaux

ASTECH IRELAND LTD Address:

AIC PLASTIC PALLETS LTD Address:

Unit 405, Greenogue Business Park, Rathcoole, Dublin 24.

(01) 401 3500 (01) 405 3501 bill.maher@ albionchemicals.ie www.albionchemicals.co.uk General Manager: Bill Maher

Tel: Fax: Email: Web: Contact:

Unit 47, Southern Cross Business Park, Boghall Road, Bray, Co. Wicklow.

(01) 286 5303 (01) 286 5655 sales@astechireland.ie www.astechireland.ie Managing Director: Shay Vella Hancock

ATC AUTOMATION LTD Address:

Unit B7, Centre Point Business Park, Oak Road, 61

BASF IRELAND LTD Address:

Tel: Fax: Email: Web: Type of Business: Contact:

Bracetown Business Park, Clonee, Co. Meath.

(01) 825 5701 (01) 825 2038 yvonne.mullins@basf.com www.basf.com Distributor of chemicals.

Business Development Manager, Pharmaceutical Industry: Yvonne Mullins

C O M PA N Y L I S T I N G S

IRISH PHARMACHEM 2008

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 2

IRISH PHARMACHEM 2008 C O M PA N Y L I S T I N G S

Tel: Fax: Email: Web:

B. BRAUN MEDICAL

BERKLEY PHARMACEUTICAL

Address:

Address:

3 Naas Road Industrial Park, Dublin 12.

Tel: (01) 709 1800 Fax: (01) 709 1889 Email: bill.proctor@bbraun.com Web: www.bbraun.com Type of Business: OEM manufacturing.

Contact: Business Unit Manager: Bill Proctor

Tel: Fax:

BCD ENGINEERING Address:

Tel: Fax: Email: Web: Contact:

Railway Road, Charleville, Co. Cork (063) 30200 (063) 30201 richard.keays@ bcdgroup.ie www.bcdgroup.ie Group Engineering Sales: Richard Keays

BEAMEX LTD Address:

Tel: Fax: Email: Web: Contact:

Newtown Grange Farm Business Park, Desford Road, Newtown Unthank, Leicestershire LE9 9FL. (0044) 1455 821 920 (0044) 1455 821 923 beamex.ltd@ beamex.com www.beamex.com Sales & Service Director: Alex Maxfield

BEAM VACUUM SYSTEMS LTD Address:

Tel: Fax: Email: Web:

Opus Business Park, 35 Aughrim Road, Magherafelt, Co. Derry, BT45 6BB. (0044) 2879 632 424 (0044) 2879 632 425 lisa.mcgonigle@ beamvacuums.ie www.beamvacuums.ie

Email: Web: Contact:

Cork: Mill House, Carrigrohane, Co. Cork.

Dublin: 509 The Capel Building, Mary’s Abbey, Dublin 7.

(021) 455 9092 (01) 872 4665 (021) 455 9095 (01) 872 0904 pharma@berkley.ie www.berkley.ie Cork: Ruth Scanlan Dublin: Joanna Houston

Contact:

(045) 439 000 (045) 434 207 environ@bnm.ie www.bnm.ie/ environmental Brand Manager: Karen Healy

BRIGHTWATER Address:

Tel: Fax: Email: Web: Contact:

Dublin: 36 Merrion Square, Dublin 2.

Cork: 49 South Mall, Co. Cork (01) 662 1000 (021) 422 1000 (01) 662 3900 (021) 422 4001 a.carty@brightwater.ie cork@brightwater.ie www.brightwater.ie Manager, Pharmaceutical: Adrian Carty

BETCO MARKETING LTD Address:

Tel: Fax: Email: Web: Contact:

Exham House, The Fingerpost, Douglas, Co. Cork.

(021) 436 4999 (021) 436 5739 dhalpin@betco.ie www.betco.ie Managing Director: Diarmuid Halpin

P.J. BONER & CO. LTD INSTRUMENT & WEIGHTING SPECIALISTS Address:

Tel: Fax: Email: Web: Contact:

Unit 35, Western Parkway Business Centre, Ballymount Road, Dublin 12.

(01) 450 5050 (01) 450 5183 info@pjboner.com www.pjboner.com Managing Director: Pat Boner

BORD NA MÓNA ENVIRONMENTAL CONSULTANCY, MONITORING & LABORATORY SERVICES Address:

Main Street, Newbridge, Co. Kildare.

62

BROCKLEY GROUP LTD Address: Tel: Fax: Web: Contact:

1 Abbey Street, Howth, Co. Dublin.

(01) 839 2016 (01) 839 2869 www.eirchem.com www.brockley.eu Sales Director: Pat Short

BS&B SAFETY SYSTEMS LTD Address:

Raheen Business Park, Raheen, Co. Limerick.

Tel: (061) 484 700 Emergency Delivery: 086 241 0615 Direct Line: 086 838 5556 Fax: (061) 352 240 Email: patrick.murphy@bsb.ie Web: www.bsb.ie Type of Business: Pressure relief devices.

Contact: Sales Manager: Patrick Murphy

BURGOYNE CONSULTANTS LTD Address:

55 Clontarf Road, Dublin 3.

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 3

Tel: Fax: Email: Web: Contact:

(01) 833 2091 (01) 833 2092 marketing@bcl.ie www.bcl.ie Operations Manager: Martin Concannon

C

Contact:

Dublin Managing Director: Donal O’Callaghan Cork - Senior Electrical Designer: Willie O’Mahony

CAMBIO LTD Address:

CALIBRATION TECHNOLOGY Address:

Innovation Works, National Technology Park, Co. Limerick.

Tel: (061) 503 132 Fax: (061) 338 065 Email: service@ calibrationtech.ie Web: www.calibrationtech.ie Type of Business: Accredited calibration of all makes of laboratory equipment.

Contact: Operations Manager: Brian Kelly

1 The Irwin Centre, Scotland Road, Dry Drayton, Cambridge, CB23 8AR. Tel: (0044) 1954 210 200 Fax: (0044) 1954 210 300 Email: support@cambio.co.uk Web: www.cambio.co.uk Type of Business: Distribution of molecular biology research reagents.

Contact: Development Manager: Bethy Booth

CASHELS ENGINEERING LTD Address:

Tel: Fax: Email: Web: Contact:

CATALENT PHARMA SOLUTIONS Address:

Tel: Fax: Email: Web: Contact:

A. R. CAMERON LTD CALIPER LIFE SCIENCES 1 Wellfield, Preston Brook, Runcorn, Cheshire.

Tel: (0044) 1928 711 448 Fax: (0044) 1928 791 228 Email: lydia.mcintyre@ caliperls.com Web: www.caliperls.com Type of Business: Laboratory Automation.

Contact: Sales Manager Ireland: Simon Minchin

Address:

Address:

CALLAGHAN ENGINEERING Address:

Dublin: Wentworth House, 19-20 Hogan Place, Lower Grand Canal Street, Dublin 2.

Cork: Penrose House, Penrose Quay, Co. Cork.

Tel: (01) 661 4420 (021) 455 1646 Fax: (01) 661 4424 (021) 455 1770 Email: donal.ocallaghan@calleng.ie willieomahony@calleng.ie Web: www.calleng.ie Type of Business: Engineering.

Tel: Fax: Email: Contact:

Malahide Road Industrial Park, Coolock, Dublin 17 (01) 847 4122 (01) 847 4761 tonyjr@durcon.ie Tony Cameron Jr., Sales

CAMIDA LTD Address:

Tel: Fax: Email: Web: Contact:

Tower House, New Quay, Clonmel, Co. Tipperary.

(052) 25455 (052) 25466 info@camida.com www.camida.com Company Secretary: Deirdre McGrath

CARBON GROUP Address:

Factory Cross, Ringaskiddy, Co. Cork.

Tel: (021) 437 8988 UK Local Lo-Call: (0044) 8708 504 831 Fax: (021) 437 8950 Email: cdeegan@indigo.ie sales@carbon.ie Web: www.carbon.ie Type of Business: Pharmachemicals.

Contact: Area Sales Manager: Carol Deegan 63

Aghamore, Ballyhaunis, Co. Mayo (094) 963 0517 (094) 963 0214 sales@cashels.net www.cashels.net Managing Director: Peter Cunnane

Unit 26, Cherry Orchard Industrial Estate, Dublin 10.

(01) 620 0600 (01) 626 2815 diarmuid.wilson@ catalent.com www.catalent.com Sales Director Ireland: Diarmuid Wilson

CELTIC FORWARDING LTD Address:

Dublin: Celtic House, 30 Marlborough Street, Dublin 1.

Waterford: Belview Port, Slieverue, Co. Waterford.

Limerick: 2 Church Street, John’s Square, Co. Limerick.

Tel: (01) 865 6000 (051) 851 821 (061) 467 969 Fax: (01) 874 6745 (051) 851 823 (061) 467 972 Email: info@celticfwd.ie Web: www.celticfwd.ie Type of Business: Shipping.

Contact: Director: Finbarr Cleary Sales Manager: Gerald Kiernan Waterford: DGSA Tank Division Manager: Patty deCourcey

C O M PA N Y L I S T I N G S

IRISH PHARMACHEM 2008

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 4

IRISH PHARMACHEM 2008 C O M PA N Y L I S T I N G S

C & G LOGISTICS GROUP Address:

Tel: Fax: Email: Web: Contact:

Westpoint Business Park, Navan Road, Mulhuddart, Dublin 15.

(01) 820 8455 (01) 820 8457 info@cglogistics.ie www.cglogistics.ie General Manager/ Director : Patrick Wogan

Co. Kildare.

Tel: (045) 896 660 Fax: (045) 896 713 Email: info@classictechnology.ie Web: www.classictechnology.ie Type of Business: Instrumentation.

Contact: Director/Sales: William Kinsella UKAS Calibration: Patrick Kinsella

COMPLAS PACKAGING LTD CHARPAK MEDICAL Address:

Tel: Fax: Email: Web: Contact:

30 St. Peters Road, Huntingdon, Cambs. UK. 0044 1480 434434 0044 1480 434545 sales@charpak.co.uk www.charpak medical.com Director: Paul Smith

Address:

Tel: Fax: Email: Web: Contact:

Naas Industrial Estate, Dublin Road, Naas, Co. Kildare.

(045) 874 088/9 (045) 874 090 sales@complas.ie www.complas.ie Managing Director: Patrick Gregory

Unit 49, Robinhood Industrial Estate, Longmile Road, Dublin 22.

Tel: (01) 456 9761 Fax: (01) 456 9765 Email: sales@chemco.ie Web: www.chemco.ie Type of Business: Chemical Distribution.

Contact: Operations Manager: David Hannon

CHEMTEK SALES LTD Address:

Tel: Fax: Email: Web: Contact:

Estuary House, New Street, Malahide, Co. Dublin.

(01) 845 3766/63 (01) 845 3172 sales@chemtek.ie www.chemtek.ie Director: David Shaw

CLASSIC TECHNOLOGY LTD Address:

Unit 4, Block B, Johnstown Manor, Johnstown, Naas,

3 Crannagh House, Old Clones Road, Beltubet, Co. Cavan.

Tel: (049) 952 2789 Fax: (049) 952 2790 Email: info@crannaghtrade.eu carol.lynch@crannaghtrade.eu Web: www.crannaghtrade.eu Type of Business: International trade and customs consultants.

Contact: Managing Director: Carol Lynch

CROSS TECHNICAL SOLUTIONS

Knockmeenagh Road, Newlands Cross, Clondalkin, Dublin 22.

Tel: (01) 459 3471 Fax: (01) 459 1093 Email: info@consolidatedpumps.com Web: www.consolidatedpumps.com Contact: Managing Director: RK Tolan

CORCORAN CHEMICALS LTD

CURTEC UK LTD

Address:

Address:

Address:

Address:

Address:

Unit 22, Kilcarbery Business Park, Nangor Road, Clondalkin, Dublin 22.

Tel: (01) 405 6777 Fax: (01) 413 6932 Email: sales@crosstechnical solutions.ie Web: www.crosstechnical solutions.ie Type of Business: Specialist refrigeration.

Contact: Director: David Killalea General Manager Jason Keating

CONSOLIDATED PUMPS LTD

CHEMCO IRELAND LTD.

CRANNAGH & CO.

Kingsbridge House, 17-22 Parkgate Street, Dublin 8.

Tel: (01) 633 0400 Fax: (01) 679 3521 Email: abyrne@ corcoranchemicals.com Web: www.corcoranchemicals.com Contact: Managing Director: A. Byrne

Address:

75 Cannon Street, London, EC4 5BN. Tel: (0044) 2085 684 445 Fax: (0044) 2085 684 446 Email: curtec.uk@curtec.com Web: www.curtec.com Type of Business: Packaging Manufacturer.

Contact: Eva Klotz

D CPI TECHNOLOGY LTD Address:

Tel: Fax: Email: Web: Contact:

Unit 5, Link Road Business Park, Ballincollig, Co. Cork.

(021) 487 4142 (021) 487 8764 info@cpitechnology.com www.cpitechnology.com Managing Director: Adrian Giltinan 64

DALKIA Address:

Tel: Fax: Email: Web: Contact:

145 Lakeview Drive, Airside Business Park, Swords, Co. Dublin (01) 870 1200 (01) 870 1201 info@dalkia.ie www.dalkia.ie Managing Director:

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 5

Pat Gilroy Associate Director Pharmaceutical Division: Fergus Elebert General Manager: Jerome Aguesse

Tel: Fax: Email: Web: Contact:

Co. Cork.

(021) 438 7200 (021) 438 7299 cork@enva.ie www.enva.ie Sales Manager: Brian Magrane

Contact:

EUROTHERM IRELAND LTD Address:

DGP IRELAND LTD Address:

1 Airways Technology Park, Kinsale Road, Co. Cork.

Tel: (021) 484 9082 Fax: (021) 484 9084 Email: rwalsh@dgpir.com Web: www.dgpir.com Type of Business: Packaging manufacturer.

Contact: Product Development Manager: Richard Walsh

Tel: Fax: Email: Web: Contact:

ENVIRONMENTAL PROTECTION AGENCY Address:

Tel: Fax: Email: Web:

PO Box 3000, Johnstown Castle Estate, Co. Wexford.

(053) 916 0600 (053) 916 0699 info@epa.ie www.epa.ie

DIONEX IRELAND LTD Address:

Unit 9A, Suite 3C, Plato Business Park, Damastown, Dublin 15.

Tel: (01) 644 0064 Fax: (01) 885 1673 Email: ireland.info@dionex.com Web: www.dionex.com Type of Business: Scientific analytical equipment.

Contact: Siobhan Curley

E ENDRESS & HAUSER (IRELAND) LTD Clane Business Park, Clane, Co. Kildare.

Tel: (045) 868 615 Fax: (045) 868 182 Email: info@ie.endress.com Web: www.endress.com Type of Business: Process automation solutions supplier.

Contact: Sales Manager: Tony Donnelly

ESB INDEPENDENT ENERGY Address:

Tel: Fax: Email: Web: Contact:

Address:

ENVA IRELAND LTD Address:

Raffeen Industrial Estate, Ringaskiddy,

Dublin: Woodford Business Park, Santry, Dublin 17.

Belfast: 33 Clarendon Dock, Laganside, Belfast, BT1 38G. (01) 862 8300 (028) 9051 1246 (01) 862 8350 (028) 9027 8400 info@esbie.ie www.esbie.ie Marketing Manager: John Conlon Customer Operations Manager: Susan Kinane Commercial Manager: Bob Turley

EUROLEC INSTRUMENTATION LTD Address:

Technology House, Cluan Enda, Dundalk, Co. Louth.

Tel: (042) 933 3423 Fax: (042) 933 1758 Email: eurolec@esatclear.ie Web: www.eurolec-instruments.com Type of Business: Electronic instrumentation.

65

Sales/Marketing Executive: Chris Mears

Unit W4i, Tougher Business Park, Naas, Co. Kildare.

(01) 469 1800 (01) 469 1300 info@eurotherm.ie www.eurotherm.ie Area Engineer: Rory Lynch

F FDT CONSULTING ENGINEERS & PROJECT MANAGERS LTD Address:

Fisrst Floor, 170 Walkinstown Road, Dublin 12.

Tel: (01) 429 1900 Fax: (01) 429 1901 Email: info@fdt.ie Web: www.fdt.ie Type of Business: Consulting engineers specialising in process engineering, project management & energy efficiency.

Contact: Project Manager: Michael Clancy

FESTO LTD Address:

Unit 5, Sandyford Park, Sandyford Industrial Estate, Dublin 18.

Tel: (01) 295 4955 Fax: (01) 295 5680 Email: sales_ie@festo.com Web: www.festo.com/ie Type of Business: Automation company specialising in factory and process automation.

Contact: Sales Manager: Brian Reardon

FEHILY TIMONEY & COMPANY Address:

Cork: Core House,

C O M PA N Y L I S T I N G S

IRISH PHARMACHEM 2008

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 6

IRISH PHARMACHEM 2008 C O M PA N Y L I S T I N G S

Tel: Fax:

Tel: Fax: Email: Web: Contact:

Pouladuff Road, Co. Cork.

(021) 496 4133 (021) 496 4464 Dublin: 2nd Floor, Mill House, Ashtown Gate, Navan Road, Dublin 15.

(01) 658 3500 (01) 658 3501 info@fehilytimoney.ie www.fehilytimoney.ie Principal: John Lynch

FISHER SCIENTIFIC Suite 3, Plaza 212, Blanchardstown Corporate Park 2, Ballycoolin, Dublin 15.

Tel: (01) 885 5854 Fax: (01) 899 1855 Email: fsie.sales @thermofisher.com Web: www.ie.fishersci.com Type of Business: Laboratory supplies.

Contact: Marketing Communications Manager: Bob Sharman

Tel: Fax: Email: Web: Contact:

G GEA PROCESS TECHNOLOGIES IRELAND LTD Address:

Tel: Fax: Email: Web: Contact:

Address:

FLEXACHEM MANUFACTURING LTD Address:

Donnybrook Commercial Centre, Douglas, Co. Cork.

Tel: (021) 463 6742 Fax: (021) 489 1297 Email: sales@flexachem.com Web: www.flexachem.com Type of Business: Manufacturer/ Distributor.

Contact: Commercial Director: Agnes Mullins

FLUOROCHEM LTD Address:

Wesley Street, Old Glossop, Derbyshire, SK13 7RY.

(0044) 1457 868921 (0044) 1457 869360 enquiries@ fluorochem.co.uk www.fluorochem.net Sales Director: Martin Woolley

Ash House, Lime Tree Avenue, Millennium Park, Naas, Co. Kildare.

(045) 981 200 (045) 981 232 postbox@geapt.ie www.geapt.ie Business Development Manager: Adrian Field

GRAHAM HART (PROCESS TECHNOLOGY) LTD Address:

Tel: Fax: Email: Web: Contact:

Friars Ind. Estate, Bradford Road, Idle,Bradford, BD10 8SW, UK. (0044) 1274 617021 (0044) 1274 618614 sales@graham-hart.com www.graham-hart.com Sales Director: Stephen Hart

GROWCORP GROUP LTD Address:

3015 Lake Drive, Citywest Business Campus, Dublin 24.

Tel: (01) 466 1000 Fax: (01) 466 1002 Email: grow@growcorp.net Web: www.growcorp.net Type of Business: Bioscience investor, advisor and business incubator.

Contact: Chairman: Michael Donnelly

GS1 IRELAND Address:

GOLIATH PACKAGING SYSTEMS LTD Address:

Beechwood, Nenagh, Co. Tipperary.

Tel: (067) 37893 Fax: (067) 34794 Email: info@goliath.ie Web: www.goliath.ie Type of Business: Supply & installation of packaging equipment and materials handling systems.

Contact: Director: George Oâ&#x20AC;&#x2122;Leary

Tel: Fax: Email: Web: Contact:

GUNNEBO IRELAND LTD Address:

GOULDING CHEMICALS LTD Centre Park Road, Marina, Co. Cork.

Tel: (021) 491 1611 Fax: (021) 491 1660 Email: pollockm@gouldings.ie Web: www.gouldings.ie Type of Business: Chemical distributor.

Contact: Manager Industrial Chemicals: Matt Pollock

Address:

66

The Nutley Building Merrion Road, Dublin 4.

(01) 208 0671 (01) 208 0670 adreena.cullen@ gs1ie.org www.gs1ie.org Marketing Executive: Adreena Cullen

Tel: Fax: Email: Web: Contact:

Dublin: 601 Western Industrial Estate, Dublin 12.

Cork: Unit 4, Hillview Campus, Euro Business Park, Little Island, Co. Cork.

(01) 458 4836 (021) 452 4940 (01) 458 4835 (021) 452 4409 noel@gunnebolifting.com bryan@gunnebolifting.com www.gunnebolifting.com Managing Director:

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 7

Patrick Doyle Director (Cork): Noel Howard Sales Rep (Munster Area): Bryan Davies

H

Tel: Fax: Email: Type of Business: Contact:

HAZCHEM TRAINING LTD Address:

Tel: Fax: Email: Web: Contact:

G10, Maynooth Business Campus, Maynooth, Co. Kildare.

(01) 629 1800 (01) 629 1822 info@hazchem.ie www.hazchem.ie Office Manager: Michelle Cleere

HENLEY FORKLIFT GROUP LTD Address:

Henley Industrial Park, Killeen Road, Dublin 10.

Tel: (01) 620 9200 Fax: (01) 626 5406 Email: henleysales@henley.ie mbyrne@henley.ie Web: www.henley.ie Type of Business: Forklifts. Specialists in flameproof forklift trucks.

Contact: Director: Brian Oâ&#x20AC;&#x2122;Connell

HIGHER EDUCATION AUTHORITY Address:

Brooklawn House, Crampton Avenue, Shelbourne Road, Dublin 4.

Tel: (01) 231 7100 Fax: (01) 231 7172 Email: info@hea.ie Web: www.hea.ie Type of Business: Government agency.

Contact: Head of Research Programme: Dr. Eucharia Meehan

H.R. HOLFELD (ENGINEERING) LTD Address:

2-4 Merville Road,

Stillorgan, Co. Dublin.

(01) 288 7361 (01) 283 6293 engineering@holfeld.ie Steam Boiler Supplier.

General Manager: Oliver Collier

INTERMEC IRELAND LTD Address:

Tel: Fax: Email: Web: Contact:

19/20, York Road, Dun Laoghaire, Co. Dublin.

(01) 205 4200 (01) 205 4201 sales@intermec.ie www.intermec.ie General Manager: Joe Lynch

INTERPAC Address:

H.R. HOLFELD (HYDRAULICS) LTD Address:

Tel: Fax: Email: Type of Business: Contact:

2-4 Merville Road, Stillorgan, Co. Dublin.

(01) 288 7361 (01) 288 7380 pumps@holfeld.ie Process Pump Supplier.

Business Development & Key Accounts: Emmet Connelly

I ICDS RECRUITMENT CONSULTANTS Address:

24 Upper Fitzwilliam Street, Dublin 2.

Tel: (01) 632 1200 Fax: (01) 676 2079 Email: info@icds.ie Web: www.icds.ie Type of Business: Recruitment consultants.

Contact: Recruitment Director: Anthony McLoughlin

67E Heather Road, Sandyford Industrial Estate, Dublin 18.

Tel: (01) 294 0600 Fax: (01) 294 0602 Email: ian@interpac.ie Web: www.interpac.ie Type of Business: Packaging.

Contact: Managing Director: Ian Sutton

IRISH NATIONAL ACCREDITATION BOARD, THE Address:

Wilton Park House, Wilton Place, Dublin 2.

Tel: (01) 607 3003 Fax: (01) 607 3109 Email: inab@inab.ie Web: www.inab.ie Type of Business: Provides accreditation of laboratories, certification & inspection bodies .

Contact: Information Officer: Orla Doyle

ITT WATER & WASTE WATER IRELAND LTD Address:

INDUSTRIAL PACKAGING LTD Address:

Killarney Road, Bray, Co. Wicklow.

Tel: (01) 286 4010 Fax: (01) 286 4015 Email: mail@industrialpackaging.ie Web: www.industrialpackaging.ie Type of Business: Manufacturer.

Contact: Sales & Marketing Director: Norman Lee 67

50 Broomhill Close, Airton Road, Tallaght, Dublin 24.

Tel: (01) 452 4444 Fax: (01) 452 4795 Email: flygtireland@flygt.com Web: www.flygt.ie www.ittwww.com Type of Business: Supplier of products, systems & services for the transport and treatment of water

C O M PA N Y L I S T I N G S

IRISH PHARMACHEM 2008

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 8

IRISH PHARMACHEM 2008 C O M PA N Y L I S T I N G S

Contact:

and waste water.

Director/General Manager: Alison Kirwan

Type of Business: Recruitment agency.

Contact: Country Manager Ireland: Amanda Swift

J KELLS STAINLESS LTD JOHNSEN & JORGENSEN LTD Address:

Unit 8, Westpoint Enterprise Park, Clarence Avenue, Trafford Park, Manchester, M17 1QS. Tel: (0044) 1618 741930 Fax: (0044) 1618 741931 Email: mscott@jjpack.com Web: www.jjpack.com Type of Business: Bottle, jar & stopper suppliers.

Contact: Sales Manager: Matthew Scott

Address:

Oldcastle Road, Kells, Co. Meath Tel: (046) 924 1520 Fax: (046) 924 1528 Email: sales@ksl.ie Web: www.kellsstainless.com Type of Business: Stainless equipment design & fabrication.

Contact: Technical Sales Director: Dara Fay

KWE (IRELAND) LTD Address:

JOHNSTON LOGISTICS LTD Address:

Blackchurch Business Park, Rathcoole, Co. Dublin.

Tel: + 353 1 401 3333 Fax: + 353 1 458 8015 Email: info@jol.ie Web: www.johnstonlogistics.ie Type of Business: Logistics & distribution.

JVA ANALYTICAL LTD Address:

Tel: Fax: Email: Web: Contact:

Unit 1, Longmile Business Park, Longmile Road, Dublin 12.

(01) 456 9822 (01) 456 9825 sales@jva.ie www.jva.ie Managing Director: John Ryan

K

Tel: Fax: Email: Web: Contact:

Fax: Email: Web:

Tel: Fax: Email: Web: Contact:

Unit 6, Trinity Enterprise Centre, Pearse Street, Dublin 2.

(01) 677 6133 (01) 671 0135 info@lendac.ie www.lendac.ie lrs.lendac.ie Joint Managing Director: Don Lehane

LENNOX LABORATORY SUPPLIES LTD Address:

John F. Kennedy Drive, Naas Road, Dublin 12.

Tel: (01) 455 2201 Fax: (01) 450 7906 Email: sales@lennox.ie greg@lennox.ie Web: www.lennox.ie Type of Business: Laboratory suppliers.

Contact: Director: Gregory Kearns

LIANCO Address: Tel: Fax: Email: Web: Type of Business:

Contact:

Rathclaren, Kilbrittain, Co. Cork.

(023) 49681 087 260 5447 (023) 49677 lianco@iol.ie www.lianco.net Powder drying, processing, conveying, and containment.

Sales Director: Finbar Smith

NORMAN LAUDER LTD Address:

Tel:

Address:

L

KELLY SERVICES Address:

Dublin: Unit 4 Horizon Logistics Park, New Naul Road, Harristown, Swords, Co. Dublin.

Cork: Unit 4&5, South Ring West Business Park, Tramore Road, Co. Cork.

(01) 823 9600 (021) 497 5722 (01) 836 1111 (021) 497 5727 kwedub@ea.kwe.com kweork@ea.kwe.com www.kwe.com Sales Manager: Karl Oâ&#x20AC;&#x2122;Reilly

LENDAC DATA SYSTEMS LTD

20-21 Grafton Street, Dublin 2.

(01) 679 3111 086 822 0851 (01) 677 3048 swiftam@ kellyservices.ie www.kellyservices.ie

Tel: Fax: Email: Web: Contact:

2A Richview Office Park, Clonskeagh, Dublin 14.

(01) 260 0442 (01) 260 0675 sales@nll.ie www.nll.ie Sales Manager: Susan Ellis 68

LISTER MACHINE TOOLS LTD Address:

Tel: Fax: Email: Web:

PO Box 838, Bluebell Industrial Estate, Dublin 12.

(01) 450 8866 (01) 450 9836 sales@ listermachinetools.com www.listermachinetools.com

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 9

Type of Business: Contact:

Sales of machines, tools & associated equipment.

Liam Cashe

LOGSTRUP (IRELAND) LTD Address:

Dunmore Road, Tuam, Co. Galway.

Tel: (093) 70900 Fax: (093) 70901 Email: info@logstrup.ie Web: www.logstrup.com Type of Business: Maunfacturing Contact: General Manager: Sean Mulryan

Tel:

Fax:

M MANOTHERM LTD Address:

4 Walkinstown Road, Dublin 12.

Tel: (01) 452 2355 Fax: (01) 451 6919 Email: info@manotherm.ie Web: www.manothern.ie Type of Business: Distributors of controls and instrumentation.

Contact: Managing Director: R.C. Gilbert

MANPOWER IRELAND Address:

Dublin City Centre: 2nd Floor, 8 Harcourt Street, Dublin 2.

Dublin North: 29 North Street, Swords, Co. Dublin.

Dublin West: Unit 7, Tuansgate, The Square, Tallaght, Dublin 24.

Dublin South: Unit D12, The Cubes Plaza, Beacon Street Quarter, Sandyford, Dublin 18.

Cork: Carbery House, 67-69 South Mall Co. Cork.

Email: Web: Contact:

Limerick: 1 Michael Street, Co. Limerick.

Westmeath: 32 Austin Friars Street, Mullingar, Co. Westmeath.

(01) 645 5200 (01) 813 9782 (01) 405 7715 (01) 293 4666 (021) 427 9733 (061) 312 230 (044) 933 1016 (01) 645 5299 (01) 813 9787 (021) 427 9735 (061) 312 280 (044) 933 1018 scientificengineering@ manpower.ie www.manpower.ie Managing Director: Jason Kennedy Dublin Branch Manager: Deborah Mealy

MATHESON ORMSBY PRENTICE Address:

70 Sir John Rogerson’s Quay, Dublin 2.

Tel: (01) 232 2000 Fax: (01) 232 3333 Email: helen.middleton@mop.ie Web: www.mop.ie Type of Business: Law firm Contact: Helen Middleton, Associate

MEASOM FREER Address:

Tel: Fax: Email: Web: Contact:

37-41 Chartwell Drive, Wigston, Leicestershire LE18 2FL, UK. (0044) 1162 881588 (0044) 1162 813000 sales@measomfreer.co.uk www.measomfreer.co.uk Sales Director; Mark Freer 69

MICRO HYDRAULICS LTD/ MICRO INDUSTRIES IRELAND Address:

Dublin: 2003 Orchard Avenue, Citywest Business Campus, Dublin 24.

Cork: Unit 6/7 Cherrywood Business Park, Little Island, Co. Cork.

Tel: (01) 463 9000 Fax: (01) 410 5609 Email: info@microhydraulics.ie Web: www.microhydraulics.ie Type of Business: Sanitary hose, tube & accessories.

Contact: Sales Representative: Ralph Fitzsimons Sales Representative: Dave O’Donavan

MIELE IRELAND LTD Address:

Tel: Fax: Email: Web: Contact:

Broomhill Business Complex, Broomhill Road, Tallaght, Dublin 24.

(01) 461 0710 (01) 461 0797 info@miele.ie www.miele.ie Professional Sales Manager: Aidan Carey

MSL ENGINEERING LTD Address:

Rushbrooke Industrial Park, Cobh, Co. Cork.

Tel: (021) 481 5806 Fax: (021) 481 2965 Email: info@mslengineering.ie Type of Business: Mechanical engineering contractors.

Contact: Managing Director: Maurice McGrath

N NATIONAL CHEMICAL CO. LTD Address:

Tel: Fax:

NCC House, 42 Lower Leeson St., Dublin 2.

(01) 613 1400 (01) 634 0132

C O M PA N Y L I S T I N G S

IRISH PHARMACHEM 2008

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 10

IRISH PHARMACHEM 2008 C O M PA N Y L I S T I N G S

Email: info@ncc.ie Web: www.ncc.ie Type of Business: Distributor.

Contact: Commercial Director: Rosanna Duignan

Web: Contact:

NATIONAL INSTRUMENTS

Tel: Fax: Email: Web: Contact:

Measurement House, Newbury Business Park, London Road, Newbury, Berkshire, RG14 2PS. (01) 867 4374 (01) 867 4375 info.ie@ni.com www.ni.com/ireland Sales Manager Ireland: Seamus Casserly

Tel: Fax: Email: Web: Contact:

137 Slaney Close, Dublin Industrial Estate, Glasnevin, Dublin 11.

(01) 830 0288 (01) 830 0082 enquiry@ie.norgren.com www.ienorgren.com Field Sales Manager : Dave Whelan Technical Sales Supervisor: John Lanney

O

NEDERMAN LTD

OCON CHEMICALS LTD

Address:

Address:

Premier Business Centre, 3013 LakeDrive, Citywest Business Campus, Dublin 24.

Tel: (01) 469 3729 Fax: (01) 469 3321 Email: ciaran.wilkinson@ nederman.ie Web: www.nederman.ie Type of Business: Fume, Dust & Materials Handling.

Contact: Country Manager: Ciaran Wilkinson

Tel: Fax: Email: Web: Contact:

NEW ERA PACKAGING LTD Drogheda Industrial Estate, Donore Road, Drogheda, Co. Louth.

Tel: (041) 987 5600 Fax: (041) 983 4481 Email: enquiries@newera.ie Web: www.newera.ie Type of Business: Label printing.

Contact: Director: David Nevin Director: Peter Higgins

Address:

NITL Address: Tel: Fax: Email:

17 Herbert Street, Dublin 2.

(01) 669 0806 (01) 661 1943 edward.sweeney@dit.ie

Unit 5, South Cork Industrial Estate, Vicars Road, Pouladuff, Co. Cork.

(021) 431 8555 (021) 431 8560 sales@oconchemicals.com www.oconchemicals.com Managing Director: Frank Mulcahy

ODENBERG ENGINEERING LTD Address:

Tel: Fax: Email: Web: Contact:

TBA. Office Manager: Rob Arnold

P

NORGREN LTD Address:

Address:

www.nitl.ie Director of Learning: Edward Sweeney

2004 Orchard Avenue, Citywest Business Campus, Naas Road, Dublin 24.

(01) 413 6200 (01) 457 0219 info@odenberg.com www.odenberg.ie Business Unit Manager: Jimmy Deane

HANLON O’GRADY & CO. LTD Address:

Victoria House, Beaumont Avenue, Churchtown, Dublin 14.

Tel: (01) 295 1101 Fax: (01) 298 1790 Email: rarnold@tyco-valves.com Type of Business: Industrial valves & controls.

Contact: General Manager: 70

PEGLER & LOUDEN IRELAND A DIVISION OF BSS (IRELAND) LTD Address: Dublin: 301 South Circular Road, White Heather Industrial Estate, Dublin 8.

Tel: (01) 416 5170 Fax: (01) 416 5175 Email: jmelinn@pli.ie jgeraghty@pli.ie Web: www.fcx-pli.com Contact: Joe Melinn John Geraghty Pat Kelly John Quinn Cork: South Link Park, Ballycurreen Road Grange, Co. Cork.

Tel: (021) 497 7128 Fax: (021) 491 5213 Email: Cork: p.obrien@pli.ie p.cronin@pli.ie Web: www.fcx-pli.com Contact: Cork: Pat Cronin Pat O’Brien Colman Hesse

P.K. CHEMICALS LTD Address:

Unit 23, Sandyford Office Park, Blackthorn Avenue, Foxrock, Dublin 18.

Tel: (01) 295 6977 Fax: (01) 295 8338 Email: debbie@ pkchemicals.com Type of Business: Chemical distributor.

Contact: Accounts Administrator: Deborah Holmes

PLATE TEK ENGINEERING LTD Address:

IDA Industrial Estate, Kilmallock Road, Co. Cork.

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 11

Tel: (063) 21277 Fax: (063) 21280 Email: platetek@platetek.ie Web: www.platetek.ie Type of Business: Heat exchangers, supply, testing and certification.

Contact: General Manager: PJ Greensmith

Address:

Tel: Fax: Email: Web: Contact:

PM GROUP Address:

Tel: Fax: Email: Web: Contact:

Cork: Loughmahon Technology Park, Blackrock, Co. Cork.

Dublin: Killakee House, Belgard Square, Tallaght, Dublin 24.

(021) 435 8922 (01) 404 0700 (021) 435 8933 info@pmg.ie www.pmg.ie Billy O’Neill Paul Hallam Business Development

POLLUTION CONTROL SYSTEMS LTD Address:

Tel: Fax: Email: Web: Contact:

Raffeen House, Ringaskiddy, Co. Cork.

(021) 437 4237 (021) 437 4236 info@biotector.com www.biotector.com Managing Director: Martin Horan

PRIMEPAC LTD Unit 2, Caulside Drive, Newpark Industrial Estate, Antrim, BT41 2DU. Tel: (0044) 2894 428 188 Fax: (0044) 2894 428 177 Email: sales@primepacltd.com Web: www.primepacltd.com Type of Business: Manufacturer & supplier of plastic containers.

Contact: Director: John McGahon

S

PROSCON LTD Rushbrooke Commercial Park, Cobh, Co. Cork.

(021) 481 1802 (021) 481 1804 info@proscon.com www.proscon.com Michael Horkan Business Development Manager

PROSYS SAMPLING SYSTEMS LTD Address:

Tel: Fax: Email: Web: Contact:

Rosehill Business Centre, Midleton, Co. Cork.

(021) 461 3890 (021) 461 3891 info@prosys.ie www.prosys.ie Technical Director: Michael McLoughlin

SARTORIUS MECHATRONICS UK LTD Address:

Unit 41, The Business Centre, Stadium Business Park, Ballycoolin Road, Dublin 11.

Tel: (01) 808 9050 Fax: (01) 808 9388 Email: info.ireland@ sartorius.com Web: www.sartorius.ie Type of Business: Laboratory & process technology provider. Sales & service of laboratory & process weighing equipment.

Contact: Nick Parsons

SCHUF VALVE TECHNOLOGY

Q

Address:

QUITMANN O’NEILL PACKAGING LTD Address:

St. Brendan’s Road, Portumna, Co. Galway.

Tel: (09097) 41148/9 Fax: (09097) 41459 Email: sales@quitmannoneill.com Web: www.qonpack.com www.quitmannoneillpackaging.com Contact: General Manager: David O’Neill

R

Address:

THE RFT GROUP Address:

6A Old Dunleary Road, Dun Laoghaire, Co. Dublin.

Tel: (01) 230 2400 Email: jobs@rftgroup.ie Web: www.rftgroup.ie Type of Business: Recruitment Agency.

Contact: Managing Director: Gerry Kennedy

71

Tel: Fax: Email: Web: Contact:

Lehenaghmore, Togher, Co. Cork.

(021) 483 7000 (021) 483 7030 sales@schuf.ie www.schuf.com Managing Director: Wolfgang Frank

SCIENCE FOUNDATION IRELAND (SFI) Address:

Wilton Park House, Wilton Place, Dublin 2.

Tel: (01) 607 3200 Fax: (01) 607 3201 Email: info@sfi.ie Web: www.sfi.ie Type of Business: Government funding agency for research.

Contact: Head of Industry Research Development: Dr. Paul Dodd

SCIENCE RECRUITMENT IRELAND Address:

40 Grand Canal Street Upper, Dublin 4.

C O M PA N Y L I S T I N G S

IRISH PHARMACHEM 2008

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 12

IRISH PHARMACHEM 2008 C O M PA N Y L I S T I N G S

Tel: (01) 667 5008 Fax: (01) 667 6714 Email: info@sri.ie Web: www.sri.ie Type of Business: Specialist science recruitment agency.

Contact: Managing Director: Helen McGardle

SCIENTIFIC & CHEMICAL SUPPLIES LTD Address:

Eastlink House, Carrigtwohill, Co. Cork.

Tel: (021) 488 2388 Fax: (021) 488 2389 Email: cork@scichem.com Web: www.scichem.com Type of Business: Laboratory Suppliers.

Contact: Branch Manager: John Molloy

SEALPACK LTD Address:

Tel: Fax: Email: Web: Contact:

Jamestown Industrial Centre, Jamestown Rd, Inchicore, Dublin 8 (01) 453 4387 (01) 453 2051 info@sealpack.ie www.sealpack.ie Production: Alan Saul Marketing:Barry Saul Sales: Joe Saul

SHAW SCIENTIFIC LTD Address:

Tel: Fax: Email: Web: Contact:

Greenhills Industrial Estate, Walkinstown, Dublin 12.

(01) 450 4077 (01) 450 4328 seamus@shawscientific.com www.shawscientific.com Seamus Amond

SHELL CHEMICALS Address:

Tel: Fax: Email: Web: Contact:

C/o Cork Bulk Storage Limited, Tivoli Industrial Estate, Co. Cork.

(021) 491 8184 (021) 491 8184 mark.dalton@shell.com www.shell.com/chemicals Mark Dalton Solvents Sales Manager

SIEMENS LTD Address:

Fitzwilliam Court, Leeson Close, Dublin 2.

Tel: (01) 216 2000 Fax: (01) 216 2079 Email: industry.irl@siemens.com Web: www.siemens.ie Type of Business: Electrical engineering.

Contact: Sales Engineer: Liam Cotter General Manager: Domhnall Carroll

SIGMA-ALDRICH IRELAND LTD Address:

Airton Road, Tallaght, Dublin 24.

Tel: (01) 404 1900 Fax: (01) 404 1910 Email: safcei@sial.com Web: www.safcsupplysolutions.com Contact: Kate Buggle

SMURFIT KAPPA PACKAGING SOLUTIONS CORK Address:

Bolands Industrial Estate, Mallow Road, Co. Cork.

Tel: (021) 430 7122 Fax: (021) 430 7124 Email: garrett.quinn@ smurfitkappa.ie Type of Business: General packaging.

Contact: Plant Manager: Garrett Quinn

SOLTEC (IRELAND) LTD Address:

Tel: Fax: Email: Web: Contact:

SMURFIT KAPPA IRELAND Address:

Tel: Fax: Email: Web: Contact:

Ballymount Road, Walkinstown, Dublin 12.

(01) 409 0000 (01) 456 4506 info@smurfitkappa.ie www.smurfitkappa.ie Marketing Manager: Daragh Wall

Zone A, Mullingar Business Park, Mullingar, Co. Westmeath.

(044) 933 5133 (044) 934 5248 michael@soltec.ie www.soltec.ie Managing Director: Michael Corcoran

SUSTAINABLE ENERGY IRELAND Address:

Glasnevin, Dublin 9 Tel: (01) 836 9080 Fax: (01) 837 2848 Email: info@sei.ie Web: www.sei.ie Type of Business: Energy advice & information.

T SMURFIT KAPPA CORK Address:

Sitecast Industrial Estate, Pouladuff Road, Co. Cork.

Tel: (021) 496 2033 Fax: (021) 496 2051 Email: tim.odonoghue@ smurfitkappa.ie Web: www.smurfitkappa.ie Type of Business: Packaging supplies.

Contact: Regional Sales Manager: Tim Oâ&#x20AC;&#x2122;Donoghue

72

TOPCHEM LABORATORIES LTD Address:

70 Western Parkway Business Park, Ballymount Drive, Dublin 12.

Tel: (01) 460 8818 Fax: (01) 450 4833 Email: sales@topchemlabs.com dwalsh@topchem.ie Web: www.topchem.ie Type of Business: Chemical synthesis.

Contact: Managing Director: Dr. Donal Coveney

PC_Listings '08 WIP.qxd

23/09/2008

16:45

Page 13

TOYOTA MATERIALS HANDLING IRELAND

V

Address:

VEOLIA ENVIRONMENTAL SERVICES

Toyota Ireland, Killeen Road, Dublin 12.

Tel: (01) 419 0200 Fax: (01) 419 0325 Email: materialhandling@ toyota.ie Web: www.toyota-forklifts.ie Type of Business: Materials handling.

Contact: Sales Manager: Robert O’Reilly

WRENTECH LTD Address:

Address: Tel: Fax: Email: Web: Contact:

Ballymount Cross, Ballymount,Dublin 24.

(01) 413 6500 (01) 413 6502 info@veolia.ie www.veolia.ie Ian Mangan

Tel: Fax: Email: Web: Contact:

Wrentech House, Crosshaven Hill, Crosshaven, Co. Cork.

(021) 483 2644 (021) 483 1363 smurray@wrentech.ie www.wrentech.ie Sales Administrator: Siobhan Murray

Z

TURBOAIR Address:

Tel: Fax: Email: Web: Contact:

62 Cherry Orchard Industrial Estate, Dublin 10.

(01) 626 9500 (01) 623 7002 info@turboair.ie www.turboair.ie Director: John Jones

U

UNIVAR LTD 536 Grants Crescent, Greenogue Business Park, Rathcoole, Co. Dublin.

Tel: (01) 401 9800 Fax: (01) 401 9142 Email: pharma.sales@ univareurope.com Web: www.univareurope.com Type of Business: Ingredients pharma industry including API’s, excipients, process chems, solvents & intermediates.

Contact: Account Manager: John McCluskey

VIKING PUMP (EUROPE) LTD Address:

R79, Shannon Industrial Estate, Shannon, Co. Clare.

Tel: (061) 471 933 Fax: (061) 475 046 Email: coconnell @idexcorp.com Web: www.vikingpumpeurope.com Contact: Customer Service Administrator: Claire O’Connell

Portgate Business Park, Ringaskiddy, Co. Cork Tel: (021) 437 0200 Fax: (021) 437 0299 Email: peter.sheehan@ zenithtechnologies.com Web: www.zenithtechnologies.com Contact: Sales & Marketing Manager: Peter Sheehan

Address:

Address:

WEBER LABELLING & CODING

Tel: Fax: Email: Web: Contact:

Address:

ZETES BLACKBIRD

W

Address:

Zenith Technologies

Kilcannon Industrial Estate, Old Dublin Road, Enniscorthy, Co. Wexford.

(053) 923 3778 (053) 923 3284 sales@weberireland.com www.webermarking.com Area Sales Manager: Richard Smith

73

The National Technology Park, Plassey, Co. Limerick.

Tel: (061) 333 188 (01) 822 5123 Fax: (061) 333 133 Email info@ie.zetes.com Web: www.zetes.com/ie Type of Business: Systems Integrator of Supply Chain Automation and Inventory Management Solutions and Services.

Contact: Sales Manager: Barry Long

C O M PA N Y L I S T I N G S

IRISH PHARMACHEM 2008

Year Planner 2009

23/09/2008

16:10

Page 1

Ye a r P l a n n e r 2 0 0 9 SUN

MON

TUE

WED

1

J A N F E B M A R

THU

FRI

SAT

SUN

MON

WED

THU

FRI

SAT

SUN

MON

TUE

WED

2

3

4

5

6

7

8

9

10

11

12

13

14

6

7

8

9

10

11

12

13

14

15

16

17

18

15

16

17

18

Public Holiday

1

2

3

4

5

St. Valentine’s Day

1

2

3

4

5

6

7

8

9

10

11

12

13

14

St. Patrick’s Day

1

A P R

2

3

4

5

6

7

8

9

10

11

Good Friday

1

M A Y

2

3

4

12

13

Easter Sunday

Public Holiday

14

15

5

6

7

8

9

10

11

12

13

Public Holiday

1

J U N

2

3

4

5

6

7

8

9

10

11

12

13

14

15

17

17

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

1

2

3

4

5

6

7

8

9

10

11

12

Public Holiday

J U L A U G

Public Holiday

1

S E P

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

1

2

3

4

5

6

7

8

9

10

11

12

13

14

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

2

3

4

5

6

7

8

9

11

12

13

14

15

WED

THU

SAT

SUN

O C T N O V

TUE

1

2

3

1

D E C SUN

MON

TUE

FRI

MON

TUE

WED

10

THU

FRI

SAT

SUN

MON

TUE

16

WED

Year Planner 2009

THU

FRI

23/09/2008

16:10

Page 2

SAT

SUN

MON

TUE

WED

THU

FRI

SAT

15

16

17

18

19

20

21

22

23

24

19

20

21

22

23

24

25

26

27

28

26

27

28

SUN

25

MON

26

TUE

27

WED

28

THU

29

FRI

30

SAT

SUN

MON

31

J A N F E B

Ash Wednesday

19

20

21

22

23

24

25

29

30

31

M A R

Summer Time Begins

Mother’s Day

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

18

19

20

21

22

23

24

25

26

27

28

29

30

A P R 29

30

31

M A Y J U N

Father’s Day

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

17

18

19

20

21

22

23

24

25

26

27

28

29

30

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Summer Time Ends

Public Holiday

29

20

21

22

23

24

25

26

27

28

29

30

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

SUN

MON

TUE

WED

THU

THU

FRI

SAT

SUN

MON

TUE

WED

THU

St.Stephen’s Day

FRI

SAT

29

30

31

A U G S E P

19

Christmas Day

J U L

30

31

O C T N O V D E C

FRI

SAT

SUN

MON

Useful Refs_17.09.08.qxd

23/09/2008

16:12

Page 1

USEFUL REFERENCES

USEFUL REFERENCES ACADEMY OF MEDICAL LABORATORY SCIENCE Tel: (01) 677 5602 E-mail: mail@amls.ie Web: www.amls.ie

ENVIRONMENTAL HEALTH OFFICERS ASSOCIATION Tel: (01) 276 1211 E-mail: secretary@ehoa.ie Web: www.ehoa.ie

IRISH ASSOCIATION OF DISTRIBUTIVE TRADES Tel: (01) 288 7584 E-mail: rgdata@rgdata.ie Web: www.rgdata.ie

ADVISORY COUNCIL FOR SCIENCE, TECHNOLOGY & INNOVATION Tel: (01) 607 3162 E-mail: sciencecouncil@forfas.ie Web: www.sciencecouncil.ie

ENVIRONMENTAL PROTECTION AGENCY Tel: (053) 916 0600 E-mail: info@epa.ie Web: www.epa.ie

IRISH BIOINDUSTRY ASSOCIATION Tel: (01) 605 1584 E-mail: firstname.surname@ibec.ie Web: www.ibec.ie/ibia

AN BORD PLEANALA Tel: (01) 858 8100 LoCall: 1890 275 175 E-mail: bord@pleanala.ie Web: www.pleanala.ie CHAMBERS IRELAND Tel: (01) 400 4300 E-mail: info@chambers.ie Web: www.chambers.ie COMPANIES REGISTRATION OFFICE Tel: (01) 804 5200 LoCall: 1890 220 226 E-mail: info@cro.ie Web: www.cro.ie DEPT. OF CHEMICAL ENGINEERS, UCD Tel: (01) 716 1825 DEPT. OF ENTERPRISE, TRADE & EMPLOYMENT Tel: (01) 631 2121 LOCALL: 1890 220 222 E-mail: info@entemp.ie Web: www.entemp.ie DEPT. OF THE ENVIRONMENT, HERITAGE & LOCAL GOVERNMENT Tel: (01) 888 2000 LoCall: 1890 20 20 21 E-mail: press-office@environ.irlgov.ie Web: www.environ.ie ELECTRICITY SUPPLY BOARD Emergencies CallSave: 1850 37 29 99 Web: www.esb.ie ENTERPRISE IRELAND Tel: (01) 808 2000 E-mail: client.service@ enterprise-ireland.com Web: www.enterprise-ireland.com

EUROPEAN FEDERATION OF BIOTECHNOLOGY Tel: (01) 808 2692 E-mail: editor@biotechnologyireland.com www.biotechnologyireland.com

IRISH BUSINESS & EMPLOYERS CONFEDERATION (IBEC) Tel: (01) 605 1500 E-mail: info@ibec.ie Web: www.ibec.ie

FAS - TRAINING & EMPLOYMENT AGENCY Tel: (01) 607 0500 E-mail: info@fas.ie Web: www.fas.ie

IRISH CLEANROOM SOCIETY Tel: 087 285 9679 Web: www.cleanrooms-ireland.ie

FORFAS Tel: (01) 607 3000 E-mail: firstname.surname@forfas.ie Web: www.forfas.ie

IRISH COSMETICS, DETERGENT & ALLIED PRODUCTS ASSOCIATION Tel: (01) 605 1584 E-mail: firstname.surname@ibec.ie Web: www.ibec.ie

HEALTH AND SAFETY AUTHORITY Tel: 1890 289 389 E-mail: wcu@hsa.ie Web: www.hsa.ie

IRISH EXPORTERS ASSOCIATION Tel: (01) 661 282 E-mail: iea@irishexporters.ie Web: www.irishexporters.ie

HEALTH RESEARCH BOARD Tel: (01) 234 5000 E-mail: hrb@hrb.ie Web: www.hrb.ie

IRISH MEDICAL DEVICES ASSOCIATION Tel: (01) 605 1529 E-mail: imda@ibec.ie Web: www.ibec.ie/imda

HIGHER EDUCATION AUTHORITY Tel: (01) 231 7100 E-mail: info@hea.ie Web: www.hea.ie

IRISH MEDICINES BOARD Tel: (01) 676 4971 E-mail: imb@imb.ie Web: www.imb.ie

IDA - INDUSTRIAL DEVELOPMENT AGENCY Tel: (01) 603 4000 E-mail: idaireland@ida.ie Web: www.idaireland.com

IRISH NATIONAL ACCREDITATION BOARD Tel: (01) 607 3003 E-mail: inab@inab.ie Web: www.inab.ie

INSTITUTE OF CHEMISTRY OF IRELAND E-mail: info@instituteofchemistry.org www.instituteofchemistry.org

IRISH PATENTS OFFICE Tel: (056) 772 0111 E-mail: patlib@entemp.ie Web: www.patentsoffice.ie

76

IRISH PHARMACY UNION Tel: (01) 4936401 E-mail: firstname.surname@ipu.ie Web: www.ipu.ie IRISH VENTURE CAPITAL ASSOCIATION Tel: (01) 276 4647 E-mail: secretary@ivca.ie Web: www.ivca.ie INVEST NORTHERN IRELAND Tel: (028) 9023 9060 E-mail: eo@investni.com Web: www.investni.com MANDATE TRADE UNION Tel: (01) 874 6321 E-mail: mandate@mandate.ie Web: www.mandate.ie NATIONAL INSTITUTE FOR TRANSPORT & LOGISTICS (NITL) Tel: (01) 669 0806 E-mail: nitl@dit.ie Web: www.nitl.ie PHARMACHEMICAL IRELAND Tel: (01) 605 1584 E-mail: firstname.surname@ibec.ie Web: www.ibec.ie/ipcmf PHARMACEUTICAL SOCIETY OF IRELAND Tel: (01) 218 4000 E-mail: info@pharmaceuticalsociety.ie Web: www.pharmaceuticalsociety.ie REPAK Tel: (01) 467 0190 E-mail: info@repak.ie Web: www.repak.ie SCIENCE FOUNDATION IRELAND Tel: (01) 607 3201 E-mail: info@sfi..ie Web: www.sfi.ie TEAGASC Tel: (01) 805 9500 E-mail: firstname.surname@teagasc.ie Web: www.teagasc.ie

Wrentech ad

23/09/2008

17:03

Page 1

Your Solutions Provider

Wrentech House, Crosshaven Hill, Crosshaven, Co. Cork, Ireland Tel: 021 483 2644 Fax: 021 483 1363 Mobile: 087 696 3344 E-mail: mwren@wrentech.ie